Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:myopathia'
(id=15516265 ; fe=en:myopathia ; type=1 ; niveau=200 ; luminosité=2 ; somme entrante=1676 creation date=2020-10-23 touchdate=2025-09-02 00:58:38.000)
≈ 1634 relations sortantes

  1. en:myopathia -- r_associated #0: 35 / 1 -> atrophie
    n1=en:myopathia | n2=atrophie | rel=r_associated | relid=0 | w=35
  2. en:myopathia -- r_associated #0: 35 / 1 -> desmoïde
    n1=en:myopathia | n2=desmoïde | rel=r_associated | relid=0 | w=35
  3. en:myopathia -- r_associated #0: 35 / 1 -> en:myopathy
    n1=en:myopathia | n2=en:myopathy | rel=r_associated | relid=0 | w=35
  4. en:myopathia -- r_associated #0: 35 / 1 -> en:soft tissue disorder
    n1=en:myopathia | n2=en:soft tissue disorder | rel=r_associated | relid=0 | w=35
  5. en:myopathia -- r_associated #0: 35 / 1 -> glycogénose de type III
    n1=en:myopathia | n2=glycogénose de type III | rel=r_associated | relid=0 | w=35
  6. en:myopathia -- r_associated #0: 35 / 1 -> musculaire
    n1=en:myopathia | n2=musculaire | rel=r_associated | relid=0 | w=35
  7. en:myopathia -- r_associated #0: 35 / 1 -> myopathie à axes multiples
    n1=en:myopathia | n2=myopathie à axes multiples | rel=r_associated | relid=0 | w=35
  8. en:myopathia -- r_associated #0: 35 / 1 -> myopathie métabolique
    n1=en:myopathia | n2=myopathie métabolique | rel=r_associated | relid=0 | w=35
  9. en:myopathia -- r_associated #0: 35 / 1 -> myopathique
    n1=en:myopathia | n2=myopathique | rel=r_associated | relid=0 | w=35
  10. en:myopathia -- r_associated #0: 35 / 1 -> syndrome MEB
    n1=en:myopathia | n2=syndrome MEB | rel=r_associated | relid=0 | w=35
  11. en:myopathia -- r_associated #0: 34 / 0.971 -> dystrophie musculaire
    n1=en:myopathia | n2=dystrophie musculaire | rel=r_associated | relid=0 | w=34
  12. en:myopathia -- r_associated #0: 34 / 0.971 -> maladie dégénérative
    n1=en:myopathia | n2=maladie dégénérative | rel=r_associated | relid=0 | w=34
  13. en:myopathia -- r_associated #0: 34 / 0.971 -> myopathie de Duchenne
    n1=en:myopathia | n2=myopathie de Duchenne | rel=r_associated | relid=0 | w=34
  14. en:myopathia -- r_associated #0: 34 / 0.971 -> syndrome de Walker-Warburg
    n1=en:myopathia | n2=syndrome de Walker-Warburg | rel=r_associated | relid=0 | w=34
  15. en:myopathia -- r_associated #0: 33 / 0.943 -> affection musculaire
    n1=en:myopathia | n2=affection musculaire | rel=r_associated | relid=0 | w=33
  16. en:myopathia -- r_associated #0: 33 / 0.943 -> épilepsie myoclonique à fibres rouges en lambeau
    n1=en:myopathia | n2=épilepsie myoclonique à fibres rouges en lambeau | rel=r_associated | relid=0 | w=33
  17. en:myopathia -- r_associated #0: 33 / 0.943 -> maladie
    n1=en:myopathia | n2=maladie | rel=r_associated | relid=0 | w=33
  18. en:myopathia -- r_associated #0: 33 / 0.943 -> maladie héréditaire
    n1=en:myopathia | n2=maladie héréditaire | rel=r_associated | relid=0 | w=33
  19. en:myopathia -- r_associated #0: 33 / 0.943 -> myoadénylate désaminase
    n1=en:myopathia | n2=myoadénylate désaminase | rel=r_associated | relid=0 | w=33
  20. en:myopathia -- r_associated #0: 33 / 0.943 -> myofasciite à macrophages
    n1=en:myopathia | n2=myofasciite à macrophages | rel=r_associated | relid=0 | w=33
  21. en:myopathia -- r_associated #0: 33 / 0.943 -> myopathe (anesthésie d'un)
    n1=en:myopathia | n2=myopathe (anesthésie d'un) | rel=r_associated | relid=0 | w=33
  22. en:myopathia -- r_associated #0: 33 / 0.943 -> myopathie à bâtonnets
    n1=en:myopathia | n2=myopathie à bâtonnets | rel=r_associated | relid=0 | w=33
  23. en:myopathia -- r_associated #0: 33 / 0.943 -> pathologie
    (maladie)
    n1=en:myopathia | n2=pathologie
    (maladie)
    | rel=r_associated | relid=0 | w=33
  24. en:myopathia -- r_associated #0: 33 / 0.943 -> syndrome myopathique
    n1=en:myopathia | n2=syndrome myopathique | rel=r_associated | relid=0 | w=33
  25. en:myopathia -- r_associated #0: 33 / 0.943 -> xyphoïdalgie
    n1=en:myopathia | n2=xyphoïdalgie | rel=r_associated | relid=0 | w=33
  26. en:myopathia -- r_associated #0: 32 / 0.914 -> arthrogrypose
    n1=en:myopathia | n2=arthrogrypose | rel=r_associated | relid=0 | w=32
  27. en:myopathia -- r_associated #0: 32 / 0.914 -> en:central nervous system
    n1=en:myopathia | n2=en:central nervous system | rel=r_associated | relid=0 | w=32
  28. en:myopathia -- r_associated #0: 32 / 0.914 -> en:myonosus
    n1=en:myopathia | n2=en:myonosus | rel=r_associated | relid=0 | w=32
  29. en:myopathia -- r_associated #0: 32 / 0.914 -> encéphalomyopathie, acidose lactique et accidents vasculaires cérébraux
    n1=en:myopathia | n2=encéphalomyopathie, acidose lactique et accidents vasculaires cérébraux | rel=r_associated | relid=0 | w=32
  30. en:myopathia -- r_associated #0: 32 / 0.914 -> maladie génétique
    n1=en:myopathia | n2=maladie génétique | rel=r_associated | relid=0 | w=32
  31. en:myopathia -- r_associated #0: 32 / 0.914 -> PTPN22 gene
    n1=en:myopathia | n2=PTPN22 gene | rel=r_associated | relid=0 | w=32
  32. en:myopathia -- r_associated #0: 32 / 0.914 -> syndrome MELAS
    n1=en:myopathia | n2=syndrome MELAS | rel=r_associated | relid=0 | w=32
  33. en:myopathia -- r_associated #0: 32 / 0.914 -> syndrome Muscle-Eye-Brain
    n1=en:myopathia | n2=syndrome Muscle-Eye-Brain | rel=r_associated | relid=0 | w=32
  34. en:myopathia -- r_associated #0: 32 / 0.914 -> troubles musculaires
    n1=en:myopathia | n2=troubles musculaires | rel=r_associated | relid=0 | w=32
  35. en:myopathia -- r_associated #0: 31 / 0.886 -> en:other and unspecified myopathies
    n1=en:myopathia | n2=en:other and unspecified myopathies | rel=r_associated | relid=0 | w=31
  36. en:myopathia -- r_associated #0: 31 / 0.886 -> maladie du muscle
    n1=en:myopathia | n2=maladie du muscle | rel=r_associated | relid=0 | w=31
  37. en:myopathia -- r_associated #0: 31 / 0.886 -> médecine
    n1=en:myopathia | n2=médecine | rel=r_associated | relid=0 | w=31
  38. en:myopathia -- r_associated #0: 31 / 0.886 -> myopathies
    n1=en:myopathia | n2=myopathies | rel=r_associated | relid=0 | w=31
  39. en:myopathia -- r_associated #0: 30 / 0.857 -> en:musculoskeletal and connective tissue disorders
    n1=en:myopathia | n2=en:musculoskeletal and connective tissue disorders | rel=r_associated | relid=0 | w=30
  40. en:myopathia -- r_associated #0: 30 / 0.857 -> en:other disorders of muscle
    n1=en:myopathia | n2=en:other disorders of muscle | rel=r_associated | relid=0 | w=30
  41. en:myopathia -- r_associated #0: 30 / 0.857 -> maladie
    (médecine)
    n1=en:myopathia | n2=maladie
    (médecine)
    | rel=r_associated | relid=0 | w=30
  42. en:myopathia -- r_associated #0: 30 / 0.857 -> mérosine
    n1=en:myopathia | n2=mérosine | rel=r_associated | relid=0 | w=30
  43. en:myopathia -- r_associated #0: 30 / 0.857 -> myopathie oculaire
    n1=en:myopathia | n2=myopathie oculaire | rel=r_associated | relid=0 | w=30
  44. en:myopathia -- r_associated #0: 30 / 0.857 -> syndrome de Stormoken
    n1=en:myopathia | n2=syndrome de Stormoken | rel=r_associated | relid=0 | w=30
  45. en:myopathia -- r_associated #0: 29 / 0.829 -> muscles
    n1=en:myopathia | n2=muscles | rel=r_associated | relid=0 | w=29
  46. en:myopathia -- r_associated #0: 29 / 0.829 -> pathologie du muscle strié
    n1=en:myopathia | n2=pathologie du muscle strié | rel=r_associated | relid=0 | w=29
  47. en:myopathia -- r_associated #0: 29 / 0.829 -> processus pathologique
    n1=en:myopathia | n2=processus pathologique | rel=r_associated | relid=0 | w=29
  48. en:myopathia -- r_associated #0: 28 / 0.8 -> dystrophie
    n1=en:myopathia | n2=dystrophie | rel=r_associated | relid=0 | w=28
  49. en:myopathia -- r_associated #0: 28 / 0.8 -> en:muscular dystrophies and other myopathies
    n1=en:myopathia | n2=en:muscular dystrophies and other myopathies | rel=r_associated | relid=0 | w=28
  50. en:myopathia -- r_associated #0: 28 / 0.8 -> maladies des muscles
    n1=en:myopathia | n2=maladies des muscles | rel=r_associated | relid=0 | w=28
  51. en:myopathia -- r_associated #0: 28 / 0.8 -> myopathie multicore congénitale avec ophtalmoplégie externe
    n1=en:myopathia | n2=myopathie multicore congénitale avec ophtalmoplégie externe | rel=r_associated | relid=0 | w=28
  52. en:myopathia -- r_associated #0: 28 / 0.8 -> non précisée, myopathie
    n1=en:myopathia | n2=non précisée, myopathie | rel=r_associated | relid=0 | w=28
  53. en:myopathia -- r_associated #0: 28 / 0.8 -> PUS1 gene
    n1=en:myopathia | n2=PUS1 gene | rel=r_associated | relid=0 | w=28
  54. en:myopathia -- r_associated #0: 28 / 0.8 -> syndrome de Fukuyama
    n1=en:myopathia | n2=syndrome de Fukuyama | rel=r_associated | relid=0 | w=28
  55. en:myopathia -- r_associated #0: 27 / 0.771 -> affections musculaires
    n1=en:myopathia | n2=affections musculaires | rel=r_associated | relid=0 | w=27
  56. en:myopathia -- r_associated #0: 27 / 0.771 -> Duchenne (myopathie de)
    n1=en:myopathia | n2=Duchenne (myopathie de) | rel=r_associated | relid=0 | w=27
  57. en:myopathia -- r_associated #0: 27 / 0.771 -> en:musculoskeletal system disorder
    n1=en:myopathia | n2=en:musculoskeletal system disorder | rel=r_associated | relid=0 | w=27
  58. en:myopathia -- r_associated #0: 27 / 0.771 -> maladie de Steinert
    n1=en:myopathia | n2=maladie de Steinert | rel=r_associated | relid=0 | w=27
  59. en:myopathia -- r_associated #0: 27 / 0.771 -> maladie musculaire
    n1=en:myopathia | n2=maladie musculaire | rel=r_associated | relid=0 | w=27
  60. en:myopathia -- r_associated #0: 27 / 0.771 -> myopathie
    n1=en:myopathia | n2=myopathie | rel=r_associated | relid=0 | w=27
  61. en:myopathia -- r_associated #0: 27 / 0.771 -> myopathie de Becker
    n1=en:myopathia | n2=myopathie de Becker | rel=r_associated | relid=0 | w=27
  62. en:myopathia -- r_associated #0: 27 / 0.771 -> myopathie de Landouzy-Déjerine
    n1=en:myopathia | n2=myopathie de Landouzy-Déjerine | rel=r_associated | relid=0 | w=27
  63. en:myopathia -- r_associated #0: 27 / 0.771 -> myopathies congénitales
    n1=en:myopathia | n2=myopathies congénitales | rel=r_associated | relid=0 | w=27
  64. en:myopathia -- r_associated #0: 27 / 0.771 -> myopathy
    n1=en:myopathia | n2=myopathy | rel=r_associated | relid=0 | w=27
  65. en:myopathia -- r_associated #0: 26 / 0.743 -> atteinte musculaire
    n1=en:myopathia | n2=atteinte musculaire | rel=r_associated | relid=0 | w=26
  66. en:myopathia -- r_associated #0: 26 / 0.743 -> dystrophie myotonique de Steinert
    n1=en:myopathia | n2=dystrophie myotonique de Steinert | rel=r_associated | relid=0 | w=26
  67. en:myopathia -- r_associated #0: 26 / 0.743 -> en:atrophy
    n1=en:myopathia | n2=en:atrophy | rel=r_associated | relid=0 | w=26
  68. en:myopathia -- r_associated #0: 26 / 0.743 -> en:myositic disorders
    n1=en:myopathia | n2=en:myositic disorders | rel=r_associated | relid=0 | w=26
  69. en:myopathia -- r_associated #0: 26 / 0.743 -> maladie des muscles
    n1=en:myopathia | n2=maladie des muscles | rel=r_associated | relid=0 | w=26
  70. en:myopathia -- r_associated #0: 26 / 0.743 -> maladies
    n1=en:myopathia | n2=maladies | rel=r_associated | relid=0 | w=26
  71. en:myopathia -- r_associated #0: 26 / 0.743 -> maladies du muscle
    n1=en:myopathia | n2=maladies du muscle | rel=r_associated | relid=0 | w=26
  72. en:myopathia -- r_associated #0: 26 / 0.743 -> maladies musculaires
    n1=en:myopathia | n2=maladies musculaires | rel=r_associated | relid=0 | w=26
  73. en:myopathia -- r_associated #0: 26 / 0.743 -> myopathies distales
    n1=en:myopathia | n2=myopathies distales | rel=r_associated | relid=0 | w=26
  74. en:myopathia -- r_associated #0: 26 / 0.743 -> myopathies inflammatoires
    n1=en:myopathia | n2=myopathies inflammatoires | rel=r_associated | relid=0 | w=26
  75. en:myopathia -- r_associated #0: 26 / 0.743 -> syndrome de myopathie, cataracte, hypogonadisme
    n1=en:myopathia | n2=syndrome de myopathie, cataracte, hypogonadisme | rel=r_associated | relid=0 | w=26
  76. en:myopathia -- r_associated #0: 26 / 0.743 -> trouble musculaire
    n1=en:myopathia | n2=trouble musculaire | rel=r_associated | relid=0 | w=26
  77. en:myopathia -- r_associated #0: 26 / 0.743 -> YARS2 gene
    n1=en:myopathia | n2=YARS2 gene | rel=r_associated | relid=0 | w=26
  78. en:myopathia -- r_associated #0: 25 / 0.714 -> en:medicine
    n1=en:myopathia | n2=en:medicine | rel=r_associated | relid=0 | w=25
  79. en:myopathia -- r_associated #0: 20 / 0.571 -> myopathie atypique
    n1=en:myopathia | n2=myopathie atypique | rel=r_associated | relid=0 | w=20
  80. en:myopathia -- r_associated #0: 15 / 0.429 -> myopathie à multicore
    n1=en:myopathia | n2=myopathie à multicore | rel=r_associated | relid=0 | w=15
  81. en:myopathia -- r_associated #0: 15 / 0.429 -> myopathie de Leyden-Moebius
    n1=en:myopathia | n2=myopathie de Leyden-Moebius | rel=r_associated | relid=0 | w=15
  82. en:myopathia -- r_associated #0: 15 / 0.429 -> myopathie de Walton et Nattrass
    n1=en:myopathia | n2=myopathie de Walton et Nattrass | rel=r_associated | relid=0 | w=15
  83. en:myopathia -- r_associated #0: 15 / 0.429 -> myopathie distale de Gowers
    n1=en:myopathia | n2=myopathie distale de Gowers | rel=r_associated | relid=0 | w=15
  84. en:myopathia -- r_associated #0: 15 / 0.429 -> myopathie facioscapulohumérale de Landouzy-Déjerine
    n1=en:myopathia | n2=myopathie facioscapulohumérale de Landouzy-Déjerine | rel=r_associated | relid=0 | w=15
  85. en:myopathia -- r_associated #0: 15 / 0.429 -> myopathie sarcotubulaire
    n1=en:myopathia | n2=myopathie sarcotubulaire | rel=r_associated | relid=0 | w=15
  86. en:myopathia -- r_associated #0: 15 / 0.429 -> myopathie scapulopéronière
    n1=en:myopathia | n2=myopathie scapulopéronière | rel=r_associated | relid=0 | w=15
  87. en:myopathia -- r_associated #0: 15 / 0.429 -> nosologie
    n1=en:myopathia | n2=nosologie | rel=r_associated | relid=0 | w=15
  88. en:myopathia -- r_associated #0: 15 / 0.429 -> pathologie
    n1=en:myopathia | n2=pathologie | rel=r_associated | relid=0 | w=15
  89. en:myopathia -- r_associated #0: 10 / 0.286 -> dystrophy
    n1=en:myopathia | n2=dystrophy | rel=r_associated | relid=0 | w=10
  90. en:myopathia -- r_associated #0: 5 / 0.143 -> acidose lactique
    n1=en:myopathia | n2=acidose lactique | rel=r_associated | relid=0 | w=5
  91. en:myopathia -- r_associated #0: 5 / 0.143 -> amyotrophie
    n1=en:myopathia | n2=amyotrophie | rel=r_associated | relid=0 | w=5
  92. en:myopathia -- r_associated #0: 5 / 0.143 -> Arthrogrypose
    n1=en:myopathia | n2=Arthrogrypose | rel=r_associated | relid=0 | w=5
  93. en:myopathia -- r_associated #0: 5 / 0.143 -> ataxie
    n1=en:myopathia | n2=ataxie | rel=r_associated | relid=0 | w=5
  94. en:myopathia -- r_associated #0: 5 / 0.143 -> ataxie cérébelleuse cataracte
    n1=en:myopathia | n2=ataxie cérébelleuse cataracte | rel=r_associated | relid=0 | w=5
  95. en:myopathia -- r_associated #0: 5 / 0.143 -> ataxie cérébelleuse cataracte, surdité et démence ou psychose
    n1=en:myopathia | n2=ataxie cérébelleuse cataracte, surdité et démence ou psychose | rel=r_associated | relid=0 | w=5
  96. en:myopathia -- r_associated #0: 5 / 0.143 -> atrophie cérébelleuse retard mental et myopathie
    n1=en:myopathia | n2=atrophie cérébelleuse retard mental et myopathie | rel=r_associated | relid=0 | w=5
  97. en:myopathia -- r_associated #0: 5 / 0.143 -> atrophie musculaire
    n1=en:myopathia | n2=atrophie musculaire | rel=r_associated | relid=0 | w=5
  98. en:myopathia -- r_associated #0: 5 / 0.143 -> atrophie optique, cataracte, et troubles neurologiques
    n1=en:myopathia | n2=atrophie optique, cataracte, et troubles neurologiques | rel=r_associated | relid=0 | w=5
  99. en:myopathia -- r_associated #0: 5 / 0.143 -> atrophie optique, surdité, épilepsie, spasticité et décès précoce
    n1=en:myopathia | n2=atrophie optique, surdité, épilepsie, spasticité et décès précoce | rel=r_associated | relid=0 | w=5
  100. en:myopathia -- r_associated #0: 5 / 0.143 -> axes
    n1=en:myopathia | n2=axes | rel=r_associated | relid=0 | w=5
  101. en:myopathia -- r_associated #0: 5 / 0.143 -> bâtonnets (myopathie à )
    n1=en:myopathia | n2=bâtonnets (myopathie à ) | rel=r_associated | relid=0 | w=5
  102. en:myopathia -- r_associated #0: 5 / 0.143 -> Becker (myopathie de)
    n1=en:myopathia | n2=Becker (myopathie de) | rel=r_associated | relid=0 | w=5
  103. en:myopathia -- r_associated #0: 5 / 0.143 -> Bramwell (myopathie type)
    n1=en:myopathia | n2=Bramwell (myopathie type) | rel=r_associated | relid=0 | w=5
  104. en:myopathia -- r_associated #0: 5 / 0.143 -> cancer
    n1=en:myopathia | n2=cancer | rel=r_associated | relid=0 | w=5
  105. en:myopathia -- r_associated #0: 5 / 0.143 -> cancer
    (maladie)
    n1=en:myopathia | n2=cancer
    (maladie)
    | rel=r_associated | relid=0 | w=5
  106. en:myopathia -- r_associated #0: 5 / 0.143 -> cardiomyopathie
    n1=en:myopathia | n2=cardiomyopathie | rel=r_associated | relid=0 | w=5
  107. en:myopathia -- r_associated #0: 5 / 0.143 -> cataracte
    n1=en:myopathia | n2=cataracte | rel=r_associated | relid=0 | w=5
  108. en:myopathia -- r_associated #0: 5 / 0.143 -> cataracte juvénile, atrophie cérébelleuse, retard mental et myopathie
    n1=en:myopathia | n2=cataracte juvénile, atrophie cérébelleuse, retard mental et myopathie | rel=r_associated | relid=0 | w=5
  109. en:myopathia -- r_associated #0: 5 / 0.143 -> cataracte liée au sexe avec dent de Hutchinson
    n1=en:myopathia | n2=cataracte liée au sexe avec dent de Hutchinson | rel=r_associated | relid=0 | w=5
  110. en:myopathia -- r_associated #0: 5 / 0.143 -> cataracte non précisée
    n1=en:myopathia | n2=cataracte non précisée | rel=r_associated | relid=0 | w=5
  111. en:myopathia -- r_associated #0: 5 / 0.143 -> cataracte totale congénitale
    n1=en:myopathia | n2=cataracte totale congénitale | rel=r_associated | relid=0 | w=5
  112. en:myopathia -- r_associated #0: 5 / 0.143 -> cataracte-ataxie-surdité
    n1=en:myopathia | n2=cataracte-ataxie-surdité | rel=r_associated | relid=0 | w=5
  113. en:myopathia -- r_associated #0: 5 / 0.143 -> cataracte-ataxie-surdité et retard mental (syndrome)
    n1=en:myopathia | n2=cataracte-ataxie-surdité et retard mental (syndrome) | rel=r_associated | relid=0 | w=5
  114. en:myopathia -- r_associated #0: 5 / 0.143 -> cataracte-atrophie du cervelet-myopathie
    n1=en:myopathia | n2=cataracte-atrophie du cervelet-myopathie | rel=r_associated | relid=0 | w=5
  115. en:myopathia -- r_associated #0: 5 / 0.143 -> cataracte, bride orale aberrante et retard de croissance
    n1=en:myopathia | n2=cataracte, bride orale aberrante et retard de croissance | rel=r_associated | relid=0 | w=5
  116. en:myopathia -- r_associated #0: 5 / 0.143 -> cataracte, microcéphalie, arrêt de croissance et cyphoscoliose (syndrome)
    n1=en:myopathia | n2=cataracte, microcéphalie, arrêt de croissance et cyphoscoliose (syndrome) | rel=r_associated | relid=0 | w=5
  117. en:myopathia -- r_associated #0: 5 / 0.143 -> cataracte, microphtalmie et nystagmus
    n1=en:myopathia | n2=cataracte, microphtalmie et nystagmus | rel=r_associated | relid=0 | w=5
  118. en:myopathia -- r_associated #0: 5 / 0.143 -> cataractes
    n1=en:myopathia | n2=cataractes | rel=r_associated | relid=0 | w=5
  119. en:myopathia -- r_associated #0: 5 / 0.143 -> cécité
    n1=en:myopathia | n2=cécité | rel=r_associated | relid=0 | w=5
  120. en:myopathia -- r_associated #0: 5 / 0.143 -> ceintures (myopathie des)
    n1=en:myopathia | n2=ceintures (myopathie des) | rel=r_associated | relid=0 | w=5
  121. en:myopathia -- r_associated #0: 5 / 0.143 -> Celesia (myopathie type)
    n1=en:myopathia | n2=Celesia (myopathie type) | rel=r_associated | relid=0 | w=5
  122. en:myopathia -- r_associated #0: 5 / 0.143 -> centronucléaire (myopathie)
    n1=en:myopathia | n2=centronucléaire (myopathie) | rel=r_associated | relid=0 | w=5
  123. en:myopathia -- r_associated #0: 5 / 0.143 -> cervelet-myopathie
    n1=en:myopathia | n2=cervelet-myopathie | rel=r_associated | relid=0 | w=5
  124. en:myopathia -- r_associated #0: 5 / 0.143 -> ciliopathie
    n1=en:myopathia | n2=ciliopathie | rel=r_associated | relid=0 | w=5
  125. en:myopathia -- r_associated #0: 5 / 0.143 -> cils longs (syndrome des)
    n1=en:myopathia | n2=cils longs (syndrome des) | rel=r_associated | relid=0 | w=5
  126. en:myopathia -- r_associated #0: 5 / 0.143 -> cils longs et retard mental
    n1=en:myopathia | n2=cils longs et retard mental | rel=r_associated | relid=0 | w=5
  127. en:myopathia -- r_associated #0: 5 / 0.143 -> congénitale
    n1=en:myopathia | n2=congénitale | rel=r_associated | relid=0 | w=5
  128. en:myopathia -- r_associated #0: 5 / 0.143 -> Cushing (myopathie de la maladie de)
    n1=en:myopathia | n2=Cushing (myopathie de la maladie de) | rel=r_associated | relid=0 | w=5
  129. en:myopathia -- r_associated #0: 5 / 0.143 -> dermatose
    n1=en:myopathia | n2=dermatose | rel=r_associated | relid=0 | w=5
  130. en:myopathia -- r_associated #0: 5 / 0.143 -> dextrinose limite
    n1=en:myopathia | n2=dextrinose limite | rel=r_associated | relid=0 | w=5
  131. en:myopathia -- r_associated #0: 5 / 0.143 -> distrophie
    n1=en:myopathia | n2=distrophie | rel=r_associated | relid=0 | w=5
  132. en:myopathia -- r_associated #0: 5 / 0.143 -> douleur musculaire
    n1=en:myopathia | n2=douleur musculaire | rel=r_associated | relid=0 | w=5
  133. en:myopathia -- r_associated #0: 5 / 0.143 -> Duchenne (myopathie de) l
    n1=en:myopathia | n2=Duchenne (myopathie de) l | rel=r_associated | relid=0 | w=5
  134. en:myopathia -- r_associated #0: 5 / 0.143 -> dystonie myotonique de Steinert
    n1=en:myopathia | n2=dystonie myotonique de Steinert | rel=r_associated | relid=0 | w=5
  135. en:myopathia -- r_associated #0: 5 / 0.143 -> dystrophie musculaire congénitale, cataracte infantile et hypogonadisme
    n1=en:myopathia | n2=dystrophie musculaire congénitale, cataracte infantile et hypogonadisme | rel=r_associated | relid=0 | w=5
  136. en:myopathia -- r_associated #0: 5 / 0.143 -> dystrophie myotonique
    n1=en:myopathia | n2=dystrophie myotonique | rel=r_associated | relid=0 | w=5
  137. en:myopathia -- r_associated #0: 5 / 0.143 -> Dystrophie myotonique de Steinert
    n1=en:myopathia | n2=Dystrophie myotonique de Steinert | rel=r_associated | relid=0 | w=5
  138. en:myopathia -- r_associated #0: 5 / 0.143 -> en:a subset of patients develop bilateral weakness
    n1=en:myopathia | n2=en:a subset of patients develop bilateral weakness | rel=r_associated | relid=0 | w=5
  139. en:myopathia -- r_associated #0: 5 / 0.143 -> en:a subset of patients have aggravation on cold exposure ('cold paresis')
    n1=en:myopathia | n2=en:a subset of patients have aggravation on cold exposure ('cold paresis') | rel=r_associated | relid=0 | w=5
  140. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abdominal muscle hypoplasia
    n1=en:myopathia | n2=en:abdominal muscle hypoplasia | rel=r_associated | relid=0 | w=5
  141. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abdominal wall muscle weakness (later onset)
    n1=en:myopathia | n2=en:abdominal wall muscle weakness (later onset) | rel=r_associated | relid=0 | w=5
  142. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal aggregation of mitochondria
    n1=en:myopathia | n2=en:abnormal aggregation of mitochondria | rel=r_associated | relid=0 | w=5
  143. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal axons with sprouting and swelling
    n1=en:myopathia | n2=en:abnormal axons with sprouting and swelling | rel=r_associated | relid=0 | w=5
  144. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal changes in the organization of the sarcolemma and the subsarcolemmal membrane cytoskeleton
    n1=en:myopathia | n2=en:abnormal changes in the organization of the sarcolemma and the subsarcolemmal membrane cytoskeleton | rel=r_associated | relid=0 | w=5
  145. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal distribution of subcutaneous fat
    n1=en:myopathia | n2=en:abnormal distribution of subcutaneous fat | rel=r_associated | relid=0 | w=5
  146. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal fat accumulation below the triceps (in some patients)
    n1=en:myopathia | n2=en:abnormal fat accumulation below the triceps (in some patients) | rel=r_associated | relid=0 | w=5
  147. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal fat accumulation in axillae (in some patients)
    n1=en:myopathia | n2=en:abnormal fat accumulation in axillae (in some patients) | rel=r_associated | relid=0 | w=5
  148. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal fat accumulation in the back (in some patients)
    n1=en:myopathia | n2=en:abnormal fat accumulation in the back (in some patients) | rel=r_associated | relid=0 | w=5
  149. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal fat distribution
    n1=en:myopathia | n2=en:abnormal fat distribution | rel=r_associated | relid=0 | w=5
  150. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal fiber size variation seen on muscle biopsy
    n1=en:myopathia | n2=en:abnormal fiber size variation seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  151. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal glycosylation of alpha-dystroglycan seen on muscle biopsy
    n1=en:myopathia | n2=en:abnormal glycosylation of alpha-dystroglycan seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  152. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal iron deposition in mitochondria
    n1=en:myopathia | n2=en:abnormal iron deposition in mitochondria | rel=r_associated | relid=0 | w=5
  153. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal irregular myofibrillar network
    n1=en:myopathia | n2=en:abnormal irregular myofibrillar network | rel=r_associated | relid=0 | w=5
  154. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal mitochondria
    n1=en:myopathia | n2=en:abnormal mitochondria | rel=r_associated | relid=0 | w=5
  155. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal mitochondria in skeletal muscle biopsy
    n1=en:myopathia | n2=en:abnormal mitochondria in skeletal muscle biopsy | rel=r_associated | relid=0 | w=5
  156. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal mitochondria with loss of cristae
    n1=en:myopathia | n2=en:abnormal mitochondria with loss of cristae | rel=r_associated | relid=0 | w=5
  157. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal mitochondria with paracrystalline inclusions seen on muscle biopsy
    n1=en:myopathia | n2=en:abnormal mitochondria with paracrystalline inclusions seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  158. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal mitochondrial morphology
    n1=en:myopathia | n2=en:abnormal mitochondrial morphology | rel=r_associated | relid=0 | w=5
  159. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal mitochondrial proliferation
    n1=en:myopathia | n2=en:abnormal mitochondrial proliferation | rel=r_associated | relid=0 | w=5
  160. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal muscle fibers with amorphous, granular, or hyaline deposits
    n1=en:myopathia | n2=en:abnormal muscle fibers with amorphous, granular, or hyaline deposits | rel=r_associated | relid=0 | w=5
  161. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal sarcoplasmic reticulum elements
    n1=en:myopathia | n2=en:abnormal sarcoplasmic reticulum elements | rel=r_associated | relid=0 | w=5
  162. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormal subcutaneous fat tissue distribution
    n1=en:myopathia | n2=en:abnormal subcutaneous fat tissue distribution | rel=r_associated | relid=0 | w=5
  163. en:myopathia -- r_associated #0: 5 / 0.143 -> en:abnormalities in myofibril organization
    n1=en:myopathia | n2=en:abnormalities in myofibril organization | rel=r_associated | relid=0 | w=5
  164. en:myopathia -- r_associated #0: 5 / 0.143 -> en:absence of gamma-sarcoglycan protein
    n1=en:myopathia | n2=en:absence of gamma-sarcoglycan protein | rel=r_associated | relid=0 | w=5
  165. en:myopathia -- r_associated #0: 5 / 0.143 -> en:absence of laminin alpha-2 chain in muscle
    n1=en:myopathia | n2=en:absence of laminin alpha-2 chain in muscle | rel=r_associated | relid=0 | w=5
  166. en:myopathia -- r_associated #0: 5 / 0.143 -> en:absence of merosin in muscle
    n1=en:myopathia | n2=en:absence of merosin in muscle | rel=r_associated | relid=0 | w=5
  167. en:myopathia -- r_associated #0: 5 / 0.143 -> en:absence of myotonia in infancy (congenital form)
    n1=en:myopathia | n2=en:absence of myotonia in infancy (congenital form) | rel=r_associated | relid=0 | w=5
  168. en:myopathia -- r_associated #0: 5 / 0.143 -> en:absence of necrosis
    n1=en:myopathia | n2=en:absence of necrosis | rel=r_associated | relid=0 | w=5
  169. en:myopathia -- r_associated #0: 5 / 0.143 -> en:absence of some scapular muscles (less common)
    n1=en:myopathia | n2=en:absence of some scapular muscles (less common) | rel=r_associated | relid=0 | w=5
  170. en:myopathia -- r_associated #0: 5 / 0.143 -> en:absence of spontaneous activity at birth (severe form)
    n1=en:myopathia | n2=en:absence of spontaneous activity at birth (severe form) | rel=r_associated | relid=0 | w=5
  171. en:myopathia -- r_associated #0: 5 / 0.143 -> en:absence of telethonin protein
    n1=en:myopathia | n2=en:absence of telethonin protein | rel=r_associated | relid=0 | w=5
  172. en:myopathia -- r_associated #0: 5 / 0.143 -> en:accumulated lipid droplets seen on muscle biopsy
    n1=en:myopathia | n2=en:accumulated lipid droplets seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  173. en:myopathia -- r_associated #0: 5 / 0.143 -> en:accumulation of abnormal mitochondria
    n1=en:myopathia | n2=en:accumulation of abnormal mitochondria | rel=r_associated | relid=0 | w=5
  174. en:myopathia -- r_associated #0: 5 / 0.143 -> en:accumulation of intrasarcoplasmic granulofilamentous aggregates that are immunoreactive to desmin and alpha-beta-crystallin
    n1=en:myopathia | n2=en:accumulation of intrasarcoplasmic granulofilamentous aggregates that are immunoreactive to desmin and alpha-beta-crystallin | rel=r_associated | relid=0 | w=5
  175. en:myopathia -- r_associated #0: 5 / 0.143 -> en:acetazolamide may worsen symptoms
    n1=en:myopathia | n2=en:acetazolamide may worsen symptoms | rel=r_associated | relid=0 | w=5
  176. en:myopathia -- r_associated #0: 5 / 0.143 -> en:acquire ability to walk and jump in childhood, but motor regression occurs later
    n1=en:myopathia | n2=en:acquire ability to walk and jump in childhood, but motor regression occurs later | rel=r_associated | relid=0 | w=5
  177. en:myopathia -- r_associated #0: 5 / 0.143 -> en:acute rhabdomyolysis
    n1=en:myopathia | n2=en:acute rhabdomyolysis | rel=r_associated | relid=0 | w=5
  178. en:myopathia -- r_associated #0: 5 / 0.143 -> en:adhalin deficiency seen on muscle biopsy
    n1=en:myopathia | n2=en:adhalin deficiency seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  179. en:myopathia -- r_associated #0: 5 / 0.143 -> en:adipose tissue shows many adipocytes with multiple small lipid droplets rather than a normal single lipid droplet
    n1=en:myopathia | n2=en:adipose tissue shows many adipocytes with multiple small lipid droplets rather than a normal single lipid droplet | rel=r_associated | relid=0 | w=5
  180. en:myopathia -- r_associated #0: 5 / 0.143 -> en:affected muscles show atrophy
    n1=en:myopathia | n2=en:affected muscles show atrophy | rel=r_associated | relid=0 | w=5
  181. en:myopathia -- r_associated #0: 5 / 0.143 -> en:aggregates contain granular electron-dense material
    n1=en:myopathia | n2=en:aggregates contain granular electron-dense material | rel=r_associated | relid=0 | w=5
  182. en:myopathia -- r_associated #0: 5 / 0.143 -> en:agnosia
    n1=en:myopathia | n2=en:agnosia | rel=r_associated | relid=0 | w=5
  183. en:myopathia -- r_associated #0: 5 / 0.143 -> en:alimentary edema
    n1=en:myopathia | n2=en:alimentary edema | rel=r_associated | relid=0 | w=5
  184. en:myopathia -- r_associated #0: 5 / 0.143 -> en:amyloid deposition in muscle fibers occurs rarely
    n1=en:myopathia | n2=en:amyloid deposition in muscle fibers occurs rarely | rel=r_associated | relid=0 | w=5
  185. en:myopathia -- r_associated #0: 5 / 0.143 -> en:amyotrophy of the lower limbs (in some patients)
    n1=en:myopathia | n2=en:amyotrophy of the lower limbs (in some patients) | rel=r_associated | relid=0 | w=5
  186. en:myopathia -- r_associated #0: 5 / 0.143 -> en:amyotrophy of the upper limbs (in some patients)
    n1=en:myopathia | n2=en:amyotrophy of the upper limbs (in some patients) | rel=r_associated | relid=0 | w=5
  187. en:myopathia -- r_associated #0: 5 / 0.143 -> en:amyotrophy, distal, upper and lower limbs
    n1=en:myopathia | n2=en:amyotrophy, distal, upper and lower limbs | rel=r_associated | relid=0 | w=5
  188. en:myopathia -- r_associated #0: 5 / 0.143 -> en:amyotrophy, neurogenic
    n1=en:myopathia | n2=en:amyotrophy, neurogenic | rel=r_associated | relid=0 | w=5
  189. en:myopathia -- r_associated #0: 5 / 0.143 -> en:anasarca
    n1=en:myopathia | n2=en:anasarca | rel=r_associated | relid=0 | w=5
  190. en:myopathia -- r_associated #0: 5 / 0.143 -> en:and congenital blindness
    n1=en:myopathia | n2=en:and congenital blindness | rel=r_associated | relid=0 | w=5
  191. en:myopathia -- r_associated #0: 5 / 0.143 -> en:and myopathy
    n1=en:myopathia | n2=en:and myopathy | rel=r_associated | relid=0 | w=5
  192. en:myopathia -- r_associated #0: 5 / 0.143 -> en:and ocular and facial abnormalities
    n1=en:myopathia | n2=en:and ocular and facial abnormalities | rel=r_associated | relid=0 | w=5
  193. en:myopathia -- r_associated #0: 5 / 0.143 -> en:and stroke-like episodes
    n1=en:myopathia | n2=en:and stroke-like episodes | rel=r_associated | relid=0 | w=5
  194. en:myopathia -- r_associated #0: 5 / 0.143 -> en:angular atrophic fibers
    n1=en:myopathia | n2=en:angular atrophic fibers | rel=r_associated | relid=0 | w=5
  195. en:myopathia -- r_associated #0: 5 / 0.143 -> en:angulated atrophic fibers
    n1=en:myopathia | n2=en:angulated atrophic fibers | rel=r_associated | relid=0 | w=5
  196. en:myopathia -- r_associated #0: 5 / 0.143 -> en:angulated atrophic muscle fibers
    n1=en:myopathia | n2=en:angulated atrophic muscle fibers | rel=r_associated | relid=0 | w=5
  197. en:myopathia -- r_associated #0: 5 / 0.143 -> en:angulated fibers
    n1=en:myopathia | n2=en:angulated fibers | rel=r_associated | relid=0 | w=5
  198. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ankle reflex absent
    n1=en:myopathia | n2=en:ankle reflex absent | rel=r_associated | relid=0 | w=5
  199. en:myopathia -- r_associated #0: 5 / 0.143 -> en:anterior tibial muscles first involved
    n1=en:myopathia | n2=en:anterior tibial muscles first involved | rel=r_associated | relid=0 | w=5
  200. en:myopathia -- r_associated #0: 5 / 0.143 -> en:apoptotic nuclei
    n1=en:myopathia | n2=en:apoptotic nuclei | rel=r_associated | relid=0 | w=5
  201. en:myopathia -- r_associated #0: 5 / 0.143 -> en:apraxias
    n1=en:myopathia | n2=en:apraxias | rel=r_associated | relid=0 | w=5
  202. en:myopathia -- r_associated #0: 5 / 0.143 -> en:areflexia due to muscle weakness
    n1=en:myopathia | n2=en:areflexia due to muscle weakness | rel=r_associated | relid=0 | w=5
  203. en:myopathia -- r_associated #0: 5 / 0.143 -> en:areflexia of lower limbs
    n1=en:myopathia | n2=en:areflexia of lower limbs | rel=r_associated | relid=0 | w=5
  204. en:myopathia -- r_associated #0: 5 / 0.143 -> en:arm/shoulder muscle hypoplasia
    n1=en:myopathia | n2=en:arm/shoulder muscle hypoplasia | rel=r_associated | relid=0 | w=5
  205. en:myopathia -- r_associated #0: 5 / 0.143 -> en:arthrogryposis
    n1=en:myopathia | n2=en:arthrogryposis | rel=r_associated | relid=0 | w=5
  206. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ascending muscle weakness (beginning with feet and legs)
    n1=en:myopathia | n2=en:ascending muscle weakness (beginning with feet and legs) | rel=r_associated | relid=0 | w=5
  207. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ascites (in some patients)
    n1=en:myopathia | n2=en:ascites (in some patients) | rel=r_associated | relid=0 | w=5
  208. en:myopathia -- r_associated #0: 5 / 0.143 -> en:aspects of mortality statistics
    n1=en:myopathia | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=5
  209. en:myopathia -- r_associated #0: 5 / 0.143 -> en:aspects of radionuclide imaging
    n1=en:myopathia | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=5
  210. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ataxia
    n1=en:myopathia | n2=en:ataxia | rel=r_associated | relid=0 | w=5
  211. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophia
    n1=en:myopathia | n2=en:atrophia | rel=r_associated | relid=0 | w=5
  212. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophic calf muscles
    n1=en:myopathia | n2=en:atrophic calf muscles | rel=r_associated | relid=0 | w=5
  213. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophic fibers
    n1=en:myopathia | n2=en:atrophic fibers | rel=r_associated | relid=0 | w=5
  214. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophic muscle fiber on biopsy
    n1=en:myopathia | n2=en:atrophic muscle fiber on biopsy | rel=r_associated | relid=0 | w=5
  215. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophic muscle fibers
    n1=en:myopathia | n2=en:atrophic muscle fibers | rel=r_associated | relid=0 | w=5
  216. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy of ankle and toe extensor (dorsiflexor) muscles
    n1=en:myopathia | n2=en:atrophy of ankle and toe extensor (dorsiflexor) muscles | rel=r_associated | relid=0 | w=5
  217. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy of anterior compartment tibial muscles
    n1=en:myopathia | n2=en:atrophy of anterior compartment tibial muscles | rel=r_associated | relid=0 | w=5
  218. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy of neck muscles may occur later
    n1=en:myopathia | n2=en:atrophy of neck muscles may occur later | rel=r_associated | relid=0 | w=5
  219. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy of shins
    n1=en:myopathia | n2=en:atrophy of shins | rel=r_associated | relid=0 | w=5
  220. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy of the intrinsic foot and hand muscles
    n1=en:myopathia | n2=en:atrophy of the intrinsic foot and hand muscles | rel=r_associated | relid=0 | w=5
  221. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy of the muscles in the anterior compartment of the lower leg
    n1=en:myopathia | n2=en:atrophy of the muscles in the anterior compartment of the lower leg | rel=r_associated | relid=0 | w=5
  222. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy of the small muscles in the hands and feet
    n1=en:myopathia | n2=en:atrophy of the small muscles in the hands and feet | rel=r_associated | relid=0 | w=5
  223. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy of the thenar and hypothenar muscles
    n1=en:myopathia | n2=en:atrophy of the thenar and hypothenar muscles | rel=r_associated | relid=0 | w=5
  224. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy of type 1 and type 2 fibers
    n1=en:myopathia | n2=en:atrophy of type 1 and type 2 fibers | rel=r_associated | relid=0 | w=5
  225. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy of upper girdle muscles
    n1=en:myopathia | n2=en:atrophy of upper girdle muscles | rel=r_associated | relid=0 | w=5
  226. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy, mild (in some cases)
    n1=en:myopathia | n2=en:atrophy, mild (in some cases) | rel=r_associated | relid=0 | w=5
  227. en:myopathia -- r_associated #0: 5 / 0.143 -> en:atrophy, neurogenic muscular
    n1=en:myopathia | n2=en:atrophy, neurogenic muscular | rel=r_associated | relid=0 | w=5
  228. en:myopathia -- r_associated #0: 5 / 0.143 -> en:attacks last 4 to 24 hours
    n1=en:myopathia | n2=en:attacks last 4 to 24 hours | rel=r_associated | relid=0 | w=5
  229. en:myopathia -- r_associated #0: 5 / 0.143 -> en:attacks precipitated by cold temperature
    n1=en:myopathia | n2=en:attacks precipitated by cold temperature | rel=r_associated | relid=0 | w=5
  230. en:myopathia -- r_associated #0: 5 / 0.143 -> en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise
    n1=en:myopathia | n2=en:attacks precipitated by hypokalemia, administration of glucose or insulin, heavy carbohydrate consumption, stress, fatigue, rest after exercise | rel=r_associated | relid=0 | w=5
  231. en:myopathia -- r_associated #0: 5 / 0.143 -> en:attacks precipitated by potassium
    n1=en:myopathia | n2=en:attacks precipitated by potassium | rel=r_associated | relid=0 | w=5
  232. en:myopathia -- r_associated #0: 5 / 0.143 -> en:attacks precipitated by rest after exercise
    n1=en:myopathia | n2=en:attacks precipitated by rest after exercise | rel=r_associated | relid=0 | w=5
  233. en:myopathia -- r_associated #0: 5 / 0.143 -> en:attacks relieved by potassium administration
    n1=en:myopathia | n2=en:attacks relieved by potassium administration | rel=r_associated | relid=0 | w=5
  234. en:myopathia -- r_associated #0: 5 / 0.143 -> en:attacks usually decrease or disappear after age 40 years
    n1=en:myopathia | n2=en:attacks usually decrease or disappear after age 40 years | rel=r_associated | relid=0 | w=5
  235. en:myopathia -- r_associated #0: 5 / 0.143 -> en:autophagic rimmed vacuoles
    n1=en:myopathia | n2=en:autophagic rimmed vacuoles | rel=r_associated | relid=0 | w=5
  236. en:myopathia -- r_associated #0: 5 / 0.143 -> en:autophagic vacuoles seen on biopsy (in some patients)
    n1=en:myopathia | n2=en:autophagic vacuoles seen on biopsy (in some patients) | rel=r_associated | relid=0 | w=5
  237. en:myopathia -- r_associated #0: 5 / 0.143 -> en:autophagic vacuoles with multilamellar structures seen on electron microscopy
    n1=en:myopathia | n2=en:autophagic vacuoles with multilamellar structures seen on electron microscopy | rel=r_associated | relid=0 | w=5
  238. en:myopathia -- r_associated #0: 5 / 0.143 -> en:autophagosome
    n1=en:myopathia | n2=en:autophagosome | rel=r_associated | relid=0 | w=5
  239. en:myopathia -- r_associated #0: 5 / 0.143 -> en:axial hypotonia (in some patients)
    n1=en:myopathia | n2=en:axial hypotonia (in some patients) | rel=r_associated | relid=0 | w=5
  240. en:myopathia -- r_associated #0: 5 / 0.143 -> en:axial muscle hyperextension, episodic
    n1=en:myopathia | n2=en:axial muscle hyperextension, episodic | rel=r_associated | relid=0 | w=5
  241. en:myopathia -- r_associated #0: 5 / 0.143 -> en:axial muscle weakness
    n1=en:myopathia | n2=en:axial muscle weakness | rel=r_associated | relid=0 | w=5
  242. en:myopathia -- r_associated #0: 5 / 0.143 -> en:axial weakness
    n1=en:myopathia | n2=en:axial weakness | rel=r_associated | relid=0 | w=5
  243. en:myopathia -- r_associated #0: 5 / 0.143 -> en:Becker's muscular dystrophy
    n1=en:myopathia | n2=en:Becker's muscular dystrophy | rel=r_associated | relid=0 | w=5
  244. en:myopathia -- r_associated #0: 5 / 0.143 -> en:benign soft tissue developmental anomalies
    n1=en:myopathia | n2=en:benign soft tissue developmental anomalies | rel=r_associated | relid=0 | w=5
  245. en:myopathia -- r_associated #0: 5 / 0.143 -> en:berardinelli-seip congenital lipodystrophy
    n1=en:myopathia | n2=en:berardinelli-seip congenital lipodystrophy | rel=r_associated | relid=0 | w=5
  246. en:myopathia -- r_associated #0: 5 / 0.143 -> en:biceps aplasia
    n1=en:myopathia | n2=en:biceps aplasia | rel=r_associated | relid=0 | w=5
  247. en:myopathia -- r_associated #0: 5 / 0.143 -> en:biceps brachii atrophy
    n1=en:myopathia | n2=en:biceps brachii atrophy | rel=r_associated | relid=0 | w=5
  248. en:myopathia -- r_associated #0: 5 / 0.143 -> en:bilateral facial weakness (congenital form)
    n1=en:myopathia | n2=en:bilateral facial weakness (congenital form) | rel=r_associated | relid=0 | w=5
  249. en:myopathia -- r_associated #0: 5 / 0.143 -> en:bilateral foot drop
    n1=en:myopathia | n2=en:bilateral foot drop | rel=r_associated | relid=0 | w=5
  250. en:myopathia -- r_associated #0: 5 / 0.143 -> en:biopsy muscle normal
    n1=en:myopathia | n2=en:biopsy muscle normal | rel=r_associated | relid=0 | w=5
  251. en:myopathia -- r_associated #0: 5 / 0.143 -> en:biopsy of adipose tissue shows reduced adipocyte size
    n1=en:myopathia | n2=en:biopsy of adipose tissue shows reduced adipocyte size | rel=r_associated | relid=0 | w=5
  252. en:myopathia -- r_associated #0: 5 / 0.143 -> en:biopsy shows defects in pyruvate oxidation
    n1=en:myopathia | n2=en:biopsy shows defects in pyruvate oxidation | rel=r_associated | relid=0 | w=5
  253. en:myopathia -- r_associated #0: 5 / 0.143 -> en:biopsy shows dystrophic changes
    n1=en:myopathia | n2=en:biopsy shows dystrophic changes | rel=r_associated | relid=0 | w=5
  254. en:myopathia -- r_associated #0: 5 / 0.143 -> en:biopsy shows myopathic and dystrophic changes
    n1=en:myopathia | n2=en:biopsy shows myopathic and dystrophic changes | rel=r_associated | relid=0 | w=5
  255. en:myopathia -- r_associated #0: 5 / 0.143 -> en:biopsy shows myopathy without vacuoles
    n1=en:myopathia | n2=en:biopsy shows myopathy without vacuoles | rel=r_associated | relid=0 | w=5
  256. en:myopathia -- r_associated #0: 5 / 0.143 -> en:biopsy shows nonspecific myopathy without rimmed vacuoles
    n1=en:myopathia | n2=en:biopsy shows nonspecific myopathy without rimmed vacuoles | rel=r_associated | relid=0 | w=5
  257. en:myopathia -- r_associated #0: 5 / 0.143 -> en:biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size
    n1=en:myopathia | n2=en:biopsy shows rimmed vacuoles, central nuclei, and variation in fiber size | rel=r_associated | relid=0 | w=5
  258. en:myopathia -- r_associated #0: 5 / 0.143 -> en:both type 1 and type 2 fiber predominance has been reported
    n1=en:myopathia | n2=en:both type 1 and type 2 fiber predominance has been reported | rel=r_associated | relid=0 | w=5
  259. en:myopathia -- r_associated #0: 5 / 0.143 -> en:broad-based gait
    n1=en:myopathia | n2=en:broad-based gait | rel=r_associated | relid=0 | w=5
  260. en:myopathia -- r_associated #0: 5 / 0.143 -> en:buffalo hump
    n1=en:myopathia | n2=en:buffalo hump | rel=r_associated | relid=0 | w=5
  261. en:myopathia -- r_associated #0: 5 / 0.143 -> en:buffalo hump (rare)
    n1=en:myopathia | n2=en:buffalo hump (rare) | rel=r_associated | relid=0 | w=5
  262. en:myopathia -- r_associated #0: 5 / 0.143 -> en:by fourth decade, many patients need help with ambulation
    n1=en:myopathia | n2=en:by fourth decade, many patients need help with ambulation | rel=r_associated | relid=0 | w=5
  263. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calcific tendinopathy, early-onset (in some patients)
    n1=en:myopathia | n2=en:calcific tendinopathy, early-onset (in some patients) | rel=r_associated | relid=0 | w=5
  264. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calcification
    n1=en:myopathia | n2=en:calcification | rel=r_associated | relid=0 | w=5
  265. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf and thigh cramping muscle pains
    n1=en:myopathia | n2=en:calf and thigh cramping muscle pains | rel=r_associated | relid=0 | w=5
  266. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf atrophy (later onset)
    n1=en:myopathia | n2=en:calf atrophy (later onset) | rel=r_associated | relid=0 | w=5
  267. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf hypertrophy (early in the disease)
    n1=en:myopathia | n2=en:calf hypertrophy (early in the disease) | rel=r_associated | relid=0 | w=5
  268. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf hypertrophy (in some patients)
    n1=en:myopathia | n2=en:calf hypertrophy (in some patients) | rel=r_associated | relid=0 | w=5
  269. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf hypertrophy (less common)
    n1=en:myopathia | n2=en:calf hypertrophy (less common) | rel=r_associated | relid=0 | w=5
  270. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf hypertrophy (reported in 1 family)
    n1=en:myopathia | n2=en:calf hypertrophy (reported in 1 family) | rel=r_associated | relid=0 | w=5
  271. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf hypertrophy (uncommon)
    n1=en:myopathia | n2=en:calf hypertrophy (uncommon) | rel=r_associated | relid=0 | w=5
  272. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf muscle discomfort
    n1=en:myopathia | n2=en:calf muscle discomfort | rel=r_associated | relid=0 | w=5
  273. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf muscle enlargement
    n1=en:myopathia | n2=en:calf muscle enlargement | rel=r_associated | relid=0 | w=5
  274. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf muscle hypertrophy
    n1=en:myopathia | n2=en:calf muscle hypertrophy | rel=r_associated | relid=0 | w=5
  275. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf muscle hypoplasia
    n1=en:myopathia | n2=en:calf muscle hypoplasia | rel=r_associated | relid=0 | w=5
  276. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf muscle pseudohypertrophy
    n1=en:myopathia | n2=en:calf muscle pseudohypertrophy | rel=r_associated | relid=0 | w=5
  277. en:myopathia -- r_associated #0: 5 / 0.143 -> en:calf pseudohypertrophy rare
    n1=en:myopathia | n2=en:calf pseudohypertrophy rare | rel=r_associated | relid=0 | w=5
  278. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cardiomyopathy
    n1=en:myopathia | n2=en:cardiomyopathy | rel=r_associated | relid=0 | w=5
  279. en:myopathia -- r_associated #0: 5 / 0.143 -> en:carpopedal spasm
    n1=en:myopathia | n2=en:carpopedal spasm | rel=r_associated | relid=0 | w=5
  280. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cataract
    n1=en:myopathia | n2=en:cataract | rel=r_associated | relid=0 | w=5
  281. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cellulitis or infection may occur
    n1=en:myopathia | n2=en:cellulitis or infection may occur | rel=r_associated | relid=0 | w=5
  282. en:myopathia -- r_associated #0: 5 / 0.143 -> en:central core disease
    n1=en:myopathia | n2=en:central core disease | rel=r_associated | relid=0 | w=5
  283. en:myopathia -- r_associated #0: 5 / 0.143 -> en:central core myopathy (disorder)
    n1=en:myopathia | n2=en:central core myopathy (disorder) | rel=r_associated | relid=0 | w=5
  284. en:myopathia -- r_associated #0: 5 / 0.143 -> en:central cores seen on muscle biopsy
    n1=en:myopathia | n2=en:central cores seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  285. en:myopathia -- r_associated #0: 5 / 0.143 -> en:centralized myonuclei
    n1=en:myopathia | n2=en:centralized myonuclei | rel=r_associated | relid=0 | w=5
  286. en:myopathia -- r_associated #0: 5 / 0.143 -> en:centralized nuclei may be seen
    n1=en:myopathia | n2=en:centralized nuclei may be seen | rel=r_associated | relid=0 | w=5
  287. en:myopathia -- r_associated #0: 5 / 0.143 -> en:centralized nuclei, rare
    n1=en:myopathia | n2=en:centralized nuclei, rare | rel=r_associated | relid=0 | w=5
  288. en:myopathia -- r_associated #0: 5 / 0.143 -> en:centrally located nuclei seen on muscle biopsy
    n1=en:myopathia | n2=en:centrally located nuclei seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  289. en:myopathia -- r_associated #0: 5 / 0.143 -> en:centronuclear myopathy
    n1=en:myopathia | n2=en:centronuclear myopathy | rel=r_associated | relid=0 | w=5
  290. en:myopathia -- r_associated #0: 5 / 0.143 -> en:changes in sarcoplasmic reticulum and t-tubules
    n1=en:myopathia | n2=en:changes in sarcoplasmic reticulum and t-tubules | rel=r_associated | relid=0 | w=5
  291. en:myopathia -- r_associated #0: 5 / 0.143 -> en:chemically induced
    n1=en:myopathia | n2=en:chemically induced | rel=r_associated | relid=0 | w=5
  292. en:myopathia -- r_associated #0: 5 / 0.143 -> en:chills
    n1=en:myopathia | n2=en:chills | rel=r_associated | relid=0 | w=5
  293. en:myopathia -- r_associated #0: 5 / 0.143 -> en:choristoma
    n1=en:myopathia | n2=en:choristoma | rel=r_associated | relid=0 | w=5
  294. en:myopathia -- r_associated #0: 5 / 0.143 -> en:chronic denervation seen on skeletal muscle biopsy
    n1=en:myopathia | n2=en:chronic denervation seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=5
  295. en:myopathia -- r_associated #0: 5 / 0.143 -> en:chronic weakness
    n1=en:myopathia | n2=en:chronic weakness | rel=r_associated | relid=0 | w=5
  296. en:myopathia -- r_associated #0: 5 / 0.143 -> en:clumsiness
    n1=en:myopathia | n2=en:clumsiness | rel=r_associated | relid=0 | w=5
  297. en:myopathia -- r_associated #0: 5 / 0.143 -> en:combined mitochondrial respiratory chain deficiency (in most patients)
    n1=en:myopathia | n2=en:combined mitochondrial respiratory chain deficiency (in most patients) | rel=r_associated | relid=0 | w=5
  298. en:myopathia -- r_associated #0: 5 / 0.143 -> en:complication aspects
    n1=en:myopathia | n2=en:complication aspects | rel=r_associated | relid=0 | w=5
  299. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congenital absence of gluteal muscles
    n1=en:myopathia | n2=en:congenital absence of gluteal muscles | rel=r_associated | relid=0 | w=5
  300. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congenital fiber-type disproportion
    n1=en:myopathia | n2=en:congenital fiber-type disproportion | rel=r_associated | relid=0 | w=5
  301. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congenital multicore
    n1=en:myopathia | n2=en:congenital multicore | rel=r_associated | relid=0 | w=5
  302. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congenital multicore with external ophthalmoplegia
    n1=en:myopathia | n2=en:congenital multicore with external ophthalmoplegia | rel=r_associated | relid=0 | w=5
  303. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congenital myasthenic syndrome (reported in 1 patient who survived to age 20 years)
    n1=en:myopathia | n2=en:congenital myasthenic syndrome (reported in 1 patient who survived to age 20 years) | rel=r_associated | relid=0 | w=5
  304. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congenital myodystrophies
    n1=en:myopathia | n2=en:congenital myodystrophies | rel=r_associated | relid=0 | w=5
  305. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congenital rod disease
    n1=en:myopathia | n2=en:congenital rod disease | rel=r_associated | relid=0 | w=5
  306. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congenital, nonprogressive myopathy
    n1=en:myopathia | n2=en:congenital, nonprogressive myopathy | rel=r_associated | relid=0 | w=5
  307. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congophilic amyloid material
    n1=en:myopathia | n2=en:congophilic amyloid material | rel=r_associated | relid=0 | w=5
  308. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congophilic deposits
    n1=en:myopathia | n2=en:congophilic deposits | rel=r_associated | relid=0 | w=5
  309. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congophilic eosinophilic inclusions
    n1=en:myopathia | n2=en:congophilic eosinophilic inclusions | rel=r_associated | relid=0 | w=5
  310. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congophilic inclusions
    n1=en:myopathia | n2=en:congophilic inclusions | rel=r_associated | relid=0 | w=5
  311. en:myopathia -- r_associated #0: 5 / 0.143 -> en:congophilic staining
    n1=en:myopathia | n2=en:congophilic staining | rel=r_associated | relid=0 | w=5
  312. en:myopathia -- r_associated #0: 5 / 0.143 -> en:contractures of distal lower limbs
    n1=en:myopathia | n2=en:contractures of distal lower limbs | rel=r_associated | relid=0 | w=5
  313. en:myopathia -- r_associated #0: 5 / 0.143 -> en:contractures of upper limbs (in some patients)
    n1=en:myopathia | n2=en:contractures of upper limbs (in some patients) | rel=r_associated | relid=0 | w=5
  314. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cores contain densely packed myofilaments
    n1=en:myopathia | n2=en:cores contain densely packed myofilaments | rel=r_associated | relid=0 | w=5
  315. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cores extend along length of muscle fiber
    n1=en:myopathia | n2=en:cores extend along length of muscle fiber | rel=r_associated | relid=0 | w=5
  316. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cores have abrupt borders within normal regions of the muscle fiber
    n1=en:myopathia | n2=en:cores have abrupt borders within normal regions of the muscle fiber | rel=r_associated | relid=0 | w=5
  317. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cores or minicores
    n1=en:myopathia | n2=en:cores or minicores | rel=r_associated | relid=0 | w=5
  318. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cores with lack of oxidative activity and mitochondrial depletion may also be found and extend along length of fiber
    n1=en:myopathia | n2=en:cores with lack of oxidative activity and mitochondrial depletion may also be found and extend along length of fiber | rel=r_associated | relid=0 | w=5
  319. en:myopathia -- r_associated #0: 5 / 0.143 -> en:corneal crystals
    n1=en:myopathia | n2=en:corneal crystals | rel=r_associated | relid=0 | w=5
  320. en:myopathia -- r_associated #0: 5 / 0.143 -> en:corpus callosum agenesis
    n1=en:myopathia | n2=en:corpus callosum agenesis | rel=r_associated | relid=0 | w=5
  321. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cox-negative fibers seen on muscle biopsy
    n1=en:myopathia | n2=en:cox-negative fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  322. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cranial muscles spared
    n1=en:myopathia | n2=en:cranial muscles spared | rel=r_associated | relid=0 | w=5
  323. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cytochrome c oxidase-negative fibers
    n1=en:myopathia | n2=en:cytochrome c oxidase-negative fibers | rel=r_associated | relid=0 | w=5
  324. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cytochrome-c oxidase deficiency
    n1=en:myopathia | n2=en:cytochrome-c oxidase deficiency | rel=r_associated | relid=0 | w=5
  325. en:myopathia -- r_associated #0: 5 / 0.143 -> en:cytoplasmic inclusion bodies (finding)
    n1=en:myopathia | n2=en:cytoplasmic inclusion bodies (finding) | rel=r_associated | relid=0 | w=5
  326. en:myopathia -- r_associated #0: 5 / 0.143 -> en:deafferentation
    n1=en:myopathia | n2=en:deafferentation | rel=r_associated | relid=0 | w=5
  327. en:myopathia -- r_associated #0: 5 / 0.143 -> en:deafness
    n1=en:myopathia | n2=en:deafness | rel=r_associated | relid=0 | w=5
  328. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased ability to run
    n1=en:myopathia | n2=en:decreased ability to run | rel=r_associated | relid=0 | w=5
  329. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased activities of mitochondrial-encoded respiratory chain complexes
    n1=en:myopathia | n2=en:decreased activities of mitochondrial-encoded respiratory chain complexes | rel=r_associated | relid=0 | w=5
  330. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased activities of several mitochondrial respiratory enzymes
    n1=en:myopathia | n2=en:decreased activities of several mitochondrial respiratory enzymes | rel=r_associated | relid=0 | w=5
  331. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased activity of cytochrome c oxidase (in most cases)
    n1=en:myopathia | n2=en:decreased activity of cytochrome c oxidase (in most cases) | rel=r_associated | relid=0 | w=5
  332. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased activity of cytochrome c oxidase in most cases seen on muscle biopsy
    n1=en:myopathia | n2=en:decreased activity of cytochrome c oxidase in most cases seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  333. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased activity of cytochrome c oxidase seen on muscle biopsy
    n1=en:myopathia | n2=en:decreased activity of cytochrome c oxidase seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  334. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased activity of mitochondrial complex i
    n1=en:myopathia | n2=en:decreased activity of mitochondrial complex i | rel=r_associated | relid=0 | w=5
  335. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased activity of multiple mitochondrial respiratory complex enzymes
    n1=en:myopathia | n2=en:decreased activity of multiple mitochondrial respiratory complex enzymes | rel=r_associated | relid=0 | w=5
  336. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased adipose tissue around neck
    n1=en:myopathia | n2=en:decreased adipose tissue around neck | rel=r_associated | relid=0 | w=5
  337. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased caveolae in muscle tissue
    n1=en:myopathia | n2=en:decreased caveolae in muscle tissue | rel=r_associated | relid=0 | w=5
  338. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased caveolin-3 expression on muscle biopsy
    n1=en:myopathia | n2=en:decreased caveolin-3 expression on muscle biopsy | rel=r_associated | relid=0 | w=5
  339. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased caveolin-3 expression seen on muscle biopsy
    n1=en:myopathia | n2=en:decreased caveolin-3 expression seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  340. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased cytochrome c oxidase activity
    n1=en:myopathia | n2=en:decreased cytochrome c oxidase activity | rel=r_associated | relid=0 | w=5
  341. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased cytochrome c oxidase staining
    n1=en:myopathia | n2=en:decreased cytochrome c oxidase staining | rel=r_associated | relid=0 | w=5
  342. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased density of calcium release units
    n1=en:myopathia | n2=en:decreased density of calcium release units | rel=r_associated | relid=0 | w=5
  343. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased distal reflexes
    n1=en:myopathia | n2=en:decreased distal reflexes | rel=r_associated | relid=0 | w=5
  344. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased endplate potential and amplitudes
    n1=en:myopathia | n2=en:decreased endplate potential and amplitudes | rel=r_associated | relid=0 | w=5
  345. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased exercise tolerance
    n1=en:myopathia | n2=en:decreased exercise tolerance | rel=r_associated | relid=0 | w=5
  346. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased glutamate oxidation (about 63% of normal)
    n1=en:myopathia | n2=en:decreased glutamate oxidation (about 63% of normal) | rel=r_associated | relid=0 | w=5
  347. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased glycosylation of alpha-dystroglycan
    n1=en:myopathia | n2=en:decreased glycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=5
  348. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased glycosylation of alpha-dystroglycan seen on muscle biopsy
    n1=en:myopathia | n2=en:decreased glycosylation of alpha-dystroglycan seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  349. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased hand grip strength
    n1=en:myopathia | n2=en:decreased hand grip strength | rel=r_associated | relid=0 | w=5
  350. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased immunostaining for alpha-sarcoglycan
    n1=en:myopathia | n2=en:decreased immunostaining for alpha-sarcoglycan | rel=r_associated | relid=0 | w=5
  351. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased lactate clearance from muscle after exercise (reported in 1 patient)
    n1=en:myopathia | n2=en:decreased lactate clearance from muscle after exercise (reported in 1 patient) | rel=r_associated | relid=0 | w=5
  352. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased lipoic acid
    n1=en:myopathia | n2=en:decreased lipoic acid | rel=r_associated | relid=0 | w=5
  353. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased mitochondria
    n1=en:myopathia | n2=en:decreased mitochondria | rel=r_associated | relid=0 | w=5
  354. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased mitochondrial respiratory activities (in some patients)
    n1=en:myopathia | n2=en:decreased mitochondrial respiratory activities (in some patients) | rel=r_associated | relid=0 | w=5
  355. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased muscle action potential after warming affected muscle
    n1=en:myopathia | n2=en:decreased muscle action potential after warming affected muscle | rel=r_associated | relid=0 | w=5
  356. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased muscle bulk
    n1=en:myopathia | n2=en:decreased muscle bulk | rel=r_associated | relid=0 | w=5
  357. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased muscle density on imaging
    n1=en:myopathia | n2=en:decreased muscle density on imaging | rel=r_associated | relid=0 | w=5
  358. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased muscle mass
    n1=en:myopathia | n2=en:decreased muscle mass | rel=r_associated | relid=0 | w=5
  359. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased muscle mass (especially in lower limbs)
    n1=en:myopathia | n2=en:decreased muscle mass (especially in lower limbs) | rel=r_associated | relid=0 | w=5
  360. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased muscle mass (especially of limbs)
    n1=en:myopathia | n2=en:decreased muscle mass (especially of limbs) | rel=r_associated | relid=0 | w=5
  361. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased muscle mass (predominantly in lower extremities)
    n1=en:myopathia | n2=en:decreased muscle mass (predominantly in lower extremities) | rel=r_associated | relid=0 | w=5
  362. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased muscle mass, especially distally
    n1=en:myopathia | n2=en:decreased muscle mass, especially distally | rel=r_associated | relid=0 | w=5
  363. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased muscle mitochondrial aconitase
    n1=en:myopathia | n2=en:decreased muscle mitochondrial aconitase | rel=r_associated | relid=0 | w=5
  364. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased muscle succinate dehydrogenase
    n1=en:myopathia | n2=en:decreased muscle succinate dehydrogenase | rel=r_associated | relid=0 | w=5
  365. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased or patchy amounts of alpha-dystrobrevin and beta-2-syntrophin at the sarcolemma
    n1=en:myopathia | n2=en:decreased or patchy amounts of alpha-dystrobrevin and beta-2-syntrophin at the sarcolemma | rel=r_associated | relid=0 | w=5
  366. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased postsynaptic folding at the neuromuscular junction
    n1=en:myopathia | n2=en:decreased postsynaptic folding at the neuromuscular junction | rel=r_associated | relid=0 | w=5
  367. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased postsynaptic length
    n1=en:myopathia | n2=en:decreased postsynaptic length | rel=r_associated | relid=0 | w=5
  368. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased shank muscle mass
    n1=en:myopathia | n2=en:decreased shank muscle mass | rel=r_associated | relid=0 | w=5
  369. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decreased thiamine pyrophosphate
    n1=en:myopathia | n2=en:decreased thiamine pyrophosphate | rel=r_associated | relid=0 | w=5
  370. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decrement of the compound muscle action potential on repetitive stimulation
    n1=en:myopathia | n2=en:decrement of the compound muscle action potential on repetitive stimulation | rel=r_associated | relid=0 | w=5
  371. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decremental response of compound muscle action potential on repetitive nerve stimulation
    n1=en:myopathia | n2=en:decremental response of compound muscle action potential on repetitive nerve stimulation | rel=r_associated | relid=0 | w=5
  372. en:myopathia -- r_associated #0: 5 / 0.143 -> en:decremental response to repetitive stimulation at neuromuscular junction
    n1=en:myopathia | n2=en:decremental response to repetitive stimulation at neuromuscular junction | rel=r_associated | relid=0 | w=5
  373. en:myopathia -- r_associated #0: 5 / 0.143 -> en:deep finger muscle weakness
    n1=en:myopathia | n2=en:deep finger muscle weakness | rel=r_associated | relid=0 | w=5
  374. en:myopathia -- r_associated #0: 5 / 0.143 -> en:defect in glycosylation of alpha-dystroglycan seen on skeletal muscle biopsy
    n1=en:myopathia | n2=en:defect in glycosylation of alpha-dystroglycan seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=5
  375. en:myopathia -- r_associated #0: 5 / 0.143 -> en:defective mitochondrial oxidative phosphorylation of multiple enzymes
    n1=en:myopathia | n2=en:defective mitochondrial oxidative phosphorylation of multiple enzymes | rel=r_associated | relid=0 | w=5
  376. en:myopathia -- r_associated #0: 5 / 0.143 -> en:defects in lipoate-containing mitochondrial enzyme complexes
    n1=en:myopathia | n2=en:defects in lipoate-containing mitochondrial enzyme complexes | rel=r_associated | relid=0 | w=5
  377. en:myopathia -- r_associated #0: 5 / 0.143 -> en:deficiency of mitochondrial respiratory enzymes seen on muscle biopsy
    n1=en:myopathia | n2=en:deficiency of mitochondrial respiratory enzymes seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  378. en:myopathia -- r_associated #0: 5 / 0.143 -> en:degenerating fibers
    n1=en:myopathia | n2=en:degenerating fibers | rel=r_associated | relid=0 | w=5
  379. en:myopathia -- r_associated #0: 5 / 0.143 -> en:degenerating nerve terminals
    n1=en:myopathia | n2=en:degenerating nerve terminals | rel=r_associated | relid=0 | w=5
  380. en:myopathia -- r_associated #0: 5 / 0.143 -> en:degenerative changes with increased connective tissue
    n1=en:myopathia | n2=en:degenerative changes with increased connective tissue | rel=r_associated | relid=0 | w=5
  381. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dégenerative disease
    n1=en:myopathia | n2=en:dégenerative disease | rel=r_associated | relid=0 | w=5
  382. en:myopathia -- r_associated #0: 5 / 0.143 -> en:degenerative disorder of musculoskeletal system
    n1=en:myopathia | n2=en:degenerative disorder of musculoskeletal system | rel=r_associated | relid=0 | w=5
  383. en:myopathia -- r_associated #0: 5 / 0.143 -> en:degenerative illness
    n1=en:myopathia | n2=en:degenerative illness | rel=r_associated | relid=0 | w=5
  384. en:myopathia -- r_associated #0: 5 / 0.143 -> en:degrading mitochondria
    n1=en:myopathia | n2=en:degrading mitochondria | rel=r_associated | relid=0 | w=5
  385. en:myopathia -- r_associated #0: 5 / 0.143 -> en:deltoid muscle hypoplasia
    n1=en:myopathia | n2=en:deltoid muscle hypoplasia | rel=r_associated | relid=0 | w=5
  386. en:myopathia -- r_associated #0: 5 / 0.143 -> en:demyelination
    n1=en:myopathia | n2=en:demyelination | rel=r_associated | relid=0 | w=5
  387. en:myopathia -- r_associated #0: 5 / 0.143 -> en:denervation of skeletal muscles
    n1=en:myopathia | n2=en:denervation of skeletal muscles | rel=r_associated | relid=0 | w=5
  388. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dense membranous structure surrounding nuclei on electron microscopy
    n1=en:myopathia | n2=en:dense membranous structure surrounding nuclei on electron microscopy | rel=r_associated | relid=0 | w=5
  389. en:myopathia -- r_associated #0: 5 / 0.143 -> en:denuded postsynaptic regions
    n1=en:myopathia | n2=en:denuded postsynaptic regions | rel=r_associated | relid=0 | w=5
  390. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dependent edema after excess fat has been present for several years
    n1=en:myopathia | n2=en:dependent edema after excess fat has been present for several years | rel=r_associated | relid=0 | w=5
  391. en:myopathia -- r_associated #0: 5 / 0.143 -> en:deposits immunoreactive to beta-amyloid protein
    n1=en:myopathia | n2=en:deposits immunoreactive to beta-amyloid protein | rel=r_associated | relid=0 | w=5
  392. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dermal or subcutaneous infiltrate of spindle-shaped cells arranged in a whorled pattern seen on histology
    n1=en:myopathia | n2=en:dermal or subcutaneous infiltrate of spindle-shaped cells arranged in a whorled pattern seen on histology | rel=r_associated | relid=0 | w=5
  393. en:myopathia -- r_associated #0: 5 / 0.143 -> en:diabetic amyotrophy
    n1=en:myopathia | n2=en:diabetic amyotrophy | rel=r_associated | relid=0 | w=5
  394. en:myopathia -- r_associated #0: 5 / 0.143 -> en:difficulty climbing stairs, jumping, running
    n1=en:myopathia | n2=en:difficulty climbing stairs, jumping, running | rel=r_associated | relid=0 | w=5
  395. en:myopathia -- r_associated #0: 5 / 0.143 -> en:difficulty in toe walking
    n1=en:myopathia | n2=en:difficulty in toe walking | rel=r_associated | relid=0 | w=5
  396. en:myopathia -- r_associated #0: 5 / 0.143 -> en:difficulty raising arms
    n1=en:myopathia | n2=en:difficulty raising arms | rel=r_associated | relid=0 | w=5
  397. en:myopathia -- r_associated #0: 5 / 0.143 -> en:difficulty rising from a squatting position
    n1=en:myopathia | n2=en:difficulty rising from a squatting position | rel=r_associated | relid=0 | w=5
  398. en:myopathia -- r_associated #0: 5 / 0.143 -> en:difficulty rising from chair
    n1=en:myopathia | n2=en:difficulty rising from chair | rel=r_associated | relid=0 | w=5
  399. en:myopathia -- r_associated #0: 5 / 0.143 -> en:difficulty running and jumping
    n1=en:myopathia | n2=en:difficulty running and jumping | rel=r_associated | relid=0 | w=5
  400. en:myopathia -- r_associated #0: 5 / 0.143 -> en:difficulty running or inability to run
    n1=en:myopathia | n2=en:difficulty running or inability to run | rel=r_associated | relid=0 | w=5
  401. en:myopathia -- r_associated #0: 5 / 0.143 -> en:difficulty standing
    n1=en:myopathia | n2=en:difficulty standing | rel=r_associated | relid=0 | w=5
  402. en:myopathia -- r_associated #0: 5 / 0.143 -> en:difficulty walking on heels occurs prior to difficulty walking on toes
    n1=en:myopathia | n2=en:difficulty walking on heels occurs prior to difficulty walking on toes | rel=r_associated | relid=0 | w=5
  403. en:myopathia -- r_associated #0: 5 / 0.143 -> en:difficulty walking up stairs
    n1=en:myopathia | n2=en:difficulty walking up stairs | rel=r_associated | relid=0 | w=5
  404. en:myopathia -- r_associated #0: 5 / 0.143 -> en:difficulty walking, running, climbing stairs
    n1=en:myopathia | n2=en:difficulty walking, running, climbing stairs | rel=r_associated | relid=0 | w=5
  405. en:myopathia -- r_associated #0: 5 / 0.143 -> en:disorganization of the myofibrillar pattern
    n1=en:myopathia | n2=en:disorganization of the myofibrillar pattern | rel=r_associated | relid=0 | w=5
  406. en:myopathia -- r_associated #0: 5 / 0.143 -> en:disorganization of the neuromuscular junction
    n1=en:myopathia | n2=en:disorganization of the neuromuscular junction | rel=r_associated | relid=0 | w=5
  407. en:myopathia -- r_associated #0: 5 / 0.143 -> en:disorganized myofilaments seen on muscle biopsy
    n1=en:myopathia | n2=en:disorganized myofilaments seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  408. en:myopathia -- r_associated #0: 5 / 0.143 -> en:disruption in the basal lamina seen on skeletal muscle biopsy
    n1=en:myopathia | n2=en:disruption in the basal lamina seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=5
  409. en:myopathia -- r_associated #0: 5 / 0.143 -> en:disruption of the sarcolemmal membrane seen on muscle biopsy
    n1=en:myopathia | n2=en:disruption of the sarcolemmal membrane seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  410. en:myopathia -- r_associated #0: 5 / 0.143 -> en:disruption plasma membrane (in some patients)
    n1=en:myopathia | n2=en:disruption plasma membrane (in some patients) | rel=r_associated | relid=0 | w=5
  411. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal amyotrophy (hands and feet)
    n1=en:myopathia | n2=en:distal amyotrophy (hands and feet) | rel=r_associated | relid=0 | w=5
  412. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal atrophy of the legs
    n1=en:myopathia | n2=en:distal atrophy of the legs | rel=r_associated | relid=0 | w=5
  413. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal leg muscle atrophy
    n1=en:myopathia | n2=en:distal leg muscle atrophy | rel=r_associated | relid=0 | w=5
  414. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal limb atrophy (upper and lower)
    n1=en:myopathia | n2=en:distal limb atrophy (upper and lower) | rel=r_associated | relid=0 | w=5
  415. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal limb muscle atrophy (less common)
    n1=en:myopathia | n2=en:distal limb muscle atrophy (less common) | rel=r_associated | relid=0 | w=5
  416. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal limb muscle atrophy due to peripheral neuropathy (lower limbs are more affected than upper limbs)
    n1=en:myopathia | n2=en:distal limb muscle atrophy due to peripheral neuropathy (lower limbs are more affected than upper limbs) | rel=r_associated | relid=0 | w=5
  417. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal limb muscle atrophy, lower more than upper
    n1=en:myopathia | n2=en:distal limb muscle atrophy, lower more than upper | rel=r_associated | relid=0 | w=5
  418. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal limb muscle weakness (less common)
    n1=en:myopathia | n2=en:distal limb muscle weakness (less common) | rel=r_associated | relid=0 | w=5
  419. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal limb muscle weakness and atrophy
    n1=en:myopathia | n2=en:distal limb muscle weakness and atrophy | rel=r_associated | relid=0 | w=5
  420. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal limb muscle weakness due to peripheral neuropathy (lower limbs are more affected than upper limbs)
    n1=en:myopathia | n2=en:distal limb muscle weakness due to peripheral neuropathy (lower limbs are more affected than upper limbs) | rel=r_associated | relid=0 | w=5
  421. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal limb muscle weakness occurs later
    n1=en:myopathia | n2=en:distal limb muscle weakness occurs later | rel=r_associated | relid=0 | w=5
  422. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal limb muscle weakness, lower more than upper
    n1=en:myopathia | n2=en:distal limb muscle weakness, lower more than upper | rel=r_associated | relid=0 | w=5
  423. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal lower limb amyotrophy
    n1=en:myopathia | n2=en:distal lower limb amyotrophy | rel=r_associated | relid=0 | w=5
  424. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal lower limb anterior compartment weakness
    n1=en:myopathia | n2=en:distal lower limb anterior compartment weakness | rel=r_associated | relid=0 | w=5
  425. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal lower limb muscle weakness
    n1=en:myopathia | n2=en:distal lower limb muscle weakness | rel=r_associated | relid=0 | w=5
  426. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal lower limb muscle weakness and atrophy
    n1=en:myopathia | n2=en:distal lower limb muscle weakness and atrophy | rel=r_associated | relid=0 | w=5
  427. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle atrophy (1 patient)
    n1=en:myopathia | n2=en:distal muscle atrophy (1 patient) | rel=r_associated | relid=0 | w=5
  428. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle atrophy (lower limbs more affected than upper limbs)
    n1=en:myopathia | n2=en:distal muscle atrophy (lower limbs more affected than upper limbs) | rel=r_associated | relid=0 | w=5
  429. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle atrophy due to denervation
    n1=en:myopathia | n2=en:distal muscle atrophy due to denervation | rel=r_associated | relid=0 | w=5
  430. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle atrophy due to neurologic disease
    n1=en:myopathia | n2=en:distal muscle atrophy due to neurologic disease | rel=r_associated | relid=0 | w=5
  431. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle atrophy due to neuropathy
    n1=en:myopathia | n2=en:distal muscle atrophy due to neuropathy | rel=r_associated | relid=0 | w=5
  432. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle atrophy, affecting the lower limbs
    n1=en:myopathia | n2=en:distal muscle atrophy, affecting the lower limbs | rel=r_associated | relid=0 | w=5
  433. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle atrophy, lower limbs more severely affected than upper limbs
    n1=en:myopathia | n2=en:distal muscle atrophy, lower limbs more severely affected than upper limbs | rel=r_associated | relid=0 | w=5
  434. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle atrophy, predominantly affecting the lower limbs
    n1=en:myopathia | n2=en:distal muscle atrophy, predominantly affecting the lower limbs | rel=r_associated | relid=0 | w=5
  435. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle atrophy, predominantly lower limbs
    n1=en:myopathia | n2=en:distal muscle atrophy, predominantly lower limbs | rel=r_associated | relid=0 | w=5
  436. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle wasting, mild
    n1=en:myopathia | n2=en:distal muscle wasting, mild | rel=r_associated | relid=0 | w=5
  437. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness (first affects anterior leg muscles, then posterior leg muscles)
    n1=en:myopathia | n2=en:distal muscle weakness (first affects anterior leg muscles, then posterior leg muscles) | rel=r_associated | relid=0 | w=5
  438. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness and atrophy
    n1=en:myopathia | n2=en:distal muscle weakness and atrophy | rel=r_associated | relid=0 | w=5
  439. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness and atrophy may occur, upper and lower limbs affected
    n1=en:myopathia | n2=en:distal muscle weakness and atrophy may occur, upper and lower limbs affected | rel=r_associated | relid=0 | w=5
  440. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness and atrophy of upper and lower limbs due to peripheral neuropathy
    n1=en:myopathia | n2=en:distal muscle weakness and atrophy of upper and lower limbs due to peripheral neuropathy | rel=r_associated | relid=0 | w=5
  441. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness and atrophy, upper and lower limbs
    n1=en:myopathia | n2=en:distal muscle weakness and atrophy, upper and lower limbs | rel=r_associated | relid=0 | w=5
  442. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness due to neuropathy
    n1=en:myopathia | n2=en:distal muscle weakness due to neuropathy | rel=r_associated | relid=0 | w=5
  443. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness in lower limbs, severe
    n1=en:myopathia | n2=en:distal muscle weakness in lower limbs, severe | rel=r_associated | relid=0 | w=5
  444. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness may occur
    n1=en:myopathia | n2=en:distal muscle weakness may occur | rel=r_associated | relid=0 | w=5
  445. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness occurs later
    n1=en:myopathia | n2=en:distal muscle weakness occurs later | rel=r_associated | relid=0 | w=5
  446. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness, affecting the lower limbs
    n1=en:myopathia | n2=en:distal muscle weakness, affecting the lower limbs | rel=r_associated | relid=0 | w=5
  447. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness, lower limbs more severely affected than upper limbs
    n1=en:myopathia | n2=en:distal muscle weakness, lower limbs more severely affected than upper limbs | rel=r_associated | relid=0 | w=5
  448. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness, mild
    n1=en:myopathia | n2=en:distal muscle weakness, mild | rel=r_associated | relid=0 | w=5
  449. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness, occurs initially
    n1=en:myopathia | n2=en:distal muscle weakness, occurs initially | rel=r_associated | relid=0 | w=5
  450. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness, predominantly affecting the lower limbs
    n1=en:myopathia | n2=en:distal muscle weakness, predominantly affecting the lower limbs | rel=r_associated | relid=0 | w=5
  451. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscle weakness, predominantly lower limbs
    n1=en:myopathia | n2=en:distal muscle weakness, predominantly lower limbs | rel=r_associated | relid=0 | w=5
  452. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscles may be affected
    n1=en:myopathia | n2=en:distal muscles may be affected | rel=r_associated | relid=0 | w=5
  453. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal muscular atrophy due to peripheral neuropathy
    n1=en:myopathia | n2=en:distal muscular atrophy due to peripheral neuropathy | rel=r_associated | relid=0 | w=5
  454. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal myopathies
    n1=en:myopathia | n2=en:distal myopathies | rel=r_associated | relid=0 | w=5
  455. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal myopathy (in 1 family)
    n1=en:myopathia | n2=en:distal myopathy (in 1 family) | rel=r_associated | relid=0 | w=5
  456. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal skeletal muscle atrophy (after long disease duration)
    n1=en:myopathia | n2=en:distal skeletal muscle atrophy (after long disease duration) | rel=r_associated | relid=0 | w=5
  457. en:myopathia -- r_associated #0: 5 / 0.143 -> en:distal weakness, upper and lower limbs (variable)
    n1=en:myopathia | n2=en:distal weakness, upper and lower limbs (variable) | rel=r_associated | relid=0 | w=5
  458. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dorsal and flexor muscles of the forearm are involved
    n1=en:myopathia | n2=en:dorsal and flexor muscles of the forearm are involved | rel=r_associated | relid=0 | w=5
  459. en:myopathia -- r_associated #0: 5 / 0.143 -> en:Duchenne's myopathy
    n1=en:myopathia | n2=en:Duchenne's myopathy | rel=r_associated | relid=0 | w=5
  460. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dysphagia
    n1=en:myopathia | n2=en:dysphagia | rel=r_associated | relid=0 | w=5
  461. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dystrophic changes
    n1=en:myopathia | n2=en:dystrophic changes | rel=r_associated | relid=0 | w=5
  462. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dystrophic changes may be present
    n1=en:myopathia | n2=en:dystrophic changes may be present | rel=r_associated | relid=0 | w=5
  463. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dystrophic changes occur later
    n1=en:myopathia | n2=en:dystrophic changes occur later | rel=r_associated | relid=0 | w=5
  464. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dystrophic changes on biopsy
    n1=en:myopathia | n2=en:dystrophic changes on biopsy | rel=r_associated | relid=0 | w=5
  465. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dystrophic changes seen on muscle biopsy
    n1=en:myopathia | n2=en:dystrophic changes seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  466. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dystrophic changes seen on skeletal muscle biopsy
    n1=en:myopathia | n2=en:dystrophic changes seen on skeletal muscle biopsy | rel=r_associated | relid=0 | w=5
  467. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dystrophic changes, mild, seen on muscle biopsy
    n1=en:myopathia | n2=en:dystrophic changes, mild, seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  468. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dystrophic features
    n1=en:myopathia | n2=en:dystrophic features | rel=r_associated | relid=0 | w=5
  469. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dystrophic features and atrophic fibers seen on muscle biopsy
    n1=en:myopathia | n2=en:dystrophic features and atrophic fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  470. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dystrophic features seen on muscle biopsy
    n1=en:myopathia | n2=en:dystrophic features seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  471. en:myopathia -- r_associated #0: 5 / 0.143 -> en:dystrophy
    n1=en:myopathia | n2=en:dystrophy | rel=r_associated | relid=0 | w=5
  472. en:myopathia -- r_associated #0: 5 / 0.143 -> en:easy bruisability of lower extremities
    n1=en:myopathia | n2=en:easy bruisability of lower extremities | rel=r_associated | relid=0 | w=5
  473. en:myopathia -- r_associated #0: 5 / 0.143 -> en:easy fatigability with exercise
    n1=en:myopathia | n2=en:easy fatigability with exercise | rel=r_associated | relid=0 | w=5
  474. en:myopathia -- r_associated #0: 5 / 0.143 -> en:easy fatigue
    n1=en:myopathia | n2=en:easy fatigue | rel=r_associated | relid=0 | w=5
  475. en:myopathia -- r_associated #0: 5 / 0.143 -> en:edema
    n1=en:myopathia | n2=en:edema | rel=r_associated | relid=0 | w=5
  476. en:myopathia -- r_associated #0: 5 / 0.143 -> en:edema (hands and feet)
    n1=en:myopathia | n2=en:edema (hands and feet) | rel=r_associated | relid=0 | w=5
  477. en:myopathia -- r_associated #0: 5 / 0.143 -> en:edema at birth
    n1=en:myopathia | n2=en:edema at birth | rel=r_associated | relid=0 | w=5
  478. en:myopathia -- r_associated #0: 5 / 0.143 -> en:edema is present at birth and then slowly decreases
    n1=en:myopathia | n2=en:edema is present at birth and then slowly decreases | rel=r_associated | relid=0 | w=5
  479. en:myopathia -- r_associated #0: 5 / 0.143 -> en:edema limbs
    n1=en:myopathia | n2=en:edema limbs | rel=r_associated | relid=0 | w=5
  480. en:myopathia -- r_associated #0: 5 / 0.143 -> en:edema reoccurs with infections
    n1=en:myopathia | n2=en:edema reoccurs with infections | rel=r_associated | relid=0 | w=5
  481. en:myopathia -- r_associated #0: 5 / 0.143 -> en:edema, subcutaneous, generalized
    n1=en:myopathia | n2=en:edema, subcutaneous, generalized | rel=r_associated | relid=0 | w=5
  482. en:myopathia -- r_associated #0: 5 / 0.143 -> en:edematous hands and feet (1 patient)
    n1=en:myopathia | n2=en:edematous hands and feet (1 patient) | rel=r_associated | relid=0 | w=5
  483. en:myopathia -- r_associated #0: 5 / 0.143 -> en:electromyographic decrements in some muscles
    n1=en:myopathia | n2=en:electromyographic decrements in some muscles | rel=r_associated | relid=0 | w=5
  484. en:myopathia -- r_associated #0: 5 / 0.143 -> en:electromyography shows myotonic discharges
    n1=en:myopathia | n2=en:electromyography shows myotonic discharges | rel=r_associated | relid=0 | w=5
  485. en:myopathia -- r_associated #0: 5 / 0.143 -> en:electron microscopy shows abnormal mitochondria with disorganized and vacuolated cristae
    n1=en:myopathia | n2=en:electron microscopy shows abnormal mitochondria with disorganized and vacuolated cristae | rel=r_associated | relid=0 | w=5
  486. en:myopathia -- r_associated #0: 5 / 0.143 -> en:electron microscopy shows subsarcolemmal accumulations of abnormally shaped mitochondria
    n1=en:myopathia | n2=en:electron microscopy shows subsarcolemmal accumulations of abnormally shaped mitochondria | rel=r_associated | relid=0 | w=5
  487. en:myopathia -- r_associated #0: 5 / 0.143 -> en:endomysial fibrosis
    n1=en:myopathia | n2=en:endomysial fibrosis | rel=r_associated | relid=0 | w=5
  488. en:myopathia -- r_associated #0: 5 / 0.143 -> en:enlarged mitochondria
    n1=en:myopathia | n2=en:enlarged mitochondria | rel=r_associated | relid=0 | w=5
  489. en:myopathia -- r_associated #0: 5 / 0.143 -> en:enlarged nuclei with central pallor
    n1=en:myopathia | n2=en:enlarged nuclei with central pallor | rel=r_associated | relid=0 | w=5
  490. en:myopathia -- r_associated #0: 5 / 0.143 -> en:enlarged terminal cisternae of the sarcoplasmic reticulum
    n1=en:myopathia | n2=en:enlarged terminal cisternae of the sarcoplasmic reticulum | rel=r_associated | relid=0 | w=5
  491. en:myopathia -- r_associated #0: 5 / 0.143 -> en:enlarged vesicles of sarcoplasmic reticulum origin
    n1=en:myopathia | n2=en:enlarged vesicles of sarcoplasmic reticulum origin | rel=r_associated | relid=0 | w=5
  492. en:myopathia -- r_associated #0: 5 / 0.143 -> en:enteroviral dermatomyositis syndrome
    n1=en:myopathia | n2=en:enteroviral dermatomyositis syndrome | rel=r_associated | relid=0 | w=5
  493. en:myopathia -- r_associated #0: 5 / 0.143 -> en:enzymology
    n1=en:myopathia | n2=en:enzymology | rel=r_associated | relid=0 | w=5
  494. en:myopathia -- r_associated #0: 5 / 0.143 -> en:eosinophilic inclusions
    n1=en:myopathia | n2=en:eosinophilic inclusions | rel=r_associated | relid=0 | w=5
  495. en:myopathia -- r_associated #0: 5 / 0.143 -> en:epidemiologic
    n1=en:myopathia | n2=en:epidemiologic | rel=r_associated | relid=0 | w=5
  496. en:myopathia -- r_associated #0: 5 / 0.143 -> en:episodic weakness may or may not occur independent of myotonia
    n1=en:myopathia | n2=en:episodic weakness may or may not occur independent of myotonia | rel=r_associated | relid=0 | w=5
  497. en:myopathia -- r_associated #0: 5 / 0.143 -> en:episodic, nonerythematous, nonpruritic, nontender edema, episodic
    n1=en:myopathia | n2=en:episodic, nonerythematous, nonpruritic, nontender edema, episodic | rel=r_associated | relid=0 | w=5
  498. en:myopathia -- r_associated #0: 5 / 0.143 -> en:episodic, nonpruritic, nonurticarial, nonpitting edema
    n1=en:myopathia | n2=en:episodic, nonpruritic, nonurticarial, nonpitting edema | rel=r_associated | relid=0 | w=5
  499. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ethnologic
    n1=en:myopathia | n2=en:ethnologic | rel=r_associated | relid=0 | w=5
  500. en:myopathia -- r_associated #0: 5 / 0.143 -> en:etiology aspects
    n1=en:myopathia | n2=en:etiology aspects | rel=r_associated | relid=0 | w=5
  501. en:myopathia -- r_associated #0: 5 / 0.143 -> en:evidence of lymphatic rerouting
    n1=en:myopathia | n2=en:evidence of lymphatic rerouting | rel=r_associated | relid=0 | w=5
  502. en:myopathia -- r_associated #0: 5 / 0.143 -> en:excess fat, symmetrically located in buttocks and lower extremities to ankles
    n1=en:myopathia | n2=en:excess fat, symmetrically located in buttocks and lower extremities to ankles | rel=r_associated | relid=0 | w=5
  503. en:myopathia -- r_associated #0: 5 / 0.143 -> en:exercise capacity decreased
    n1=en:myopathia | n2=en:exercise capacity decreased | rel=r_associated | relid=0 | w=5
  504. en:myopathia -- r_associated #0: 5 / 0.143 -> en:exercise intolerance (also seen in some heterozygotes)
    n1=en:myopathia | n2=en:exercise intolerance (also seen in some heterozygotes) | rel=r_associated | relid=0 | w=5
  505. en:myopathia -- r_associated #0: 5 / 0.143 -> en:exercise intolerance (less common)
    n1=en:myopathia | n2=en:exercise intolerance (less common) | rel=r_associated | relid=0 | w=5
  506. en:myopathia -- r_associated #0: 5 / 0.143 -> en:exercise-induced muscle fatigue
    n1=en:myopathia | n2=en:exercise-induced muscle fatigue | rel=r_associated | relid=0 | w=5
  507. en:myopathia -- r_associated #0: 5 / 0.143 -> en:exercise-induced muscle stiffness
    n1=en:myopathia | n2=en:exercise-induced muscle stiffness | rel=r_associated | relid=0 | w=5
  508. en:myopathia -- r_associated #0: 5 / 0.143 -> en:exercise-induced myalgia
    n1=en:myopathia | n2=en:exercise-induced myalgia | rel=r_associated | relid=0 | w=5
  509. en:myopathia -- r_associated #0: 5 / 0.143 -> en:exercise-induced weakness
    n1=en:myopathia | n2=en:exercise-induced weakness | rel=r_associated | relid=0 | w=5
  510. en:myopathia -- r_associated #0: 5 / 0.143 -> en:exertional fatigue
    n1=en:myopathia | n2=en:exertional fatigue | rel=r_associated | relid=0 | w=5
  511. en:myopathia -- r_associated #0: 5 / 0.143 -> en:exertional leg pain
    n1=en:myopathia | n2=en:exertional leg pain | rel=r_associated | relid=0 | w=5
  512. en:myopathia -- r_associated #0: 5 / 0.143 -> en:extensive fatty infiltration on biopsy
    n1=en:myopathia | n2=en:extensive fatty infiltration on biopsy | rel=r_associated | relid=0 | w=5
  513. en:myopathia -- r_associated #0: 5 / 0.143 -> en:extensor muscle weakness more severe than flexor muscle weakness
    n1=en:myopathia | n2=en:extensor muscle weakness more severe than flexor muscle weakness | rel=r_associated | relid=0 | w=5
  514. en:myopathia -- r_associated #0: 5 / 0.143 -> en:face edema
    n1=en:myopathia | n2=en:face edema | rel=r_associated | relid=0 | w=5
  515. en:myopathia -- r_associated #0: 5 / 0.143 -> en:facial asymmetry
    n1=en:myopathia | n2=en:facial asymmetry | rel=r_associated | relid=0 | w=5
  516. en:myopathia -- r_associated #0: 5 / 0.143 -> en:facial muscle atrophy of involved side
    n1=en:myopathia | n2=en:facial muscle atrophy of involved side | rel=r_associated | relid=0 | w=5
  517. en:myopathia -- r_associated #0: 5 / 0.143 -> en:facial muscle weakness and atrophy, progressive
    n1=en:myopathia | n2=en:facial muscle weakness and atrophy, progressive | rel=r_associated | relid=0 | w=5
  518. en:myopathia -- r_associated #0: 5 / 0.143 -> en:failure to thrive
    n1=en:myopathia | n2=en:failure to thrive | rel=r_associated | relid=0 | w=5
  519. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fasciculation
    n1=en:myopathia | n2=en:fasciculation | rel=r_associated | relid=0 | w=5
  520. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fasciculations (in some patients)
    n1=en:myopathia | n2=en:fasciculations (in some patients) | rel=r_associated | relid=0 | w=5
  521. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fasciculations (less common)
    n1=en:myopathia | n2=en:fasciculations (less common) | rel=r_associated | relid=0 | w=5
  522. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fat accumulation in the suprabuttock area
    n1=en:myopathia | n2=en:fat accumulation in the suprabuttock area | rel=r_associated | relid=0 | w=5
  523. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fat pad anterior to malleolus
    n1=en:myopathia | n2=en:fat pad anterior to malleolus | rel=r_associated | relid=0 | w=5
  524. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fat pads on the hands and feet
    n1=en:myopathia | n2=en:fat pads on the hands and feet | rel=r_associated | relid=0 | w=5
  525. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fatigue
    n1=en:myopathia | n2=en:fatigue | rel=r_associated | relid=0 | w=5
  526. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fatty deposition
    n1=en:myopathia | n2=en:fatty deposition | rel=r_associated | relid=0 | w=5
  527. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fatty infiltration of affected muscles
    n1=en:myopathia | n2=en:fatty infiltration of affected muscles | rel=r_associated | relid=0 | w=5
  528. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fatty infiltration seen on muscle biopsy
    n1=en:myopathia | n2=en:fatty infiltration seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  529. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fatty replacement
    n1=en:myopathia | n2=en:fatty replacement | rel=r_associated | relid=0 | w=5
  530. en:myopathia -- r_associated #0: 5 / 0.143 -> en:feebleness
    n1=en:myopathia | n2=en:feebleness | rel=r_associated | relid=0 | w=5
  531. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fiber necrosis
    n1=en:myopathia | n2=en:fiber necrosis | rel=r_associated | relid=0 | w=5
  532. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fiber size variation
    n1=en:myopathia | n2=en:fiber size variation | rel=r_associated | relid=0 | w=5
  533. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fiber size variation seen on muscle biopsy
    n1=en:myopathia | n2=en:fiber size variation seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  534. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fiber type grouping
    n1=en:myopathia | n2=en:fiber type grouping | rel=r_associated | relid=0 | w=5
  535. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fiber type variation seen on biopsy
    n1=en:myopathia | n2=en:fiber type variation seen on biopsy | rel=r_associated | relid=0 | w=5
  536. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fiber-type grouping pattern
    n1=en:myopathia | n2=en:fiber-type grouping pattern | rel=r_associated | relid=0 | w=5
  537. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fiber-type variability
    n1=en:myopathia | n2=en:fiber-type variability | rel=r_associated | relid=0 | w=5
  538. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fibrillation
    n1=en:myopathia | n2=en:fibrillation | rel=r_associated | relid=0 | w=5
  539. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fibrillations in affected muscles
    n1=en:myopathia | n2=en:fibrillations in affected muscles | rel=r_associated | relid=0 | w=5
  540. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fibromyalgia
    n1=en:myopathia | n2=en:fibromyalgia | rel=r_associated | relid=0 | w=5
  541. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fibrous dysplasia (rare)
    n1=en:myopathia | n2=en:fibrous dysplasia (rare) | rel=r_associated | relid=0 | w=5
  542. en:myopathia -- r_associated #0: 5 / 0.143 -> en:filamentous inclusions in muscle fibers
    n1=en:myopathia | n2=en:filamentous inclusions in muscle fibers | rel=r_associated | relid=0 | w=5
  543. en:myopathia -- r_associated #0: 5 / 0.143 -> en:finger and wrist extensor weakness
    n1=en:myopathia | n2=en:finger and wrist extensor weakness | rel=r_associated | relid=0 | w=5
  544. en:myopathia -- r_associated #0: 5 / 0.143 -> en:firm muscles
    n1=en:myopathia | n2=en:firm muscles | rel=r_associated | relid=0 | w=5
  545. en:myopathia -- r_associated #0: 5 / 0.143 -> en:flaccid weakness or paralysis, episodic attacks
    n1=en:myopathia | n2=en:flaccid weakness or paralysis, episodic attacks | rel=r_associated | relid=0 | w=5
  546. en:myopathia -- r_associated #0: 5 / 0.143 -> en:floppy infant
    n1=en:myopathia | n2=en:floppy infant | rel=r_associated | relid=0 | w=5
  547. en:myopathia -- r_associated #0: 5 / 0.143 -> en:focal lymphocytic and macrophage infiltrates on biopsy
    n1=en:myopathia | n2=en:focal lymphocytic and macrophage infiltrates on biopsy | rel=r_associated | relid=0 | w=5
  548. en:myopathia -- r_associated #0: 5 / 0.143 -> en:foot dorsiflexor weakness
    n1=en:myopathia | n2=en:foot dorsiflexor weakness | rel=r_associated | relid=0 | w=5
  549. en:myopathia -- r_associated #0: 5 / 0.143 -> en:foot extensor muscle weakness (later onset)
    n1=en:myopathia | n2=en:foot extensor muscle weakness (later onset) | rel=r_associated | relid=0 | w=5
  550. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fragmentation of the neuromuscular junction with pre- and postsynaptic defects
    n1=en:myopathia | n2=en:fragmentation of the neuromuscular junction with pre- and postsynaptic defects | rel=r_associated | relid=0 | w=5
  551. en:myopathia -- r_associated #0: 5 / 0.143 -> en:fragmented mitochondrial network
    n1=en:myopathia | n2=en:fragmented mitochondrial network | rel=r_associated | relid=0 | w=5
  552. en:myopathia -- r_associated #0: 5 / 0.143 -> en:gait abnormalities (occurs later)
    n1=en:myopathia | n2=en:gait abnormalities (occurs later) | rel=r_associated | relid=0 | w=5
  553. en:myopathia -- r_associated #0: 5 / 0.143 -> en:gait disturbance
    n1=en:myopathia | n2=en:gait disturbance | rel=r_associated | relid=0 | w=5
  554. en:myopathia -- r_associated #0: 5 / 0.143 -> en:gait unsteady
    n1=en:myopathia | n2=en:gait unsteady | rel=r_associated | relid=0 | w=5
  555. en:myopathia -- r_associated #0: 5 / 0.143 -> en:gait, drop foot
    n1=en:myopathia | n2=en:gait, drop foot | rel=r_associated | relid=0 | w=5
  556. en:myopathia -- r_associated #0: 5 / 0.143 -> en:gastrocnemius and soleus muscles most affected
    n1=en:myopathia | n2=en:gastrocnemius and soleus muscles most affected | rel=r_associated | relid=0 | w=5
  557. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized amyoplasia
    n1=en:myopathia | n2=en:generalized amyoplasia | rel=r_associated | relid=0 | w=5
  558. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized hypotonia
    n1=en:myopathia | n2=en:generalized hypotonia | rel=r_associated | relid=0 | w=5
  559. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized limb muscle atrophy
    n1=en:myopathia | n2=en:generalized limb muscle atrophy | rel=r_associated | relid=0 | w=5
  560. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized muscle contractions, episodic
    n1=en:myopathia | n2=en:generalized muscle contractions, episodic | rel=r_associated | relid=0 | w=5
  561. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized muscle hypertrophy
    n1=en:myopathia | n2=en:generalized muscle hypertrophy | rel=r_associated | relid=0 | w=5
  562. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized muscle wasting
    n1=en:myopathia | n2=en:generalized muscle wasting | rel=r_associated | relid=0 | w=5
  563. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized muscle weakness (less common)
    n1=en:myopathia | n2=en:generalized muscle weakness (less common) | rel=r_associated | relid=0 | w=5
  564. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized muscle weakness also seen in symptomatic carrier females
    n1=en:myopathia | n2=en:generalized muscle weakness also seen in symptomatic carrier females | rel=r_associated | relid=0 | w=5
  565. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized muscle weakness, proximal and distal
    n1=en:myopathia | n2=en:generalized muscle weakness, proximal and distal | rel=r_associated | relid=0 | w=5
  566. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized muscular appearance from birth
    n1=en:myopathia | n2=en:generalized muscular appearance from birth | rel=r_associated | relid=0 | w=5
  567. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized neonatal hypotonia
    n1=en:myopathia | n2=en:generalized neonatal hypotonia | rel=r_associated | relid=0 | w=5
  568. en:myopathia -- r_associated #0: 5 / 0.143 -> en:generalized weakness (adult-onset)
    n1=en:myopathia | n2=en:generalized weakness (adult-onset) | rel=r_associated | relid=0 | w=5
  569. en:myopathia -- r_associated #0: 5 / 0.143 -> en:genetic condition
    n1=en:myopathia | n2=en:genetic condition | rel=r_associated | relid=0 | w=5
  570. en:myopathia -- r_associated #0: 5 / 0.143 -> en:genetic disorder
    n1=en:myopathia | n2=en:genetic disorder | rel=r_associated | relid=0 | w=5
  571. en:myopathia -- r_associated #0: 5 / 0.143 -> en:genetic illness
    n1=en:myopathia | n2=en:genetic illness | rel=r_associated | relid=0 | w=5
  572. en:myopathia -- r_associated #0: 5 / 0.143 -> en:giant granules in muscle cells
    n1=en:myopathia | n2=en:giant granules in muscle cells | rel=r_associated | relid=0 | w=5
  573. en:myopathia -- r_associated #0: 5 / 0.143 -> en:global muscle weakness
    n1=en:myopathia | n2=en:global muscle weakness | rel=r_associated | relid=0 | w=5
  574. en:myopathia -- r_associated #0: 5 / 0.143 -> en:gluteal hypoplasia
    n1=en:myopathia | n2=en:gluteal hypoplasia | rel=r_associated | relid=0 | w=5
  575. en:myopathia -- r_associated #0: 5 / 0.143 -> en:gluteus maximus and thigh adductors most affected
    n1=en:myopathia | n2=en:gluteus maximus and thigh adductors most affected | rel=r_associated | relid=0 | w=5
  576. en:myopathia -- r_associated #0: 5 / 0.143 -> en:glycogen accumulation seen on biopsy
    n1=en:myopathia | n2=en:glycogen accumulation seen on biopsy | rel=r_associated | relid=0 | w=5
  577. en:myopathia -- r_associated #0: 5 / 0.143 -> en:glycogen deficiency in muscle fibers
    n1=en:myopathia | n2=en:glycogen deficiency in muscle fibers | rel=r_associated | relid=0 | w=5
  578. en:myopathia -- r_associated #0: 5 / 0.143 -> en:glycogen depletion in skeletal muscle
    n1=en:myopathia | n2=en:glycogen depletion in skeletal muscle | rel=r_associated | relid=0 | w=5
  579. en:myopathia -- r_associated #0: 5 / 0.143 -> en:glycogenosis of skeletal muscle, mild (in some patients)
    n1=en:myopathia | n2=en:glycogenosis of skeletal muscle, mild (in some patients) | rel=r_associated | relid=0 | w=5
  580. en:myopathia -- r_associated #0: 5 / 0.143 -> en:gowers sign (in some patients)
    n1=en:myopathia | n2=en:gowers sign (in some patients) | rel=r_associated | relid=0 | w=5
  581. en:myopathia -- r_associated #0: 5 / 0.143 -> en:granular deposits in the sarcomeres
    n1=en:myopathia | n2=en:granular deposits in the sarcomeres | rel=r_associated | relid=0 | w=5
  582. en:myopathia -- r_associated #0: 5 / 0.143 -> en:granulovacuolar degeneration
    n1=en:myopathia | n2=en:granulovacuolar degeneration | rel=r_associated | relid=0 | w=5
  583. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hamstring and quadriceps muscles mildly affected
    n1=en:myopathia | n2=en:hamstring and quadriceps muscles mildly affected | rel=r_associated | relid=0 | w=5
  584. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hamstring muscle affected
    n1=en:myopathia | n2=en:hamstring muscle affected | rel=r_associated | relid=0 | w=5
  585. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hand and foot weakness
    n1=en:myopathia | n2=en:hand and foot weakness | rel=r_associated | relid=0 | w=5
  586. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hand muscle atrophy
    n1=en:myopathia | n2=en:hand muscle atrophy | rel=r_associated | relid=0 | w=5
  587. en:myopathia -- r_associated #0: 5 / 0.143 -> en:handgrip myotonia
    n1=en:myopathia | n2=en:handgrip myotonia | rel=r_associated | relid=0 | w=5
  588. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hang weakness
    n1=en:myopathia | n2=en:hang weakness | rel=r_associated | relid=0 | w=5
  589. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hangrip myotonia
    n1=en:myopathia | n2=en:hangrip myotonia | rel=r_associated | relid=0 | w=5
  590. en:myopathia -- r_associated #0: 5 / 0.143 -> en:head drop due to neck muscle weakness
    n1=en:myopathia | n2=en:head drop due to neck muscle weakness | rel=r_associated | relid=0 | w=5
  591. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hematomas, recurrent large subcutaneous
    n1=en:myopathia | n2=en:hematomas, recurrent large subcutaneous | rel=r_associated | relid=0 | w=5
  592. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hemorrhage
    n1=en:myopathia | n2=en:hemorrhage | rel=r_associated | relid=0 | w=5
  593. en:myopathia -- r_associated #0: 5 / 0.143 -> en:heterotopic bone formation in subcutaneous fat
    n1=en:myopathia | n2=en:heterotopic bone formation in subcutaneous fat | rel=r_associated | relid=0 | w=5
  594. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hip abductor weakness and atrophy
    n1=en:myopathia | n2=en:hip abductor weakness and atrophy | rel=r_associated | relid=0 | w=5
  595. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hip flexor weakness
    n1=en:myopathia | n2=en:hip flexor weakness | rel=r_associated | relid=0 | w=5
  596. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hip girdle muscle atrophy
    n1=en:myopathia | n2=en:hip girdle muscle atrophy | rel=r_associated | relid=0 | w=5
  597. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hip girdle muscle weakness (usually presenting symptom)
    n1=en:myopathia | n2=en:hip girdle muscle weakness (usually presenting symptom) | rel=r_associated | relid=0 | w=5
  598. en:myopathia -- r_associated #0: 5 / 0.143 -> en:humeroperoneal weakness and atrophy
    n1=en:myopathia | n2=en:humeroperoneal weakness and atrophy | rel=r_associated | relid=0 | w=5
  599. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hyaline inclusion
    n1=en:myopathia | n2=en:hyaline inclusion | rel=r_associated | relid=0 | w=5
  600. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hyaline plaques with absent oxidative activity
    n1=en:myopathia | n2=en:hyaline plaques with absent oxidative activity | rel=r_associated | relid=0 | w=5
  601. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hyperthermia
    n1=en:myopathia | n2=en:hyperthermia | rel=r_associated | relid=0 | w=5
  602. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypertonia
    n1=en:myopathia | n2=en:hypertonia | rel=r_associated | relid=0 | w=5
  603. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypertonia at birth
    n1=en:myopathia | n2=en:hypertonia at birth | rel=r_associated | relid=0 | w=5
  604. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypertonicity (uncommon)
    n1=en:myopathia | n2=en:hypertonicity (uncommon) | rel=r_associated | relid=0 | w=5
  605. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypertonicity of the lower limbs
    n1=en:myopathia | n2=en:hypertonicity of the lower limbs | rel=r_associated | relid=0 | w=5
  606. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypertrophy of calves (in 3 of 6 patients)
    n1=en:myopathia | n2=en:hypertrophy of calves (in 3 of 6 patients) | rel=r_associated | relid=0 | w=5
  607. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypertrophy of the extensor digitorum brevis muscles
    n1=en:myopathia | n2=en:hypertrophy of the extensor digitorum brevis muscles | rel=r_associated | relid=0 | w=5
  608. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypoactive gag reflex
    n1=en:myopathia | n2=en:hypoactive gag reflex | rel=r_associated | relid=0 | w=5
  609. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypoglycosylation of alpha-dystroglycan
    n1=en:myopathia | n2=en:hypoglycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=5
  610. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypoglycosylation of alpha-dystroglycan seen on muscle biopsy
    n1=en:myopathia | n2=en:hypoglycosylation of alpha-dystroglycan seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  611. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypogonadism syndrome
    n1=en:myopathia | n2=en:hypogonadism syndrome | rel=r_associated | relid=0 | w=5
  612. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypoplasia of cervical paravertebral muscles
    n1=en:myopathia | n2=en:hypoplasia of cervical paravertebral muscles | rel=r_associated | relid=0 | w=5
  613. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypoplasia of latissimus dorsi muscle
    n1=en:myopathia | n2=en:hypoplasia of latissimus dorsi muscle | rel=r_associated | relid=0 | w=5
  614. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypoplasia of muscle
    n1=en:myopathia | n2=en:hypoplasia of muscle | rel=r_associated | relid=0 | w=5
  615. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypoplasia of serratus anterior muscle
    n1=en:myopathia | n2=en:hypoplasia of serratus anterior muscle | rel=r_associated | relid=0 | w=5
  616. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypoplasia of supraspinatus muscle
    n1=en:myopathia | n2=en:hypoplasia of supraspinatus muscle | rel=r_associated | relid=0 | w=5
  617. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypoplasia of the hand muscles (29%)
    n1=en:myopathia | n2=en:hypoplasia of the hand muscles (29%) | rel=r_associated | relid=0 | w=5
  618. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hyporeflexia
    n1=en:myopathia | n2=en:hyporeflexia | rel=r_associated | relid=0 | w=5
  619. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hyporeflexia in affected muscles
    n1=en:myopathia | n2=en:hyporeflexia in affected muscles | rel=r_associated | relid=0 | w=5
  620. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hyporeflexia of lower limbs
    n1=en:myopathia | n2=en:hyporeflexia of lower limbs | rel=r_associated | relid=0 | w=5
  621. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypothenar muscle atrophy
    n1=en:myopathia | n2=en:hypothenar muscle atrophy | rel=r_associated | relid=0 | w=5
  622. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypotonia
    n1=en:myopathia | n2=en:hypotonia | rel=r_associated | relid=0 | w=5
  623. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypotonia (2 patients)
    n1=en:myopathia | n2=en:hypotonia (2 patients) | rel=r_associated | relid=0 | w=5
  624. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypotonia (45%)
    n1=en:myopathia | n2=en:hypotonia (45%) | rel=r_associated | relid=0 | w=5
  625. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypotonia (untreated hypothyroidism)
    n1=en:myopathia | n2=en:hypotonia (untreated hypothyroidism) | rel=r_associated | relid=0 | w=5
  626. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypotonia, generalized (in some patients)
    n1=en:myopathia | n2=en:hypotonia, generalized (in some patients) | rel=r_associated | relid=0 | w=5
  627. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypotonia, infantile, severe
    n1=en:myopathia | n2=en:hypotonia, infantile, severe | rel=r_associated | relid=0 | w=5
  628. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypotonia, mild (1 patient)
    n1=en:myopathia | n2=en:hypotonia, mild (1 patient) | rel=r_associated | relid=0 | w=5
  629. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypotonia, neonatal and later
    n1=en:myopathia | n2=en:hypotonia, neonatal and later | rel=r_associated | relid=0 | w=5
  630. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypotonia, severe, neonatal
    n1=en:myopathia | n2=en:hypotonia, severe, neonatal | rel=r_associated | relid=0 | w=5
  631. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypotonia, truncal and appendicular
    n1=en:myopathia | n2=en:hypotonia, truncal and appendicular | rel=r_associated | relid=0 | w=5
  632. en:myopathia -- r_associated #0: 5 / 0.143 -> en:hypotrophy of type 1 fibers
    n1=en:myopathia | n2=en:hypotrophy of type 1 fibers | rel=r_associated | relid=0 | w=5
  633. en:myopathia -- r_associated #0: 5 / 0.143 -> en:imaging shows muscle atrophy and fatty replacement
    n1=en:myopathia | n2=en:imaging shows muscle atrophy and fatty replacement | rel=r_associated | relid=0 | w=5
  634. en:myopathia -- r_associated #0: 5 / 0.143 -> en:imaging shows progressive fatty infiltration of muscle
    n1=en:myopathia | n2=en:imaging shows progressive fatty infiltration of muscle | rel=r_associated | relid=0 | w=5
  635. en:myopathia -- r_associated #0: 5 / 0.143 -> en:impaired heel-walking
    n1=en:myopathia | n2=en:impaired heel-walking | rel=r_associated | relid=0 | w=5
  636. en:myopathia -- r_associated #0: 5 / 0.143 -> en:impaired mitochondrial respiration
    n1=en:myopathia | n2=en:impaired mitochondrial respiration | rel=r_associated | relid=0 | w=5
  637. en:myopathia -- r_associated #0: 5 / 0.143 -> en:impaired toe-walking
    n1=en:myopathia | n2=en:impaired toe-walking | rel=r_associated | relid=0 | w=5
  638. en:myopathia -- r_associated #0: 5 / 0.143 -> en:inability to jump or squat
    n1=en:myopathia | n2=en:inability to jump or squat | rel=r_associated | relid=0 | w=5
  639. en:myopathia -- r_associated #0: 5 / 0.143 -> en:inability to sit or hold head up
    n1=en:myopathia | n2=en:inability to sit or hold head up | rel=r_associated | relid=0 | w=5
  640. en:myopathia -- r_associated #0: 5 / 0.143 -> en:inability to stand on tiptoes
    n1=en:myopathia | n2=en:inability to stand on tiptoes | rel=r_associated | relid=0 | w=5
  641. en:myopathia -- r_associated #0: 5 / 0.143 -> en:inclusion body myopathy
    n1=en:myopathia | n2=en:inclusion body myopathy | rel=r_associated | relid=0 | w=5
  642. en:myopathia -- r_associated #0: 5 / 0.143 -> en:inclusions form a lobulated structure seen on electron microscopy
    n1=en:myopathia | n2=en:inclusions form a lobulated structure seen on electron microscopy | rel=r_associated | relid=0 | w=5
  643. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased adipose fibrosis
    n1=en:myopathia | n2=en:increased adipose fibrosis | rel=r_associated | relid=0 | w=5
  644. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased central nucleation
    n1=en:myopathia | n2=en:increased central nucleation | rel=r_associated | relid=0 | w=5
  645. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased centralized internal nuclei
    n1=en:myopathia | n2=en:increased centralized internal nuclei | rel=r_associated | relid=0 | w=5
  646. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased centralized nuclei
    n1=en:myopathia | n2=en:increased centralized nuclei | rel=r_associated | relid=0 | w=5
  647. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased connective tissue
    n1=en:myopathia | n2=en:increased connective tissue | rel=r_associated | relid=0 | w=5
  648. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased connective tissue (in some patients)
    n1=en:myopathia | n2=en:increased connective tissue (in some patients) | rel=r_associated | relid=0 | w=5
  649. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased connective tissue and fat in muscles
    n1=en:myopathia | n2=en:increased connective tissue and fat in muscles | rel=r_associated | relid=0 | w=5
  650. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased endo- and perimysial connective tissue
    n1=en:myopathia | n2=en:increased endo- and perimysial connective tissue | rel=r_associated | relid=0 | w=5
  651. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased endomysial connective tissue around muscle fibers
    n1=en:myopathia | n2=en:increased endomysial connective tissue around muscle fibers | rel=r_associated | relid=0 | w=5
  652. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased endomysial fibrosis
    n1=en:myopathia | n2=en:increased endomysial fibrosis | rel=r_associated | relid=0 | w=5
  653. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased fat and fibrous tissue
    n1=en:myopathia | n2=en:increased fat and fibrous tissue | rel=r_associated | relid=0 | w=5
  654. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased fatigue
    n1=en:myopathia | n2=en:increased fatigue | rel=r_associated | relid=0 | w=5
  655. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased fatty and connective tissue in skeletal muscle
    n1=en:myopathia | n2=en:increased fatty and connective tissue in skeletal muscle | rel=r_associated | relid=0 | w=5
  656. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased fatty infiltration
    n1=en:myopathia | n2=en:increased fatty infiltration | rel=r_associated | relid=0 | w=5
  657. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased fiber size variability
    n1=en:myopathia | n2=en:increased fiber size variability | rel=r_associated | relid=0 | w=5
  658. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased focal mitochondrial density
    n1=en:myopathia | n2=en:increased focal mitochondrial density | rel=r_associated | relid=0 | w=5
  659. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased glycogen
    n1=en:myopathia | n2=en:increased glycogen | rel=r_associated | relid=0 | w=5
  660. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased glycogen in muscle
    n1=en:myopathia | n2=en:increased glycogen in muscle | rel=r_associated | relid=0 | w=5
  661. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased intermyofibrillar and subsarcolemmal glycogen
    n1=en:myopathia | n2=en:increased intermyofibrillar and subsarcolemmal glycogen | rel=r_associated | relid=0 | w=5
  662. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased internal nuclei
    n1=en:myopathia | n2=en:increased internal nuclei | rel=r_associated | relid=0 | w=5
  663. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased internal nuclei in skeletal muscle fibers
    n1=en:myopathia | n2=en:increased internal nuclei in skeletal muscle fibers | rel=r_associated | relid=0 | w=5
  664. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased intraabdominal fat
    n1=en:myopathia | n2=en:increased intraabdominal fat | rel=r_associated | relid=0 | w=5
  665. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased intramuscular fat
    n1=en:myopathia | n2=en:increased intramuscular fat | rel=r_associated | relid=0 | w=5
  666. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased lipid
    n1=en:myopathia | n2=en:increased lipid | rel=r_associated | relid=0 | w=5
  667. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased lipid droplets and abnormal mitochondria
    n1=en:myopathia | n2=en:increased lipid droplets and abnormal mitochondria | rel=r_associated | relid=0 | w=5
  668. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased lysosomal glycogen
    n1=en:myopathia | n2=en:increased lysosomal glycogen | rel=r_associated | relid=0 | w=5
  669. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased mitochondria seen on muscle biopsy
    n1=en:myopathia | n2=en:increased mitochondria seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  670. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased mitochondria with abnormal cristae
    n1=en:myopathia | n2=en:increased mitochondria with abnormal cristae | rel=r_associated | relid=0 | w=5
  671. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased mitochondria with rare paracrystalline inclusions
    n1=en:myopathia | n2=en:increased mitochondria with rare paracrystalline inclusions | rel=r_associated | relid=0 | w=5
  672. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased muscle glycogen content
    n1=en:myopathia | n2=en:increased muscle glycogen content | rel=r_associated | relid=0 | w=5
  673. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased muscle lipid content
    n1=en:myopathia | n2=en:increased muscle lipid content | rel=r_associated | relid=0 | w=5
  674. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased muscle tone (early in life)
    n1=en:myopathia | n2=en:increased muscle tone (early in life) | rel=r_associated | relid=0 | w=5
  675. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased muscle tone at birth
    n1=en:myopathia | n2=en:increased muscle tone at birth | rel=r_associated | relid=0 | w=5
  676. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased numbers of abnormally-shaped mitochondria in subsarcolemmal areas
    n1=en:myopathia | n2=en:increased numbers of abnormally-shaped mitochondria in subsarcolemmal areas | rel=r_associated | relid=0 | w=5
  677. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased numbers of type 1 fibers
    n1=en:myopathia | n2=en:increased numbers of type 1 fibers | rel=r_associated | relid=0 | w=5
  678. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased perisarcolemmal calcium deposition
    n1=en:myopathia | n2=en:increased perisarcolemmal calcium deposition | rel=r_associated | relid=0 | w=5
  679. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased staining for myotilin, dystrophin, desmin
    n1=en:myopathia | n2=en:increased staining for myotilin, dystrophin, desmin | rel=r_associated | relid=0 | w=5
  680. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased subcutaneous truncal adipose tissue
    n1=en:myopathia | n2=en:increased subcutaneous truncal adipose tissue | rel=r_associated | relid=0 | w=5
  681. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased variability in muscle fiber diameter
    n1=en:myopathia | n2=en:increased variability in muscle fiber diameter | rel=r_associated | relid=0 | w=5
  682. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased variability of fiber size seen on muscle biopsy
    n1=en:myopathia | n2=en:increased variability of fiber size seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  683. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased variation in fiber size seen on muscle biopsy
    n1=en:myopathia | n2=en:increased variation in fiber size seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  684. en:myopathia -- r_associated #0: 5 / 0.143 -> en:increased variation in muscle fiber diameter
    n1=en:myopathia | n2=en:increased variation in muscle fiber diameter | rel=r_associated | relid=0 | w=5
  685. en:myopathia -- r_associated #0: 5 / 0.143 -> en:indentations or folds of the sarcolemma are connected to the membranes enclosing the vacuoles
    n1=en:myopathia | n2=en:indentations or folds of the sarcolemma are connected to the membranes enclosing the vacuoles | rel=r_associated | relid=0 | w=5
  686. en:myopathia -- r_associated #0: 5 / 0.143 -> en:independent walking may not be achieved
    n1=en:myopathia | n2=en:independent walking may not be achieved | rel=r_associated | relid=0 | w=5
  687. en:myopathia -- r_associated #0: 5 / 0.143 -> en:infantile axial hypotonia
    n1=en:myopathia | n2=en:infantile axial hypotonia | rel=r_associated | relid=0 | w=5
  688. en:myopathia -- r_associated #0: 5 / 0.143 -> en:inflammatory cells absent
    n1=en:myopathia | n2=en:inflammatory cells absent | rel=r_associated | relid=0 | w=5
  689. en:myopathia -- r_associated #0: 5 / 0.143 -> en:inflammatory myopathies
    n1=en:myopathia | n2=en:inflammatory myopathies | rel=r_associated | relid=0 | w=5
  690. en:myopathia -- r_associated #0: 5 / 0.143 -> en:inherited disease
    n1=en:myopathia | n2=en:inherited disease | rel=r_associated | relid=0 | w=5
  691. en:myopathia -- r_associated #0: 5 / 0.143 -> en:interfibrillar and subsarcolemmal vacuoles
    n1=en:myopathia | n2=en:interfibrillar and subsarcolemmal vacuoles | rel=r_associated | relid=0 | w=5
  692. en:myopathia -- r_associated #0: 5 / 0.143 -> en:intermyofibrillar and subsarcolemmal accumulation of electron-dense material (in some patients)
    n1=en:myopathia | n2=en:intermyofibrillar and subsarcolemmal accumulation of electron-dense material (in some patients) | rel=r_associated | relid=0 | w=5
  693. en:myopathia -- r_associated #0: 5 / 0.143 -> en:intermyofibrillar and subsarcolemmal granulofilamentous protein aggregates
    n1=en:myopathia | n2=en:intermyofibrillar and subsarcolemmal granulofilamentous protein aggregates | rel=r_associated | relid=0 | w=5
  694. en:myopathia -- r_associated #0: 5 / 0.143 -> en:internal nuclei
    n1=en:myopathia | n2=en:internal nuclei | rel=r_associated | relid=0 | w=5
  695. en:myopathia -- r_associated #0: 5 / 0.143 -> en:internal nuclei seen on biopsy (in some patients)
    n1=en:myopathia | n2=en:internal nuclei seen on biopsy (in some patients) | rel=r_associated | relid=0 | w=5
  696. en:myopathia -- r_associated #0: 5 / 0.143 -> en:internal nuclei seen on muscle biopsy
    n1=en:myopathia | n2=en:internal nuclei seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  697. en:myopathia -- r_associated #0: 5 / 0.143 -> en:interosseus muscles involved
    n1=en:myopathia | n2=en:interosseus muscles involved | rel=r_associated | relid=0 | w=5
  698. en:myopathia -- r_associated #0: 5 / 0.143 -> en:intrasarcoplasmic dense granulofilamentous aggregates that are immunoreactive with desmin
    n1=en:myopathia | n2=en:intrasarcoplasmic dense granulofilamentous aggregates that are immunoreactive with desmin | rel=r_associated | relid=0 | w=5
  699. en:myopathia -- r_associated #0: 5 / 0.143 -> en:involves upper and lower proximal muscles
    n1=en:myopathia | n2=en:involves upper and lower proximal muscles | rel=r_associated | relid=0 | w=5
  700. en:myopathia -- r_associated #0: 5 / 0.143 -> en:jitter
    n1=en:myopathia | n2=en:jitter | rel=r_associated | relid=0 | w=5
  701. en:myopathia -- r_associated #0: 5 / 0.143 -> en:Kearns-Sayre's syndrome
    n1=en:myopathia | n2=en:Kearns-Sayre's syndrome | rel=r_associated | relid=0 | w=5
  702. en:myopathia -- r_associated #0: 5 / 0.143 -> en:kernicterus
    n1=en:myopathia | n2=en:kernicterus | rel=r_associated | relid=0 | w=5
  703. en:myopathia -- r_associated #0: 5 / 0.143 -> en:knee and hip flexor weakness due to peripheral neuropathy
    n1=en:myopathia | n2=en:knee and hip flexor weakness due to peripheral neuropathy | rel=r_associated | relid=0 | w=5
  704. en:myopathia -- r_associated #0: 5 / 0.143 -> en:kyphoscoliose syndrome
    n1=en:myopathia | n2=en:kyphoscoliose syndrome | rel=r_associated | relid=0 | w=5
  705. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lack of adipose tissue on limbs and femorogluteal regions
    n1=en:myopathia | n2=en:lack of adipose tissue on limbs and femorogluteal regions | rel=r_associated | relid=0 | w=5
  706. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lack of integrin alpha-7 staining
    n1=en:myopathia | n2=en:lack of integrin alpha-7 staining | rel=r_associated | relid=0 | w=5
  707. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lactic acidosis
    n1=en:myopathia | n2=en:lactic acidosis | rel=r_associated | relid=0 | w=5
  708. en:myopathia -- r_associated #0: 5 / 0.143 -> en:large hypertrophied fibers
    n1=en:myopathia | n2=en:large hypertrophied fibers | rel=r_associated | relid=0 | w=5
  709. en:myopathia -- r_associated #0: 5 / 0.143 -> en:large lipid droplets
    n1=en:myopathia | n2=en:large lipid droplets | rel=r_associated | relid=0 | w=5
  710. en:myopathia -- r_associated #0: 5 / 0.143 -> en:left cataract
    n1=en:myopathia | n2=en:left cataract | rel=r_associated | relid=0 | w=5
  711. en:myopathia -- r_associated #0: 5 / 0.143 -> en:leg cramps may occur with exercise
    n1=en:myopathia | n2=en:leg cramps may occur with exercise | rel=r_associated | relid=0 | w=5
  712. en:myopathia -- r_associated #0: 5 / 0.143 -> en:leg edema
    n1=en:myopathia | n2=en:leg edema | rel=r_associated | relid=0 | w=5
  713. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lens disorder
    n1=en:myopathia | n2=en:lens disorder | rel=r_associated | relid=0 | w=5
  714. en:myopathia -- r_associated #0: 5 / 0.143 -> en:levator palpebrae superioris atrophy
    n1=en:myopathia | n2=en:levator palpebrae superioris atrophy | rel=r_associated | relid=0 | w=5
  715. en:myopathia -- r_associated #0: 5 / 0.143 -> en:limb lymphedema (in some patients)
    n1=en:myopathia | n2=en:limb lymphedema (in some patients) | rel=r_associated | relid=0 | w=5
  716. en:myopathia -- r_associated #0: 5 / 0.143 -> en:limb muscle weakness and atrophy, distal, neurogenic
    n1=en:myopathia | n2=en:limb muscle weakness and atrophy, distal, neurogenic | rel=r_associated | relid=0 | w=5
  717. en:myopathia -- r_associated #0: 5 / 0.143 -> en:limb muscle weakness, proximal, upper and lower
    n1=en:myopathia | n2=en:limb muscle weakness, proximal, upper and lower | rel=r_associated | relid=0 | w=5
  718. en:myopathia -- r_associated #0: 5 / 0.143 -> en:limb muscular atrophy
    n1=en:myopathia | n2=en:limb muscular atrophy | rel=r_associated | relid=0 | w=5
  719. en:myopathia -- r_associated #0: 5 / 0.143 -> en:limb weakness and atrophy
    n1=en:myopathia | n2=en:limb weakness and atrophy | rel=r_associated | relid=0 | w=5
  720. en:myopathia -- r_associated #0: 5 / 0.143 -> en:limb weakness, proximal followed by distal
    n1=en:myopathia | n2=en:limb weakness, proximal followed by distal | rel=r_associated | relid=0 | w=5
  721. en:myopathia -- r_associated #0: 5 / 0.143 -> en:limb-girdle muscle atrophy
    n1=en:myopathia | n2=en:limb-girdle muscle atrophy | rel=r_associated | relid=0 | w=5
  722. en:myopathia -- r_associated #0: 5 / 0.143 -> en:limb-girdle muscle weakness (2 families)
    n1=en:myopathia | n2=en:limb-girdle muscle weakness (2 families) | rel=r_associated | relid=0 | w=5
  723. en:myopathia -- r_associated #0: 5 / 0.143 -> en:limb-girdle muscle weakness, proximal, upper greater than lower
    n1=en:myopathia | n2=en:limb-girdle muscle weakness, proximal, upper greater than lower | rel=r_associated | relid=0 | w=5
  724. en:myopathia -- r_associated #0: 5 / 0.143 -> en:limb-girdle myopathy
    n1=en:myopathia | n2=en:limb-girdle myopathy | rel=r_associated | relid=0 | w=5
  725. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipid accumulation in muscle tissue
    n1=en:myopathia | n2=en:lipid accumulation in muscle tissue | rel=r_associated | relid=0 | w=5
  726. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipid and glycogen accumulation
    n1=en:myopathia | n2=en:lipid and glycogen accumulation | rel=r_associated | relid=0 | w=5
  727. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipid droplet accumulation
    n1=en:myopathia | n2=en:lipid droplet accumulation | rel=r_associated | relid=0 | w=5
  728. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipid droplets seen on muscle biopsy
    n1=en:myopathia | n2=en:lipid droplets seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  729. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipoatrophic appearance
    n1=en:myopathia | n2=en:lipoatrophic appearance | rel=r_associated | relid=0 | w=5
  730. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipoatrophy (lower face, upper limb, buttock)
    n1=en:myopathia | n2=en:lipoatrophy (lower face, upper limb, buttock) | rel=r_associated | relid=0 | w=5
  731. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipoatrophy of trunk
    n1=en:myopathia | n2=en:lipoatrophy of trunk | rel=r_associated | relid=0 | w=5
  732. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipoatrophy, generalized
    n1=en:myopathia | n2=en:lipoatrophy, generalized | rel=r_associated | relid=0 | w=5
  733. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipodystrophy (in some patients)
    n1=en:myopathia | n2=en:lipodystrophy (in some patients) | rel=r_associated | relid=0 | w=5
  734. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipodystrophy, generalized, panniculitis-induced (in some)
    n1=en:myopathia | n2=en:lipodystrophy, generalized, panniculitis-induced (in some) | rel=r_associated | relid=0 | w=5
  735. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipohypoplasia, regional
    n1=en:myopathia | n2=en:lipohypoplasia, regional | rel=r_associated | relid=0 | w=5
  736. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipoma
    n1=en:myopathia | n2=en:lipoma | rel=r_associated | relid=0 | w=5
  737. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lipomas or lipomatous masses (most cases)
    n1=en:myopathia | n2=en:lipomas or lipomatous masses (most cases) | rel=r_associated | relid=0 | w=5
  738. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of ability to walk in early childhood
    n1=en:myopathia | n2=en:loss of ability to walk in early childhood | rel=r_associated | relid=0 | w=5
  739. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of adipose tissue occurs around puberty
    n1=en:myopathia | n2=en:loss of adipose tissue occurs around puberty | rel=r_associated | relid=0 | w=5
  740. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of ambulation (in some patients)
    n1=en:myopathia | n2=en:loss of ambulation (in some patients) | rel=r_associated | relid=0 | w=5
  741. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of ambulation between third and sixth decade
    n1=en:myopathia | n2=en:loss of ambulation between third and sixth decade | rel=r_associated | relid=0 | w=5
  742. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of antigravity strength
    n1=en:myopathia | n2=en:loss of antigravity strength | rel=r_associated | relid=0 | w=5
  743. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of consciousness
    n1=en:myopathia | n2=en:loss of consciousness | rel=r_associated | relid=0 | w=5
  744. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of gluteal adipose tissue
    n1=en:myopathia | n2=en:loss of gluteal adipose tissue | rel=r_associated | relid=0 | w=5
  745. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of independent ambulation around age 12 years
    n1=en:myopathia | n2=en:loss of independent ambulation around age 12 years | rel=r_associated | relid=0 | w=5
  746. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of lower-limb tendon reflexes
    n1=en:myopathia | n2=en:loss of lower-limb tendon reflexes | rel=r_associated | relid=0 | w=5
  747. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of sarcomeric striations
    n1=en:myopathia | n2=en:loss of sarcomeric striations | rel=r_associated | relid=0 | w=5
  748. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of subcutaneous adipose tissue from gluteal region
    n1=en:myopathia | n2=en:loss of subcutaneous adipose tissue from gluteal region | rel=r_associated | relid=0 | w=5
  749. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of subcutaneous adipose tissue from upper limbs and trunk
    n1=en:myopathia | n2=en:loss of subcutaneous adipose tissue from upper limbs and trunk | rel=r_associated | relid=0 | w=5
  750. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of subcutaneous adipose tissue in limbs
    n1=en:myopathia | n2=en:loss of subcutaneous adipose tissue in limbs | rel=r_associated | relid=0 | w=5
  751. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of subcutaneous adipose tissue primarily in gluteal region and lower limbs
    n1=en:myopathia | n2=en:loss of subcutaneous adipose tissue primarily in gluteal region and lower limbs | rel=r_associated | relid=0 | w=5
  752. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of subcutaneous and visceral adipose tissue, mild
    n1=en:myopathia | n2=en:loss of subcutaneous and visceral adipose tissue, mild | rel=r_associated | relid=0 | w=5
  753. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of subcutaneous fat, generalized
    n1=en:myopathia | n2=en:loss of subcutaneous fat, generalized | rel=r_associated | relid=0 | w=5
  754. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of subcutaneous fat, particularly affecting the limbs
    n1=en:myopathia | n2=en:loss of subcutaneous fat, particularly affecting the limbs | rel=r_associated | relid=0 | w=5
  755. en:myopathia -- r_associated #0: 5 / 0.143 -> en:loss of truncal subcutaneous adipose tissue
    n1=en:myopathia | n2=en:loss of truncal subcutaneous adipose tissue | rel=r_associated | relid=0 | w=5
  756. en:myopathia -- r_associated #0: 5 / 0.143 -> en:low maximum workload on exercise testing
    n1=en:myopathia | n2=en:low maximum workload on exercise testing | rel=r_associated | relid=0 | w=5
  757. en:myopathia -- r_associated #0: 5 / 0.143 -> en:low muscle mass
    n1=en:myopathia | n2=en:low muscle mass | rel=r_associated | relid=0 | w=5
  758. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lower and upper limbs affected
    n1=en:myopathia | n2=en:lower and upper limbs affected | rel=r_associated | relid=0 | w=5
  759. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lower limb muscle atrophy (in 2 of 3 families)
    n1=en:myopathia | n2=en:lower limb muscle atrophy (in 2 of 3 families) | rel=r_associated | relid=0 | w=5
  760. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lower limb muscle hypotrophy
    n1=en:myopathia | n2=en:lower limb muscle hypotrophy | rel=r_associated | relid=0 | w=5
  761. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lower limb muscle weakness (in 2 of 3 families)
    n1=en:myopathia | n2=en:lower limb muscle weakness (in 2 of 3 families) | rel=r_associated | relid=0 | w=5
  762. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lower limbs more often affected
    n1=en:myopathia | n2=en:lower limbs more often affected | rel=r_associated | relid=0 | w=5
  763. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphangiectasia
    n1=en:myopathia | n2=en:lymphangiectasia | rel=r_associated | relid=0 | w=5
  764. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphangitis, episodic
    n1=en:myopathia | n2=en:lymphangitis, episodic | rel=r_associated | relid=0 | w=5
  765. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphedema (lower limb)
    n1=en:myopathia | n2=en:lymphedema (lower limb) | rel=r_associated | relid=0 | w=5
  766. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphedema of lower limbs (in some patients)
    n1=en:myopathia | n2=en:lymphedema of lower limbs (in some patients) | rel=r_associated | relid=0 | w=5
  767. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphedema of the extremities
    n1=en:myopathia | n2=en:lymphedema of the extremities | rel=r_associated | relid=0 | w=5
  768. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphedema of the hands (in some patients)
    n1=en:myopathia | n2=en:lymphedema of the hands (in some patients) | rel=r_associated | relid=0 | w=5
  769. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphedema of the lower limbs (swelling is confined to below the knees)
    n1=en:myopathia | n2=en:lymphedema of the lower limbs (swelling is confined to below the knees) | rel=r_associated | relid=0 | w=5
  770. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphedema of upper and/or lower limbs (in some patients)
    n1=en:myopathia | n2=en:lymphedema of upper and/or lower limbs (in some patients) | rel=r_associated | relid=0 | w=5
  771. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphedema, dorsa of feet
    n1=en:myopathia | n2=en:lymphedema, dorsa of feet | rel=r_associated | relid=0 | w=5
  772. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphedema, hands (rare)
    n1=en:myopathia | n2=en:lymphedema, hands (rare) | rel=r_associated | relid=0 | w=5
  773. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphedema, of upper and/or lower extremity (rare)
    n1=en:myopathia | n2=en:lymphedema, of upper and/or lower extremity (rare) | rel=r_associated | relid=0 | w=5
  774. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphography shows hypoplasia of lymphatic vessels
    n1=en:myopathia | n2=en:lymphography shows hypoplasia of lymphatic vessels | rel=r_associated | relid=0 | w=5
  775. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphography shows increased number of dilated lymphatic vessels (hyperplasia)
    n1=en:myopathia | n2=en:lymphography shows increased number of dilated lymphatic vessels (hyperplasia) | rel=r_associated | relid=0 | w=5
  776. en:myopathia -- r_associated #0: 5 / 0.143 -> en:lymphoscintigraphy shows impaired lymphatic uptake and drainage
    n1=en:myopathia | n2=en:lymphoscintigraphy shows impaired lymphatic uptake and drainage | rel=r_associated | relid=0 | w=5
  777. en:myopathia -- r_associated #0: 5 / 0.143 -> en:macies
    n1=en:myopathia | n2=en:macies | rel=r_associated | relid=0 | w=5
  778. en:myopathia -- r_associated #0: 5 / 0.143 -> en:macrophagic myofasciitis
    n1=en:myopathia | n2=en:macrophagic myofasciitis | rel=r_associated | relid=0 | w=5
  779. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mallory-like bodies
    n1=en:myopathia | n2=en:mallory-like bodies | rel=r_associated | relid=0 | w=5
  780. en:myopathia -- r_associated #0: 5 / 0.143 -> en:many fibers with internal nuclei
    n1=en:myopathia | n2=en:many fibers with internal nuclei | rel=r_associated | relid=0 | w=5
  781. en:myopathia -- r_associated #0: 5 / 0.143 -> en:marked lack of adipose tissue
    n1=en:myopathia | n2=en:marked lack of adipose tissue | rel=r_associated | relid=0 | w=5
  782. en:myopathia -- r_associated #0: 5 / 0.143 -> en:marked loss of subcutaneous fat in the limbs, face, and sometimes chest
    n1=en:myopathia | n2=en:marked loss of subcutaneous fat in the limbs, face, and sometimes chest | rel=r_associated | relid=0 | w=5
  783. en:myopathia -- r_associated #0: 5 / 0.143 -> en:marked muscular hypertrophy
    n1=en:myopathia | n2=en:marked muscular hypertrophy | rel=r_associated | relid=0 | w=5
  784. en:myopathia -- r_associated #0: 5 / 0.143 -> en:marked predominance of slow-twitch, oxidative (type 1) muscle fibers
    n1=en:myopathia | n2=en:marked predominance of slow-twitch, oxidative (type 1) muscle fibers | rel=r_associated | relid=0 | w=5
  785. en:myopathia -- r_associated #0: 5 / 0.143 -> en:marked variability of fiber size
    n1=en:myopathia | n2=en:marked variability of fiber size | rel=r_associated | relid=0 | w=5
  786. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mental delay syndrome
    n1=en:myopathia | n2=en:mental delay syndrome | rel=r_associated | relid=0 | w=5
  787. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mental retardation
    n1=en:myopathia | n2=en:mental retardation | rel=r_associated | relid=0 | w=5
  788. en:myopathia -- r_associated #0: 5 / 0.143 -> en:merosin
    n1=en:myopathia | n2=en:merosin | rel=r_associated | relid=0 | w=5
  789. en:myopathia -- r_associated #0: 5 / 0.143 -> en:merosin-positive biopsy
    n1=en:myopathia | n2=en:merosin-positive biopsy | rel=r_associated | relid=0 | w=5
  790. en:myopathia -- r_associated #0: 5 / 0.143 -> en:microbiological
    n1=en:myopathia | n2=en:microbiological | rel=r_associated | relid=0 | w=5
  791. en:myopathia -- r_associated #0: 5 / 0.143 -> en:microcephaly
    n1=en:myopathia | n2=en:microcephaly | rel=r_associated | relid=0 | w=5
  792. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mild atrophy of the proximal lower limbs
    n1=en:myopathia | n2=en:mild atrophy of the proximal lower limbs | rel=r_associated | relid=0 | w=5
  793. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mild decrease in mitochondrial respiratory chain activity
    n1=en:myopathia | n2=en:mild decrease in mitochondrial respiratory chain activity | rel=r_associated | relid=0 | w=5
  794. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mild distal muscle atrophy
    n1=en:myopathia | n2=en:mild distal muscle atrophy | rel=r_associated | relid=0 | w=5
  795. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mild muscle atrophy in forearm muscles
    n1=en:myopathia | n2=en:mild muscle atrophy in forearm muscles | rel=r_associated | relid=0 | w=5
  796. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mild proximal muscle weakness (<10% of patients)
    n1=en:myopathia | n2=en:mild proximal muscle weakness (<10% of patients) | rel=r_associated | relid=0 | w=5
  797. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mild variability in muscle fiber size
    n1=en:myopathia | n2=en:mild variability in muscle fiber size | rel=r_associated | relid=0 | w=5
  798. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mild weakness
    n1=en:myopathia | n2=en:mild weakness | rel=r_associated | relid=0 | w=5
  799. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mild weakness of the small hand muscles
    n1=en:myopathia | n2=en:mild weakness of the small hand muscles | rel=r_associated | relid=0 | w=5
  800. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mildly decreased cytochrome c oxidase activity
    n1=en:myopathia | n2=en:mildly decreased cytochrome c oxidase activity | rel=r_associated | relid=0 | w=5
  801. en:myopathia -- r_associated #0: 5 / 0.143 -> en:minicore regions are poorly defined and do not extend through entire fiber length
    n1=en:myopathia | n2=en:minicore regions are poorly defined and do not extend through entire fiber length | rel=r_associated | relid=0 | w=5
  802. en:myopathia -- r_associated #0: 5 / 0.143 -> en:minicore-like lesions with mitochondrial depletion and sarcomeric disorganization
    n1=en:myopathia | n2=en:minicore-like lesions with mitochondrial depletion and sarcomeric disorganization | rel=r_associated | relid=0 | w=5
  803. en:myopathia -- r_associated #0: 5 / 0.143 -> en:minicores (in some)
    n1=en:myopathia | n2=en:minicores (in some) | rel=r_associated | relid=0 | w=5
  804. en:myopathia -- r_associated #0: 5 / 0.143 -> en:minicores extend full fiber diameter
    n1=en:myopathia | n2=en:minicores extend full fiber diameter | rel=r_associated | relid=0 | w=5
  805. en:myopathia -- r_associated #0: 5 / 0.143 -> en:minicores or core-like regions may be present
    n1=en:myopathia | n2=en:minicores or core-like regions may be present | rel=r_associated | relid=0 | w=5
  806. en:myopathia -- r_associated #0: 5 / 0.143 -> en:minimal subcutaneous fat
    n1=en:myopathia | n2=en:minimal subcutaneous fat | rel=r_associated | relid=0 | w=5
  807. en:myopathia -- r_associated #0: 5 / 0.143 -> en:minipolymyoclonus
    n1=en:myopathia | n2=en:minipolymyoclonus | rel=r_associated | relid=0 | w=5
  808. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mitochondria are placed at the periphery of muscle fibers
    n1=en:myopathia | n2=en:mitochondria are placed at the periphery of muscle fibers | rel=r_associated | relid=0 | w=5
  809. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mitochondria show paracrystalline inclusions
    n1=en:myopathia | n2=en:mitochondria show paracrystalline inclusions | rel=r_associated | relid=0 | w=5
  810. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mitochondrial encephalomyopathy
    n1=en:myopathia | n2=en:mitochondrial encephalomyopathy | rel=r_associated | relid=0 | w=5
  811. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mitochondrial myopathy
    n1=en:myopathia | n2=en:mitochondrial myopathy | rel=r_associated | relid=0 | w=5
  812. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mitochondrial myopathy with deletion of mitochondrial DNA
    n1=en:myopathia | n2=en:mitochondrial myopathy with deletion of mitochondrial DNA | rel=r_associated | relid=0 | w=5
  813. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mitochondrial paracrystalline inclusion bodies
    n1=en:myopathia | n2=en:mitochondrial paracrystalline inclusion bodies | rel=r_associated | relid=0 | w=5
  814. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mitochondrial proliferation
    n1=en:myopathia | n2=en:mitochondrial proliferation | rel=r_associated | relid=0 | w=5
  815. en:myopathia -- r_associated #0: 5 / 0.143 -> en:mitochondrial vacuolization seen on muscle biopsy
    n1=en:myopathia | n2=en:mitochondrial vacuolization seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  816. en:myopathia -- r_associated #0: 5 / 0.143 -> en:Miyoshi's myopathie
    n1=en:myopathia | n2=en:Miyoshi's myopathie | rel=r_associated | relid=0 | w=5
  817. en:myopathia -- r_associated #0: 5 / 0.143 -> en:motor clumsiness
    n1=en:myopathia | n2=en:motor clumsiness | rel=r_associated | relid=0 | w=5
  818. en:myopathia -- r_associated #0: 5 / 0.143 -> en:multi-core congenital myopathy
    n1=en:myopathia | n2=en:multi-core congenital myopathy | rel=r_associated | relid=0 | w=5
  819. en:myopathia -- r_associated #0: 5 / 0.143 -> en:multicore disease
    n1=en:myopathia | n2=en:multicore disease | rel=r_associated | relid=0 | w=5
  820. en:myopathia -- r_associated #0: 5 / 0.143 -> en:multiple core myopathy
    n1=en:myopathia | n2=en:multiple core myopathy | rel=r_associated | relid=0 | w=5
  821. en:myopathia -- r_associated #0: 5 / 0.143 -> en:multiple mitochondrial respiratory enzymes deficiencies seen on biopsy
    n1=en:myopathia | n2=en:multiple mitochondrial respiratory enzymes deficiencies seen on biopsy | rel=r_associated | relid=0 | w=5
  822. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle aches, cramps
    n1=en:myopathia | n2=en:muscle aches, cramps | rel=r_associated | relid=0 | w=5
  823. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle aches, intermittent
    n1=en:myopathia | n2=en:muscle aches, intermittent | rel=r_associated | relid=0 | w=5
  824. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle amyotrophy
    n1=en:myopathia | n2=en:muscle amyotrophy | rel=r_associated | relid=0 | w=5
  825. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy
    n1=en:myopathia | n2=en:muscle atrophy | rel=r_associated | relid=0 | w=5
  826. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy (1 patient)
    n1=en:myopathia | n2=en:muscle atrophy (1 patient) | rel=r_associated | relid=0 | w=5
  827. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy (in some patients)
    n1=en:myopathia | n2=en:muscle atrophy (in some patients) | rel=r_associated | relid=0 | w=5
  828. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy (variable)
    n1=en:myopathia | n2=en:muscle atrophy (variable) | rel=r_associated | relid=0 | w=5
  829. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy affecting the upper back and neck muscles
    n1=en:myopathia | n2=en:muscle atrophy affecting the upper back and neck muscles | rel=r_associated | relid=0 | w=5
  830. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy appears later in disease course
    n1=en:myopathia | n2=en:muscle atrophy appears later in disease course | rel=r_associated | relid=0 | w=5
  831. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy in the limbs
    n1=en:myopathia | n2=en:muscle atrophy in the limbs | rel=r_associated | relid=0 | w=5
  832. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy later in the disease
    n1=en:myopathia | n2=en:muscle atrophy later in the disease | rel=r_associated | relid=0 | w=5
  833. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy restricted to the upper limb
    n1=en:myopathia | n2=en:muscle atrophy restricted to the upper limb | rel=r_associated | relid=0 | w=5
  834. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy, diffuse, severe
    n1=en:myopathia | n2=en:muscle atrophy, diffuse, severe | rel=r_associated | relid=0 | w=5
  835. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy, especially quadriceps and forearm muscles
    n1=en:myopathia | n2=en:muscle atrophy, especially quadriceps and forearm muscles | rel=r_associated | relid=0 | w=5
  836. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy, limb-girdle and proximal
    n1=en:myopathia | n2=en:muscle atrophy, limb-girdle and proximal | rel=r_associated | relid=0 | w=5
  837. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy, mild
    n1=en:myopathia | n2=en:muscle atrophy, mild | rel=r_associated | relid=0 | w=5
  838. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy, mild, more proximal than distal
    n1=en:myopathia | n2=en:muscle atrophy, mild, more proximal than distal | rel=r_associated | relid=0 | w=5
  839. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy, primarily in the legs
    n1=en:myopathia | n2=en:muscle atrophy, primarily in the legs | rel=r_associated | relid=0 | w=5
  840. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy, progressive
    n1=en:myopathia | n2=en:muscle atrophy, progressive | rel=r_associated | relid=0 | w=5
  841. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy, proximal and distal (predominant lower limb involvement)
    n1=en:myopathia | n2=en:muscle atrophy, proximal and distal (predominant lower limb involvement) | rel=r_associated | relid=0 | w=5
  842. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle atrophy, severe
    n1=en:myopathia | n2=en:muscle atrophy, severe | rel=r_associated | relid=0 | w=5
  843. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy in acute stage shows increased numbers of abnormal mitochondria
    n1=en:myopathia | n2=en:muscle biopsy in acute stage shows increased numbers of abnormal mitochondria | rel=r_associated | relid=0 | w=5
  844. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy is immunopositive for merosin (156225)
    n1=en:myopathia | n2=en:muscle biopsy is immunopositive for merosin (156225) | rel=r_associated | relid=0 | w=5
  845. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy may show deficiency of multiple mitochondrial respiratory complexes
    n1=en:myopathia | n2=en:muscle biopsy may show deficiency of multiple mitochondrial respiratory complexes | rel=r_associated | relid=0 | w=5
  846. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy may show inflammatory changes
    n1=en:myopathia | n2=en:muscle biopsy may show inflammatory changes | rel=r_associated | relid=0 | w=5
  847. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows 'spheroid bodies' in type 1 muscle fibers
    n1=en:myopathia | n2=en:muscle biopsy shows 'spheroid bodies' in type 1 muscle fibers | rel=r_associated | relid=0 | w=5
  848. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows 60-80-nm tubular aggregates arranged in hexagonal arrays in type 2 fibers
    n1=en:myopathia | n2=en:muscle biopsy shows 60-80-nm tubular aggregates arranged in hexagonal arrays in type 2 fibers | rel=r_associated | relid=0 | w=5
  849. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows abnormal fiber size and variation
    n1=en:myopathia | n2=en:muscle biopsy shows abnormal fiber size and variation | rel=r_associated | relid=0 | w=5
  850. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows abnormal mitochondria
    n1=en:myopathia | n2=en:muscle biopsy shows abnormal mitochondria | rel=r_associated | relid=0 | w=5
  851. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows atrophic fibers
    n1=en:myopathia | n2=en:muscle biopsy shows atrophic fibers | rel=r_associated | relid=0 | w=5
  852. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows atrophy
    n1=en:myopathia | n2=en:muscle biopsy shows atrophy | rel=r_associated | relid=0 | w=5
  853. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows centralized nuclei
    n1=en:myopathia | n2=en:muscle biopsy shows centralized nuclei | rel=r_associated | relid=0 | w=5
  854. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows chronic and active denervation
    n1=en:myopathia | n2=en:muscle biopsy shows chronic and active denervation | rel=r_associated | relid=0 | w=5
  855. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows core-like regions devoid of oxidative activity
    n1=en:myopathia | n2=en:muscle biopsy shows core-like regions devoid of oxidative activity | rel=r_associated | relid=0 | w=5
  856. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows cytochrome c oxidase-negative fibers
    n1=en:myopathia | n2=en:muscle biopsy shows cytochrome c oxidase-negative fibers | rel=r_associated | relid=0 | w=5
  857. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows decrease or absence of cytochrome c oxidase
    n1=en:myopathia | n2=en:muscle biopsy shows decrease or absence of cytochrome c oxidase | rel=r_associated | relid=0 | w=5
  858. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows decreased activity of cytochrome c oxidase
    n1=en:myopathia | n2=en:muscle biopsy shows decreased activity of cytochrome c oxidase | rel=r_associated | relid=0 | w=5
  859. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan
    n1=en:myopathia | n2=en:muscle biopsy shows decreased glycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=5
  860. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows decreased muscle-specific phosphorylase kinase activity
    n1=en:myopathia | n2=en:muscle biopsy shows decreased muscle-specific phosphorylase kinase activity | rel=r_associated | relid=0 | w=5
  861. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows decreased or absent dysferlin staining
    n1=en:myopathia | n2=en:muscle biopsy shows decreased or absent dysferlin staining | rel=r_associated | relid=0 | w=5
  862. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows degenerating endplates and junctional folds
    n1=en:myopathia | n2=en:muscle biopsy shows degenerating endplates and junctional folds | rel=r_associated | relid=0 | w=5
  863. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows degeneration of muscle fibers, variation in fiber size, fiber splitting, rimmed vacuoles, and central myonuclei
    n1=en:myopathia | n2=en:muscle biopsy shows degeneration of muscle fibers, variation in fiber size, fiber splitting, rimmed vacuoles, and central myonuclei | rel=r_associated | relid=0 | w=5
  864. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows disruption of the sarcolemmal membrane
    n1=en:myopathia | n2=en:muscle biopsy shows disruption of the sarcolemmal membrane | rel=r_associated | relid=0 | w=5
  865. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows dystrophic changes
    n1=en:myopathia | n2=en:muscle biopsy shows dystrophic changes | rel=r_associated | relid=0 | w=5
  866. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows dystrophic features
    n1=en:myopathia | n2=en:muscle biopsy shows dystrophic features | rel=r_associated | relid=0 | w=5
  867. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows dystrophic features (later in disease course)
    n1=en:myopathia | n2=en:muscle biopsy shows dystrophic features (later in disease course) | rel=r_associated | relid=0 | w=5
  868. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows dystrophic pattern
    n1=en:myopathia | n2=en:muscle biopsy shows dystrophic pattern | rel=r_associated | relid=0 | w=5
  869. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows fiber type disproportion
    n1=en:myopathia | n2=en:muscle biopsy shows fiber type disproportion | rel=r_associated | relid=0 | w=5
  870. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows fiber type variation (in some patients)
    n1=en:myopathia | n2=en:muscle biopsy shows fiber type variation (in some patients) | rel=r_associated | relid=0 | w=5
  871. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows fibrosis and increased connective tissue
    n1=en:myopathia | n2=en:muscle biopsy shows fibrosis and increased connective tissue | rel=r_associated | relid=0 | w=5
  872. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows glycogen accumulation in myofibrils and lysosomes
    n1=en:myopathia | n2=en:muscle biopsy shows glycogen accumulation in myofibrils and lysosomes | rel=r_associated | relid=0 | w=5
  873. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows glycogen storage
    n1=en:myopathia | n2=en:muscle biopsy shows glycogen storage | rel=r_associated | relid=0 | w=5
  874. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows grouped atrophy
    n1=en:myopathia | n2=en:muscle biopsy shows grouped atrophy | rel=r_associated | relid=0 | w=5
  875. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows groups of small angulated fibers consistent with denervation
    n1=en:myopathia | n2=en:muscle biopsy shows groups of small angulated fibers consistent with denervation | rel=r_associated | relid=0 | w=5
  876. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows hypoglycosylation of alpha-dystroglycan
    n1=en:myopathia | n2=en:muscle biopsy shows hypoglycosylation of alpha-dystroglycan | rel=r_associated | relid=0 | w=5
  877. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows hypotrophy of type 1 muscle fibers
    n1=en:myopathia | n2=en:muscle biopsy shows hypotrophy of type 1 muscle fibers | rel=r_associated | relid=0 | w=5
  878. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows increased subsarcolemmal vacuolar glycogen accumulation
    n1=en:myopathia | n2=en:muscle biopsy shows increased subsarcolemmal vacuolar glycogen accumulation | rel=r_associated | relid=0 | w=5
  879. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows increased variation in fiber size
    n1=en:myopathia | n2=en:muscle biopsy shows increased variation in fiber size | rel=r_associated | relid=0 | w=5
  880. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows intranuclear tubulofilamentous inclusions
    n1=en:myopathia | n2=en:muscle biopsy shows intranuclear tubulofilamentous inclusions | rel=r_associated | relid=0 | w=5
  881. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows lipid deposition
    n1=en:myopathia | n2=en:muscle biopsy shows lipid deposition | rel=r_associated | relid=0 | w=5
  882. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows lipid droplets
    n1=en:myopathia | n2=en:muscle biopsy shows lipid droplets | rel=r_associated | relid=0 | w=5
  883. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows loss of myofibrillar organization
    n1=en:myopathia | n2=en:muscle biopsy shows loss of myofibrillar organization | rel=r_associated | relid=0 | w=5
  884. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows merosin (156225)-positive muscle fibers
    n1=en:myopathia | n2=en:muscle biopsy shows merosin (156225)-positive muscle fibers | rel=r_associated | relid=0 | w=5
  885. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows mild dystrophic changes
    n1=en:myopathia | n2=en:muscle biopsy shows mild dystrophic changes | rel=r_associated | relid=0 | w=5
  886. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows mitochondrial aggregates
    n1=en:myopathia | n2=en:muscle biopsy shows mitochondrial aggregates | rel=r_associated | relid=0 | w=5
  887. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows mitochondrial paracrystalline inclusions
    n1=en:myopathia | n2=en:muscle biopsy shows mitochondrial paracrystalline inclusions | rel=r_associated | relid=0 | w=5
  888. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows myodegenerative changes with beta-amyloid and phosphorylated tau deposits
    n1=en:myopathia | n2=en:muscle biopsy shows myodegenerative changes with beta-amyloid and phosphorylated tau deposits | rel=r_associated | relid=0 | w=5
  889. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows myofiber degeneration
    n1=en:myopathia | n2=en:muscle biopsy shows myofiber degeneration | rel=r_associated | relid=0 | w=5
  890. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows myofibrillar changes
    n1=en:myopathia | n2=en:muscle biopsy shows myofibrillar changes | rel=r_associated | relid=0 | w=5
  891. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows myofibrillar disruption
    n1=en:myopathia | n2=en:muscle biopsy shows myofibrillar disruption | rel=r_associated | relid=0 | w=5
  892. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows myofibrillar myopathy
    n1=en:myopathia | n2=en:muscle biopsy shows myofibrillar myopathy | rel=r_associated | relid=0 | w=5
  893. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows myopathic changes
    n1=en:myopathia | n2=en:muscle biopsy shows myopathic changes | rel=r_associated | relid=0 | w=5
  894. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows myopathic or dystrophic changes
    n1=en:myopathia | n2=en:muscle biopsy shows myopathic or dystrophic changes | rel=r_associated | relid=0 | w=5
  895. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows necrotic and atrophic fibers with centralized nuclei
    n1=en:myopathia | n2=en:muscle biopsy shows necrotic and atrophic fibers with centralized nuclei | rel=r_associated | relid=0 | w=5
  896. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows necrotic and regenerating fibers
    n1=en:myopathia | n2=en:muscle biopsy shows necrotic and regenerating fibers | rel=r_associated | relid=0 | w=5
  897. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows nemaline rods
    n1=en:myopathia | n2=en:muscle biopsy shows nemaline rods | rel=r_associated | relid=0 | w=5
  898. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows neurogenic atrophy
    n1=en:myopathia | n2=en:muscle biopsy shows neurogenic atrophy | rel=r_associated | relid=0 | w=5
  899. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows neurogenic atrophy affecting both fibers types
    n1=en:myopathia | n2=en:muscle biopsy shows neurogenic atrophy affecting both fibers types | rel=r_associated | relid=0 | w=5
  900. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows no dystrophic changes
    n1=en:myopathia | n2=en:muscle biopsy shows no dystrophic changes | rel=r_associated | relid=0 | w=5
  901. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows nonspecific myopathic changes
    n1=en:myopathia | n2=en:muscle biopsy shows nonspecific myopathic changes | rel=r_associated | relid=0 | w=5
  902. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows nonspecific myopathic changes without dystrophic or inflammatory changes
    n1=en:myopathia | n2=en:muscle biopsy shows nonspecific myopathic changes without dystrophic or inflammatory changes | rel=r_associated | relid=0 | w=5
  903. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows peripheral accumulation of abnormal mitochondria
    n1=en:myopathia | n2=en:muscle biopsy shows peripheral accumulation of abnormal mitochondria | rel=r_associated | relid=0 | w=5
  904. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows ragged red fibers
    n1=en:myopathia | n2=en:muscle biopsy shows ragged red fibers | rel=r_associated | relid=0 | w=5
  905. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows rimmed vacuoles
    n1=en:myopathia | n2=en:muscle biopsy shows rimmed vacuoles | rel=r_associated | relid=0 | w=5
  906. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows sarcoplasmic rods in myofibers
    n1=en:myopathia | n2=en:muscle biopsy shows sarcoplasmic rods in myofibers | rel=r_associated | relid=0 | w=5
  907. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows small fibers with central nuclei and accumulation of mitochondria in the central part of the fibers
    n1=en:myopathia | n2=en:muscle biopsy shows small fibers with central nuclei and accumulation of mitochondria in the central part of the fibers | rel=r_associated | relid=0 | w=5
  908. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows small rounded fibers
    n1=en:myopathia | n2=en:muscle biopsy shows small rounded fibers | rel=r_associated | relid=0 | w=5
  909. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows small, membrane-bound vacuoles predominantly in type 2 fibers
    n1=en:myopathia | n2=en:muscle biopsy shows small, membrane-bound vacuoles predominantly in type 2 fibers | rel=r_associated | relid=0 | w=5
  910. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows type 1 fiber predominance
    n1=en:myopathia | n2=en:muscle biopsy shows type 1 fiber predominance | rel=r_associated | relid=0 | w=5
  911. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows type 1 fiber predominance and hypertrophy
    n1=en:myopathia | n2=en:muscle biopsy shows type 1 fiber predominance and hypertrophy | rel=r_associated | relid=0 | w=5
  912. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows type 2 fiber atrophy
    n1=en:myopathia | n2=en:muscle biopsy shows type 2 fiber atrophy | rel=r_associated | relid=0 | w=5
  913. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle biopsy shows variation in fiber size
    n1=en:myopathia | n2=en:muscle biopsy shows variation in fiber size | rel=r_associated | relid=0 | w=5
  914. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle cramps (also seen in some heterozygotes)
    n1=en:myopathia | n2=en:muscle cramps (also seen in some heterozygotes) | rel=r_associated | relid=0 | w=5
  915. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle cramps affect the upper and lower limbs
    n1=en:myopathia | n2=en:muscle cramps affect the upper and lower limbs | rel=r_associated | relid=0 | w=5
  916. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle cramps during exercise
    n1=en:myopathia | n2=en:muscle cramps during exercise | rel=r_associated | relid=0 | w=5
  917. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle cramps may affect jaw muscles
    n1=en:myopathia | n2=en:muscle cramps may affect jaw muscles | rel=r_associated | relid=0 | w=5
  918. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle cramps, painful, recurrent
    n1=en:myopathia | n2=en:muscle cramps, painful, recurrent | rel=r_associated | relid=0 | w=5
  919. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fatigability
    n1=en:myopathia | n2=en:muscle fatigability | rel=r_associated | relid=0 | w=5
  920. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fatigue
    n1=en:myopathia | n2=en:muscle fatigue | rel=r_associated | relid=0 | w=5
  921. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fiber atrophy, profound (rare)
    n1=en:myopathia | n2=en:muscle fiber atrophy, profound (rare) | rel=r_associated | relid=0 | w=5
  922. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fiber necrosis
    n1=en:myopathia | n2=en:muscle fiber necrosis | rel=r_associated | relid=0 | w=5
  923. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fiber regeneration
    n1=en:myopathia | n2=en:muscle fiber regeneration | rel=r_associated | relid=0 | w=5
  924. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fiber splitting
    n1=en:myopathia | n2=en:muscle fiber splitting | rel=r_associated | relid=0 | w=5
  925. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fiber splitting (in some patients)
    n1=en:myopathia | n2=en:muscle fiber splitting (in some patients) | rel=r_associated | relid=0 | w=5
  926. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fiber splitting and fibrosis seen on muscle biopsy
    n1=en:myopathia | n2=en:muscle fiber splitting and fibrosis seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  927. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fibers appear as fetal myotubules
    n1=en:myopathia | n2=en:muscle fibers appear as fetal myotubules | rel=r_associated | relid=0 | w=5
  928. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fibers are immunoreactive for desmin and vimentin
    n1=en:myopathia | n2=en:muscle fibers are immunoreactive for desmin and vimentin | rel=r_associated | relid=0 | w=5
  929. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fibers contain internal nuclei
    n1=en:myopathia | n2=en:muscle fibers contain internal nuclei | rel=r_associated | relid=0 | w=5
  930. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle fibers may contain abnormal polysaccharide
    n1=en:myopathia | n2=en:muscle fibers may contain abnormal polysaccharide | rel=r_associated | relid=0 | w=5
  931. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle hematoma
    n1=en:myopathia | n2=en:muscle hematoma | rel=r_associated | relid=0 | w=5
  932. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle hyperirritability
    n1=en:myopathia | n2=en:muscle hyperirritability | rel=r_associated | relid=0 | w=5
  933. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle hypertrophy
    n1=en:myopathia | n2=en:muscle hypertrophy | rel=r_associated | relid=0 | w=5
  934. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle hypertrophy in affected area
    n1=en:myopathia | n2=en:muscle hypertrophy in affected area | rel=r_associated | relid=0 | w=5
  935. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle hypertrophy of the lower extremities
    n1=en:myopathia | n2=en:muscle hypertrophy of the lower extremities | rel=r_associated | relid=0 | w=5
  936. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle mitochondria normal by histochemical analysis
    n1=en:myopathia | n2=en:muscle mitochondria normal by histochemical analysis | rel=r_associated | relid=0 | w=5
  937. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle mounding
    n1=en:myopathia | n2=en:muscle mounding | rel=r_associated | relid=0 | w=5
  938. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle pain (less common)
    n1=en:myopathia | n2=en:muscle pain (less common) | rel=r_associated | relid=0 | w=5
  939. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle pain after exercise
    n1=en:myopathia | n2=en:muscle pain after exercise | rel=r_associated | relid=0 | w=5
  940. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle pain and cramping on exertion
    n1=en:myopathia | n2=en:muscle pain and cramping on exertion | rel=r_associated | relid=0 | w=5
  941. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle pain and cramps following exercise
    n1=en:myopathia | n2=en:muscle pain and cramps following exercise | rel=r_associated | relid=0 | w=5
  942. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle pain with exercise (in older patients)
    n1=en:myopathia | n2=en:muscle pain with exercise (in older patients) | rel=r_associated | relid=0 | w=5
  943. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle paralysis, episodic
    n1=en:myopathia | n2=en:muscle paralysis, episodic | rel=r_associated | relid=0 | w=5
  944. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle shows lipid accumulation
    n1=en:myopathia | n2=en:muscle shows lipid accumulation | rel=r_associated | relid=0 | w=5
  945. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle stiffness (in older patients)
    n1=en:myopathia | n2=en:muscle stiffness (in older patients) | rel=r_associated | relid=0 | w=5
  946. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle stiffness or aching
    n1=en:myopathia | n2=en:muscle stiffness or aching | rel=r_associated | relid=0 | w=5
  947. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle strength and bulk is preserved
    n1=en:myopathia | n2=en:muscle strength and bulk is preserved | rel=r_associated | relid=0 | w=5
  948. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle wasting (especially legs and arms)
    n1=en:myopathia | n2=en:muscle wasting (especially legs and arms) | rel=r_associated | relid=0 | w=5
  949. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle wasting due to chronic denervation
    n1=en:myopathia | n2=en:muscle wasting due to chronic denervation | rel=r_associated | relid=0 | w=5
  950. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle wasting in lower limbs
    n1=en:myopathia | n2=en:muscle wasting in lower limbs | rel=r_associated | relid=0 | w=5
  951. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle wasting, severe, primarily in the legs
    n1=en:myopathia | n2=en:muscle wasting, severe, primarily in the legs | rel=r_associated | relid=0 | w=5
  952. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness
    n1=en:myopathia | n2=en:muscle weakness | rel=r_associated | relid=0 | w=5
  953. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness (1 patient)
    n1=en:myopathia | n2=en:muscle weakness (1 patient) | rel=r_associated | relid=0 | w=5
  954. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness (in 90% of patients)
    n1=en:myopathia | n2=en:muscle weakness (in 90% of patients) | rel=r_associated | relid=0 | w=5
  955. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness (in some patients)
    n1=en:myopathia | n2=en:muscle weakness (in some patients) | rel=r_associated | relid=0 | w=5
  956. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness after cooling or on warming affected muscle
    n1=en:myopathia | n2=en:muscle weakness after cooling or on warming affected muscle | rel=r_associated | relid=0 | w=5
  957. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness and atrophy
    n1=en:myopathia | n2=en:muscle weakness and atrophy | rel=r_associated | relid=0 | w=5
  958. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness and atrophy may be asymmetric
    n1=en:myopathia | n2=en:muscle weakness and atrophy may be asymmetric | rel=r_associated | relid=0 | w=5
  959. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness and atrophy, distal
    n1=en:myopathia | n2=en:muscle weakness and atrophy, distal | rel=r_associated | relid=0 | w=5
  960. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness and atrophy, progressive
    n1=en:myopathia | n2=en:muscle weakness and atrophy, progressive | rel=r_associated | relid=0 | w=5
  961. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness and atrophy, proximal
    n1=en:myopathia | n2=en:muscle weakness and atrophy, proximal | rel=r_associated | relid=0 | w=5
  962. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness associated with fasting or infection
    n1=en:myopathia | n2=en:muscle weakness associated with fasting or infection | rel=r_associated | relid=0 | w=5
  963. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness due to peripheral neuropathy
    n1=en:myopathia | n2=en:muscle weakness due to peripheral neuropathy | rel=r_associated | relid=0 | w=5
  964. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness following prolonged exercise
    n1=en:myopathia | n2=en:muscle weakness following prolonged exercise | rel=r_associated | relid=0 | w=5
  965. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness in forearm muscles
    n1=en:myopathia | n2=en:muscle weakness in forearm muscles | rel=r_associated | relid=0 | w=5
  966. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness is not a feature
    n1=en:myopathia | n2=en:muscle weakness is not a feature | rel=r_associated | relid=0 | w=5
  967. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness is predominantly of extremities and tongue
    n1=en:myopathia | n2=en:muscle weakness is predominantly of extremities and tongue | rel=r_associated | relid=0 | w=5
  968. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness may affect upper limbs
    n1=en:myopathia | n2=en:muscle weakness may affect upper limbs | rel=r_associated | relid=0 | w=5
  969. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness of proximal and distal upper and lower limbs
    n1=en:myopathia | n2=en:muscle weakness of proximal and distal upper and lower limbs | rel=r_associated | relid=0 | w=5
  970. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness of the face and neck, mild to moderate
    n1=en:myopathia | n2=en:muscle weakness of the face and neck, mild to moderate | rel=r_associated | relid=0 | w=5
  971. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness restricted to the upper limb
    n1=en:myopathia | n2=en:muscle weakness restricted to the upper limb | rel=r_associated | relid=0 | w=5
  972. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness usually does not occur
    n1=en:myopathia | n2=en:muscle weakness usually does not occur | rel=r_associated | relid=0 | w=5
  973. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, congenital
    n1=en:myopathia | n2=en:muscle weakness, congenital | rel=r_associated | relid=0 | w=5
  974. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, distal (in some patients)
    n1=en:myopathia | n2=en:muscle weakness, distal (in some patients) | rel=r_associated | relid=0 | w=5
  975. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, distal more than proximal
    n1=en:myopathia | n2=en:muscle weakness, distal more than proximal | rel=r_associated | relid=0 | w=5
  976. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, distal, particularly affecting the hands
    n1=en:myopathia | n2=en:muscle weakness, distal, particularly affecting the hands | rel=r_associated | relid=0 | w=5
  977. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, distal, restricted to the lower limbs
    n1=en:myopathia | n2=en:muscle weakness, distal, restricted to the lower limbs | rel=r_associated | relid=0 | w=5
  978. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, episodic
    n1=en:myopathia | n2=en:muscle weakness, episodic | rel=r_associated | relid=0 | w=5
  979. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, hypokalemia-related
    n1=en:myopathia | n2=en:muscle weakness, hypokalemia-related | rel=r_associated | relid=0 | w=5
  980. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, limb-girdle (lower and upper limbs may be affected)
    n1=en:myopathia | n2=en:muscle weakness, limb-girdle (lower and upper limbs may be affected) | rel=r_associated | relid=0 | w=5
  981. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, limb-girdle, mild
    n1=en:myopathia | n2=en:muscle weakness, limb-girdle, mild | rel=r_associated | relid=0 | w=5
  982. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, lower limbs, during exercise
    n1=en:myopathia | n2=en:muscle weakness, lower limbs, during exercise | rel=r_associated | relid=0 | w=5
  983. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, mainly proximal and axial
    n1=en:myopathia | n2=en:muscle weakness, mainly proximal and axial | rel=r_associated | relid=0 | w=5
  984. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, mild, proximal and distal
    n1=en:myopathia | n2=en:muscle weakness, mild, proximal and distal | rel=r_associated | relid=0 | w=5
  985. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, predominantly proximal
    n1=en:myopathia | n2=en:muscle weakness, predominantly proximal | rel=r_associated | relid=0 | w=5
  986. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, predominantly proximal (in some patients)
    n1=en:myopathia | n2=en:muscle weakness, predominantly proximal (in some patients) | rel=r_associated | relid=0 | w=5
  987. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, primarily proximal
    n1=en:myopathia | n2=en:muscle weakness, primarily proximal | rel=r_associated | relid=0 | w=5
  988. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, proximal and distal
    n1=en:myopathia | n2=en:muscle weakness, proximal and distal | rel=r_associated | relid=0 | w=5
  989. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, proximal and distal (predominant lower limb involvement)
    n1=en:myopathia | n2=en:muscle weakness, proximal and distal (predominant lower limb involvement) | rel=r_associated | relid=0 | w=5
  990. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, proximal and distal, affecting upper and lower limbs
    n1=en:myopathia | n2=en:muscle weakness, proximal and distal, affecting upper and lower limbs | rel=r_associated | relid=0 | w=5
  991. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, proximal greater than distal
    n1=en:myopathia | n2=en:muscle weakness, proximal greater than distal | rel=r_associated | relid=0 | w=5
  992. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, proximal limb muscle, mild to moderate
    n1=en:myopathia | n2=en:muscle weakness, proximal limb muscle, mild to moderate | rel=r_associated | relid=0 | w=5
  993. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, proximal, distal, and axial, severe
    n1=en:myopathia | n2=en:muscle weakness, proximal, distal, and axial, severe | rel=r_associated | relid=0 | w=5
  994. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, proximal, limb-girdle
    n1=en:myopathia | n2=en:muscle weakness, proximal, limb-girdle | rel=r_associated | relid=0 | w=5
  995. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, proximal, lower limbs (upper limbs may become affected later)
    n1=en:myopathia | n2=en:muscle weakness, proximal, lower limbs (upper limbs may become affected later) | rel=r_associated | relid=0 | w=5
  996. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, proximal, pelvic girdle (in severe cases)
    n1=en:myopathia | n2=en:muscle weakness, proximal, pelvic girdle (in severe cases) | rel=r_associated | relid=0 | w=5
  997. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, proximal, slowly progressive
    n1=en:myopathia | n2=en:muscle weakness, proximal, slowly progressive | rel=r_associated | relid=0 | w=5
  998. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, proximal, upper and lower limbs affected
    n1=en:myopathia | n2=en:muscle weakness, proximal, upper and lower limbs affected | rel=r_associated | relid=0 | w=5
  999. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, severe
    n1=en:myopathia | n2=en:muscle weakness, severe | rel=r_associated | relid=0 | w=5
  1000. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, severe, axial and proximal predominance
    n1=en:myopathia | n2=en:muscle weakness, severe, axial and proximal predominance | rel=r_associated | relid=0 | w=5
  1001. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, severe, diffuse
    n1=en:myopathia | n2=en:muscle weakness, severe, diffuse | rel=r_associated | relid=0 | w=5
  1002. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, severe, proximal and distal
    n1=en:myopathia | n2=en:muscle weakness, severe, proximal and distal | rel=r_associated | relid=0 | w=5
  1003. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, symmetric, proximal, lower limbs
    n1=en:myopathia | n2=en:muscle weakness, symmetric, proximal, lower limbs | rel=r_associated | relid=0 | w=5
  1004. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscle weakness, upper and lower limbs
    n1=en:myopathia | n2=en:muscle weakness, upper and lower limbs | rel=r_associated | relid=0 | w=5
  1005. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscles become hard and tender during exercise
    n1=en:myopathia | n2=en:muscles become hard and tender during exercise | rel=r_associated | relid=0 | w=5
  1006. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscles have a woody consistency on palpation
    n1=en:myopathia | n2=en:muscles have a woody consistency on palpation | rel=r_associated | relid=0 | w=5
  1007. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscular appearance
    n1=en:myopathia | n2=en:muscular appearance | rel=r_associated | relid=0 | w=5
  1008. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscular dystrophy
    n1=en:myopathia | n2=en:muscular dystrophy | rel=r_associated | relid=0 | w=5
  1009. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscular dystrophy (in some patients)
    n1=en:myopathia | n2=en:muscular dystrophy (in some patients) | rel=r_associated | relid=0 | w=5
  1010. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscular dystrophy with variable age of onset (infancy to young adult)
    n1=en:myopathia | n2=en:muscular dystrophy with variable age of onset (infancy to young adult) | rel=r_associated | relid=0 | w=5
  1011. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscular hypotonia of the trunk
    n1=en:myopathia | n2=en:muscular hypotonia of the trunk | rel=r_associated | relid=0 | w=5
  1012. en:myopathia -- r_associated #0: 5 / 0.143 -> en:muscular rigidity
    n1=en:myopathia | n2=en:muscular rigidity | rel=r_associated | relid=0 | w=5
  1013. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myalgia
    n1=en:myopathia | n2=en:myalgia | rel=r_associated | relid=0 | w=5
  1014. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myalgia (in some patients)
    n1=en:myopathia | n2=en:myalgia (in some patients) | rel=r_associated | relid=0 | w=5
  1015. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myalgia with febrile episodes (rare)
    n1=en:myopathia | n2=en:myalgia with febrile episodes (rare) | rel=r_associated | relid=0 | w=5
  1016. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myalgia, episodic
    n1=en:myopathia | n2=en:myalgia, episodic | rel=r_associated | relid=0 | w=5
  1017. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myasthenias
    n1=en:myopathia | n2=en:myasthenias | rel=r_associated | relid=0 | w=5
  1018. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myoadenylate deaminase
    n1=en:myopathia | n2=en:myoadenylate deaminase | rel=r_associated | relid=0 | w=5
  1019. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myoclonic spasms
    n1=en:myopathia | n2=en:myoclonic spasms | rel=r_associated | relid=0 | w=5
  1020. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myodystrophia
    n1=en:myopathia | n2=en:myodystrophia | rel=r_associated | relid=0 | w=5
  1021. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myofibrillar disintegration
    n1=en:myopathia | n2=en:myofibrillar disintegration | rel=r_associated | relid=0 | w=5
  1022. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myofibrillar disorganization
    n1=en:myopathia | n2=en:myofibrillar disorganization | rel=r_associated | relid=0 | w=5
  1023. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myofibrillar lesions
    n1=en:myopathia | n2=en:myofibrillar lesions | rel=r_associated | relid=0 | w=5
  1024. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myofibrillar myopathy
    n1=en:myopathia | n2=en:myofibrillar myopathy | rel=r_associated | relid=0 | w=5
  1025. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myofibromatosis
    n1=en:myopathia | n2=en:myofibromatosis | rel=r_associated | relid=0 | w=5
  1026. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myofibromatosis affecting skin, muscle, bone, and viscera
    n1=en:myopathia | n2=en:myofibromatosis affecting skin, muscle, bone, and viscera | rel=r_associated | relid=0 | w=5
  1027. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myogenic profile on electromyography
    n1=en:myopathia | n2=en:myogenic profile on electromyography | rel=r_associated | relid=0 | w=5
  1028. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myokymia
    n1=en:myopathia | n2=en:myokymia | rel=r_associated | relid=0 | w=5
  1029. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathic changes on pathology
    n1=en:myopathia | n2=en:myopathic changes on pathology | rel=r_associated | relid=0 | w=5
  1030. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathic changes seen muscle biopsy
    n1=en:myopathia | n2=en:myopathic changes seen muscle biopsy | rel=r_associated | relid=0 | w=5
  1031. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathic changes seen on biopsy
    n1=en:myopathia | n2=en:myopathic changes seen on biopsy | rel=r_associated | relid=0 | w=5
  1032. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathic episodes triggered by exercise, fasting, infection, cold temperatures
    n1=en:myopathia | n2=en:myopathic episodes triggered by exercise, fasting, infection, cold temperatures | rel=r_associated | relid=0 | w=5
  1033. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathic features seen on biopsy
    n1=en:myopathia | n2=en:myopathic features seen on biopsy | rel=r_associated | relid=0 | w=5
  1034. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathic findings on biopsy have been occasionally reported
    n1=en:myopathia | n2=en:myopathic findings on biopsy have been occasionally reported | rel=r_associated | relid=0 | w=5
  1035. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathy (in some patients)
    n1=en:myopathia | n2=en:myopathy (in some patients) | rel=r_associated | relid=0 | w=5
  1036. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathy (rare)
    n1=en:myopathia | n2=en:myopathy (rare) | rel=r_associated | relid=0 | w=5
  1037. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathy and nephropathy
    n1=en:myopathia | n2=en:myopathy and nephropathy | rel=r_associated | relid=0 | w=5
  1038. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathy in approximately 45% of patients
    n1=en:myopathia | n2=en:myopathy in approximately 45% of patients | rel=r_associated | relid=0 | w=5
  1039. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathy with abnormal lipid metabolism
    n1=en:myopathia | n2=en:myopathy with abnormal lipid metabolism | rel=r_associated | relid=0 | w=5
  1040. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathy, mild
    n1=en:myopathia | n2=en:myopathy, mild | rel=r_associated | relid=0 | w=5
  1041. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathy, mild to severe
    n1=en:myopathia | n2=en:myopathy, mild to severe | rel=r_associated | relid=0 | w=5
  1042. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myopathy, nonprogressive
    n1=en:myopathia | n2=en:myopathy, nonprogressive | rel=r_associated | relid=0 | w=5
  1043. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myosin storage myopathy (in some patients)
    n1=en:myopathia | n2=en:myosin storage myopathy (in some patients) | rel=r_associated | relid=0 | w=5
  1044. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myositis (in some patients)
    n1=en:myopathia | n2=en:myositis (in some patients) | rel=r_associated | relid=0 | w=5
  1045. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotonia
    n1=en:myopathia | n2=en:myotonia | rel=r_associated | relid=0 | w=5
  1046. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotonia (delayed muscle relaxation after contraction)
    n1=en:myopathia | n2=en:myotonia (delayed muscle relaxation after contraction) | rel=r_associated | relid=0 | w=5
  1047. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotonia (usually occurs during rapid voluntary muscle movements after a period of rest)
    n1=en:myopathia | n2=en:myotonia (usually occurs during rapid voluntary muscle movements after a period of rest) | rel=r_associated | relid=0 | w=5
  1048. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotonia improves with continued activity ('warm-up phenomenon')
    n1=en:myopathia | n2=en:myotonia improves with continued activity ('warm-up phenomenon') | rel=r_associated | relid=0 | w=5
  1049. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotonia is most pronounced in the extremities
    n1=en:myopathia | n2=en:myotonia is most pronounced in the extremities | rel=r_associated | relid=0 | w=5
  1050. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotonia is present in majority of cases
    n1=en:myopathia | n2=en:myotonia is present in majority of cases | rel=r_associated | relid=0 | w=5
  1051. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotonia is usually not seen
    n1=en:myopathia | n2=en:myotonia is usually not seen | rel=r_associated | relid=0 | w=5
  1052. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotonia, cold-sensitive, predominantly of face, tongue, forearm, and hand precipitated by muscle cooling or cold exposure or rest after exercise
    n1=en:myopathia | n2=en:myotonia, cold-sensitive, predominantly of face, tongue, forearm, and hand precipitated by muscle cooling or cold exposure or rest after exercise | rel=r_associated | relid=0 | w=5
  1053. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotonia, potassium-sensitive (may be responsive to acetazolamide)
    n1=en:myopathia | n2=en:myotonia, potassium-sensitive (may be responsive to acetazolamide) | rel=r_associated | relid=0 | w=5
  1054. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotonic discharges
    n1=en:myopathia | n2=en:myotonic discharges | rel=r_associated | relid=0 | w=5
  1055. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotonic dystrophy
    n1=en:myopathia | n2=en:myotonic dystrophy | rel=r_associated | relid=0 | w=5
  1056. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myotubular myopathy
    n1=en:myopathia | n2=en:myotubular myopathy | rel=r_associated | relid=0 | w=5
  1057. en:myopathia -- r_associated #0: 5 / 0.143 -> en:myxedematous appearance
    n1=en:myopathia | n2=en:myxedematous appearance | rel=r_associated | relid=0 | w=5
  1058. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nearly complete absence of mechanical adipose tissue (joints, orbits, palms, soles)
    n1=en:myopathia | n2=en:nearly complete absence of mechanical adipose tissue (joints, orbits, palms, soles) | rel=r_associated | relid=0 | w=5
  1059. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nearly complete absence of metabolically active adipose tissue (subcutaneous, intraabdominal, intrathoracic)
    n1=en:myopathia | n2=en:nearly complete absence of metabolically active adipose tissue (subcutaneous, intraabdominal, intrathoracic) | rel=r_associated | relid=0 | w=5
  1060. en:myopathia -- r_associated #0: 5 / 0.143 -> en:neck and proximal limb muscle myopathy
    n1=en:myopathia | n2=en:neck and proximal limb muscle myopathy | rel=r_associated | relid=0 | w=5
  1061. en:myopathia -- r_associated #0: 5 / 0.143 -> en:neck flexor weakness
    n1=en:myopathia | n2=en:neck flexor weakness | rel=r_associated | relid=0 | w=5
  1062. en:myopathia -- r_associated #0: 5 / 0.143 -> en:neck muscle weakness
    n1=en:myopathia | n2=en:neck muscle weakness | rel=r_associated | relid=0 | w=5
  1063. en:myopathia -- r_associated #0: 5 / 0.143 -> en:necrosis and degeneration seen on muscle biopsy
    n1=en:myopathia | n2=en:necrosis and degeneration seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1064. en:myopathia -- r_associated #0: 5 / 0.143 -> en:necrotic and atrophic fibers with centralized nuclei
    n1=en:myopathia | n2=en:necrotic and atrophic fibers with centralized nuclei | rel=r_associated | relid=0 | w=5
  1065. en:myopathia -- r_associated #0: 5 / 0.143 -> en:necrotic and atrophic fibers with centralized nuclei seen on muscle biopsy
    n1=en:myopathia | n2=en:necrotic and atrophic fibers with centralized nuclei seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1066. en:myopathia -- r_associated #0: 5 / 0.143 -> en:necrotic and regenerating muscle fibers
    n1=en:myopathia | n2=en:necrotic and regenerating muscle fibers | rel=r_associated | relid=0 | w=5
  1067. en:myopathia -- r_associated #0: 5 / 0.143 -> en:necrotic change
    n1=en:myopathia | n2=en:necrotic change | rel=r_associated | relid=0 | w=5
  1068. en:myopathia -- r_associated #0: 5 / 0.143 -> en:necrotic fibers
    n1=en:myopathia | n2=en:necrotic fibers | rel=r_associated | relid=0 | w=5
  1069. en:myopathia -- r_associated #0: 5 / 0.143 -> en:necrotic process
    n1=en:myopathia | n2=en:necrotic process | rel=r_associated | relid=0 | w=5
  1070. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nemaline bodies
    n1=en:myopathia | n2=en:nemaline bodies | rel=r_associated | relid=0 | w=5
  1071. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nemaline bodies are rarely intranuclear
    n1=en:myopathia | n2=en:nemaline bodies are rarely intranuclear | rel=r_associated | relid=0 | w=5
  1072. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nemaline bodies are usually subsarcolemmal or sarcoplasmic
    n1=en:myopathia | n2=en:nemaline bodies are usually subsarcolemmal or sarcoplasmic | rel=r_associated | relid=0 | w=5
  1073. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nemaline bodies occur in type 1 fibers
    n1=en:myopathia | n2=en:nemaline bodies occur in type 1 fibers | rel=r_associated | relid=0 | w=5
  1074. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nemaline myopathy
    n1=en:myopathia | n2=en:nemaline myopathy | rel=r_associated | relid=0 | w=5
  1075. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nemaline myopathy (in 1 reported male)
    n1=en:myopathia | n2=en:nemaline myopathy (in 1 reported male) | rel=r_associated | relid=0 | w=5
  1076. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nemaline rod formation
    n1=en:myopathia | n2=en:nemaline rod formation | rel=r_associated | relid=0 | w=5
  1077. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nemaline rods (rare)
    n1=en:myopathia | n2=en:nemaline rods (rare) | rel=r_associated | relid=0 | w=5
  1078. en:myopathia -- r_associated #0: 5 / 0.143 -> en:neonatal hypertonias
    n1=en:myopathia | n2=en:neonatal hypertonias | rel=r_associated | relid=0 | w=5
  1079. en:myopathia -- r_associated #0: 5 / 0.143 -> en:neonatal hypotonia
    n1=en:myopathia | n2=en:neonatal hypotonia | rel=r_associated | relid=0 | w=5
  1080. en:myopathia -- r_associated #0: 5 / 0.143 -> en:neurogenic atrophy seen on muscle biopsy
    n1=en:myopathia | n2=en:neurogenic atrophy seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1081. en:myopathia -- r_associated #0: 5 / 0.143 -> en:neurogenic changes
    n1=en:myopathia | n2=en:neurogenic changes | rel=r_associated | relid=0 | w=5
  1082. en:myopathia -- r_associated #0: 5 / 0.143 -> en:neuropathic process seen on muscle biopsy
    n1=en:myopathia | n2=en:neuropathic process seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1083. en:myopathia -- r_associated #0: 5 / 0.143 -> en:no dystrophic changes
    n1=en:myopathia | n2=en:no dystrophic changes | rel=r_associated | relid=0 | w=5
  1084. en:myopathia -- r_associated #0: 5 / 0.143 -> en:no facial muscle involvement
    n1=en:myopathia | n2=en:no facial muscle involvement | rel=r_associated | relid=0 | w=5
  1085. en:myopathia -- r_associated #0: 5 / 0.143 -> en:no lipodystrophy in face and neck
    n1=en:myopathia | n2=en:no lipodystrophy in face and neck | rel=r_associated | relid=0 | w=5
  1086. en:myopathia -- r_associated #0: 5 / 0.143 -> en:no muscle fiber necrosis
    n1=en:myopathia | n2=en:no muscle fiber necrosis | rel=r_associated | relid=0 | w=5
  1087. en:myopathia -- r_associated #0: 5 / 0.143 -> en:no muscle weakness
    n1=en:myopathia | n2=en:no muscle weakness | rel=r_associated | relid=0 | w=5
  1088. en:myopathia -- r_associated #0: 5 / 0.143 -> en:no myofibrillar abnormalities or protein aggregation
    n1=en:myopathia | n2=en:no myofibrillar abnormalities or protein aggregation | rel=r_associated | relid=0 | w=5
  1089. en:myopathia -- r_associated #0: 5 / 0.143 -> en:no ragged-red fibers
    n1=en:myopathia | n2=en:no ragged-red fibers | rel=r_associated | relid=0 | w=5
  1090. en:myopathia -- r_associated #0: 5 / 0.143 -> en:no rods
    n1=en:myopathia | n2=en:no rods | rel=r_associated | relid=0 | w=5
  1091. en:myopathia -- r_associated #0: 5 / 0.143 -> en:no staining for oxidative enzymes
    n1=en:myopathia | n2=en:no staining for oxidative enzymes | rel=r_associated | relid=0 | w=5
  1092. en:myopathia -- r_associated #0: 5 / 0.143 -> en:non-pitting edema
    n1=en:myopathia | n2=en:non-pitting edema | rel=r_associated | relid=0 | w=5
  1093. en:myopathia -- r_associated #0: 5 / 0.143 -> en:noninflammatory myopathy with rimmed vacuoles and atrophic fibers seen on muscle biopsy
    n1=en:myopathia | n2=en:noninflammatory myopathy with rimmed vacuoles and atrophic fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1094. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nonspecific muscle fiber atrophy
    n1=en:myopathia | n2=en:nonspecific muscle fiber atrophy | rel=r_associated | relid=0 | w=5
  1095. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nonspecific myopathic changes
    n1=en:myopathia | n2=en:nonspecific myopathic changes | rel=r_associated | relid=0 | w=5
  1096. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nonspecific myopathic changes seen on biopsy
    n1=en:myopathia | n2=en:nonspecific myopathic changes seen on biopsy | rel=r_associated | relid=0 | w=5
  1097. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nonspecific myopathic changes without dystrophic or inflammatory changes seen on muscle biopsy
    n1=en:myopathia | n2=en:nonspecific myopathic changes without dystrophic or inflammatory changes seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1098. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nonspecific myopathy
    n1=en:myopathia | n2=en:nonspecific myopathy | rel=r_associated | relid=0 | w=5
  1099. en:myopathia -- r_associated #0: 5 / 0.143 -> en:normal dystrophin immunostaining
    n1=en:myopathia | n2=en:normal dystrophin immunostaining | rel=r_associated | relid=0 | w=5
  1100. en:myopathia -- r_associated #0: 5 / 0.143 -> en:normal mitochondrial morphology (1 patient)
    n1=en:myopathia | n2=en:normal mitochondrial morphology (1 patient) | rel=r_associated | relid=0 | w=5
  1101. en:myopathia -- r_associated #0: 5 / 0.143 -> en:normal neonatal period may occur before weakness is apparent
    n1=en:myopathia | n2=en:normal neonatal period may occur before weakness is apparent | rel=r_associated | relid=0 | w=5
  1102. en:myopathia -- r_associated #0: 5 / 0.143 -> en:normal or decreased facial and neck adipose tissue
    n1=en:myopathia | n2=en:normal or decreased facial and neck adipose tissue | rel=r_associated | relid=0 | w=5
  1103. en:myopathia -- r_associated #0: 5 / 0.143 -> en:normal or increased abdominal adipose tissue
    n1=en:myopathia | n2=en:normal or increased abdominal adipose tissue | rel=r_associated | relid=0 | w=5
  1104. en:myopathia -- r_associated #0: 5 / 0.143 -> en:normal or increased adipose tissue around the neck
    n1=en:myopathia | n2=en:normal or increased adipose tissue around the neck | rel=r_associated | relid=0 | w=5
  1105. en:myopathia -- r_associated #0: 5 / 0.143 -> en:normal or increased facial and neck adipose tissue
    n1=en:myopathia | n2=en:normal or increased facial and neck adipose tissue | rel=r_associated | relid=0 | w=5
  1106. en:myopathia -- r_associated #0: 5 / 0.143 -> en:normal or increased truncal adipose tissue
    n1=en:myopathia | n2=en:normal or increased truncal adipose tissue | rel=r_associated | relid=0 | w=5
  1107. en:myopathia -- r_associated #0: 5 / 0.143 -> en:normal phosphorylase kinase activity in muscle
    n1=en:myopathia | n2=en:normal phosphorylase kinase activity in muscle | rel=r_associated | relid=0 | w=5
  1108. en:myopathia -- r_associated #0: 5 / 0.143 -> en:nuclear clumps
    n1=en:myopathia | n2=en:nuclear clumps | rel=r_associated | relid=0 | w=5
  1109. en:myopathia -- r_associated #0: 5 / 0.143 -> en:numerous vacuole-like areas
    n1=en:myopathia | n2=en:numerous vacuole-like areas | rel=r_associated | relid=0 | w=5
  1110. en:myopathia -- r_associated #0: 5 / 0.143 -> en:onset of lymphedema around puberty
    n1=en:myopathia | n2=en:onset of lymphedema around puberty | rel=r_associated | relid=0 | w=5
  1111. en:myopathia -- r_associated #0: 5 / 0.143 -> en:onset of weakness in hands and feet
    n1=en:myopathia | n2=en:onset of weakness in hands and feet | rel=r_associated | relid=0 | w=5
  1112. en:myopathia -- r_associated #0: 5 / 0.143 -> en:optic atrophy
    n1=en:myopathia | n2=en:optic atrophy | rel=r_associated | relid=0 | w=5
  1113. en:myopathia -- r_associated #0: 5 / 0.143 -> en:other mitochondrial complex enzyme activities may also be decreased
    n1=en:myopathia | n2=en:other mitochondrial complex enzyme activities may also be decreased | rel=r_associated | relid=0 | w=5
  1114. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pain or cramping during sustained manual activity
    n1=en:myopathia | n2=en:pain or cramping during sustained manual activity | rel=r_associated | relid=0 | w=5
  1115. en:myopathia -- r_associated #0: 5 / 0.143 -> en:painful muscle cramps
    n1=en:myopathia | n2=en:painful muscle cramps | rel=r_associated | relid=0 | w=5
  1116. en:myopathia -- r_associated #0: 5 / 0.143 -> en:painful swelling in aponeuroses
    n1=en:myopathia | n2=en:painful swelling in aponeuroses | rel=r_associated | relid=0 | w=5
  1117. en:myopathia -- r_associated #0: 5 / 0.143 -> en:painful swelling in fasciae
    n1=en:myopathia | n2=en:painful swelling in fasciae | rel=r_associated | relid=0 | w=5
  1118. en:myopathia -- r_associated #0: 5 / 0.143 -> en:paracrystalline inclusions
    n1=en:myopathia | n2=en:paracrystalline inclusions | rel=r_associated | relid=0 | w=5
  1119. en:myopathia -- r_associated #0: 5 / 0.143 -> en:paradoxical myotonia (myotonia increases with exercise)
    n1=en:myopathia | n2=en:paradoxical myotonia (myotonia increases with exercise) | rel=r_associated | relid=0 | w=5
  1120. en:myopathia -- r_associated #0: 5 / 0.143 -> en:paralysis of the lower limbs (later)
    n1=en:myopathia | n2=en:paralysis of the lower limbs (later) | rel=r_associated | relid=0 | w=5
  1121. en:myopathia -- r_associated #0: 5 / 0.143 -> en:parasitology
    n1=en:myopathia | n2=en:parasitology | rel=r_associated | relid=0 | w=5
  1122. en:myopathia -- r_associated #0: 5 / 0.143 -> en:partial lipodystrophy (abnormal distribution of adipose tissue)
    n1=en:myopathia | n2=en:partial lipodystrophy (abnormal distribution of adipose tissue) | rel=r_associated | relid=0 | w=5
  1123. en:myopathia -- r_associated #0: 5 / 0.143 -> en:partial lipodystrophy (abnormal distribution of subcutaneous adipose tissue)
    n1=en:myopathia | n2=en:partial lipodystrophy (abnormal distribution of subcutaneous adipose tissue) | rel=r_associated | relid=0 | w=5
  1124. en:myopathia -- r_associated #0: 5 / 0.143 -> en:patchy muscle fiber degeneration
    n1=en:myopathia | n2=en:patchy muscle fiber degeneration | rel=r_associated | relid=0 | w=5
  1125. en:myopathia -- r_associated #0: 5 / 0.143 -> en:patients achieve independent ambulation, but may lose it
    n1=en:myopathia | n2=en:patients achieve independent ambulation, but may lose it | rel=r_associated | relid=0 | w=5
  1126. en:myopathia -- r_associated #0: 5 / 0.143 -> en:patients may have distal or proximal muscle weakness, or both
    n1=en:myopathia | n2=en:patients may have distal or proximal muscle weakness, or both | rel=r_associated | relid=0 | w=5
  1127. en:myopathia -- r_associated #0: 5 / 0.143 -> en:paucity or absence of lymph nodes in the axillae and above the inguinal ligaments seen on scintilymphangiography
    n1=en:myopathia | n2=en:paucity or absence of lymph nodes in the axillae and above the inguinal ligaments seen on scintilymphangiography | rel=r_associated | relid=0 | w=5
  1128. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pectoralis hypoplasia
    n1=en:myopathia | n2=en:pectoralis hypoplasia | rel=r_associated | relid=0 | w=5
  1129. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pectoralis major hypoplasia
    n1=en:myopathia | n2=en:pectoralis major hypoplasia | rel=r_associated | relid=0 | w=5
  1130. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pectoralis muscles may be less involved, leading to inward shrugging posture
    n1=en:myopathia | n2=en:pectoralis muscles may be less involved, leading to inward shrugging posture | rel=r_associated | relid=0 | w=5
  1131. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pelvic girdle muscle atrophy
    n1=en:myopathia | n2=en:pelvic girdle muscle atrophy | rel=r_associated | relid=0 | w=5
  1132. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pelvic girdle muscle weakness (occurs earlier)
    n1=en:myopathia | n2=en:pelvic girdle muscle weakness (occurs earlier) | rel=r_associated | relid=0 | w=5
  1133. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pelvic girdle weakness
    n1=en:myopathia | n2=en:pelvic girdle weakness | rel=r_associated | relid=0 | w=5
  1134. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pelvic girdle weakness and atrophy
    n1=en:myopathia | n2=en:pelvic girdle weakness and atrophy | rel=r_associated | relid=0 | w=5
  1135. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pelvic muscle involvement occurs later
    n1=en:myopathia | n2=en:pelvic muscle involvement occurs later | rel=r_associated | relid=0 | w=5
  1136. en:myopathia -- r_associated #0: 5 / 0.143 -> en:percussion myotonias
    n1=en:myopathia | n2=en:percussion myotonias | rel=r_associated | relid=0 | w=5
  1137. en:myopathia -- r_associated #0: 5 / 0.143 -> en:percussion-induced muscle mounding (muscle rippling)
    n1=en:myopathia | n2=en:percussion-induced muscle mounding (muscle rippling) | rel=r_associated | relid=0 | w=5
  1138. en:myopathia -- r_associated #0: 5 / 0.143 -> en:peroneal muscle atrophy
    n1=en:myopathia | n2=en:peroneal muscle atrophy | rel=r_associated | relid=0 | w=5
  1139. en:myopathia -- r_associated #0: 5 / 0.143 -> en:peroneal muscle weakness
    n1=en:myopathia | n2=en:peroneal muscle weakness | rel=r_associated | relid=0 | w=5
  1140. en:myopathia -- r_associated #0: 5 / 0.143 -> en:peroneal muscle weakness and atrophy due to peripheral neuropathy
    n1=en:myopathia | n2=en:peroneal muscle weakness and atrophy due to peripheral neuropathy | rel=r_associated | relid=0 | w=5
  1141. en:myopathia -- r_associated #0: 5 / 0.143 -> en:phagocytic vacuoles with degraded membranous material
    n1=en:myopathia | n2=en:phagocytic vacuoles with degraded membranous material | rel=r_associated | relid=0 | w=5
  1142. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pharmacotherapeutic
    n1=en:myopathia | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=5
  1143. en:myopathia -- r_associated #0: 5 / 0.143 -> en:plantar fibromatosis
    n1=en:myopathia | n2=en:plantar fibromatosis | rel=r_associated | relid=0 | w=5
  1144. en:myopathia -- r_associated #0: 5 / 0.143 -> en:plaques immunoreactive for desmin and alpha-beta-crystallin
    n1=en:myopathia | n2=en:plaques immunoreactive for desmin and alpha-beta-crystallin | rel=r_associated | relid=0 | w=5
  1145. en:myopathia -- r_associated #0: 5 / 0.143 -> en:poikilodermatomyositis
    n1=en:myopathia | n2=en:poikilodermatomyositis | rel=r_associated | relid=0 | w=5
  1146. en:myopathia -- r_associated #0: 5 / 0.143 -> en:polycystic kidney
    n1=en:myopathia | n2=en:polycystic kidney | rel=r_associated | relid=0 | w=5
  1147. en:myopathia -- r_associated #0: 5 / 0.143 -> en:polyglucosan accumulation
    n1=en:myopathia | n2=en:polyglucosan accumulation | rel=r_associated | relid=0 | w=5
  1148. en:myopathia -- r_associated #0: 5 / 0.143 -> en:polymyositis
    n1=en:myopathia | n2=en:polymyositis | rel=r_associated | relid=0 | w=5
  1149. en:myopathia -- r_associated #0: 5 / 0.143 -> en:poor exercise tolerance
    n1=en:myopathia | n2=en:poor exercise tolerance | rel=r_associated | relid=0 | w=5
  1150. en:myopathia -- r_associated #0: 5 / 0.143 -> en:poor head control
    n1=en:myopathia | n2=en:poor head control | rel=r_associated | relid=0 | w=5
  1151. en:myopathia -- r_associated #0: 5 / 0.143 -> en:poor head control in infancy
    n1=en:myopathia | n2=en:poor head control in infancy | rel=r_associated | relid=0 | w=5
  1152. en:myopathia -- r_associated #0: 5 / 0.143 -> en:poor muscle build
    n1=en:myopathia | n2=en:poor muscle build | rel=r_associated | relid=0 | w=5
  1153. en:myopathia -- r_associated #0: 5 / 0.143 -> en:poor muscle bulk
    n1=en:myopathia | n2=en:poor muscle bulk | rel=r_associated | relid=0 | w=5
  1154. en:myopathia -- r_associated #0: 5 / 0.143 -> en:poor muscle mass
    n1=en:myopathia | n2=en:poor muscle mass | rel=r_associated | relid=0 | w=5
  1155. en:myopathia -- r_associated #0: 5 / 0.143 -> en:poor musculature
    n1=en:myopathia | n2=en:poor musculature | rel=r_associated | relid=0 | w=5
  1156. en:myopathia -- r_associated #0: 5 / 0.143 -> en:poor sarcomeric structure (in some patients)
    n1=en:myopathia | n2=en:poor sarcomeric structure (in some patients) | rel=r_associated | relid=0 | w=5
  1157. en:myopathia -- r_associated #0: 5 / 0.143 -> en:positive staining for slow myosin heavy chain
    n1=en:myopathia | n2=en:positive staining for slow myosin heavy chain | rel=r_associated | relid=0 | w=5
  1158. en:myopathia -- r_associated #0: 5 / 0.143 -> en:potassium sensitivity has been reported
    n1=en:myopathia | n2=en:potassium sensitivity has been reported | rel=r_associated | relid=0 | w=5
  1159. en:myopathia -- r_associated #0: 5 / 0.143 -> en:predominance of oxidative fibers
    n1=en:myopathia | n2=en:predominance of oxidative fibers | rel=r_associated | relid=0 | w=5
  1160. en:myopathia -- r_associated #0: 5 / 0.143 -> en:predominantly lower limb lymphedema
    n1=en:myopathia | n2=en:predominantly lower limb lymphedema | rel=r_associated | relid=0 | w=5
  1161. en:myopathia -- r_associated #0: 5 / 0.143 -> en:premature exertional muscle weakness
    n1=en:myopathia | n2=en:premature exertional muscle weakness | rel=r_associated | relid=0 | w=5
  1162. en:myopathia -- r_associated #0: 5 / 0.143 -> en:preservation of visceral, neck, and axillary fat pads
    n1=en:myopathia | n2=en:preservation of visceral, neck, and axillary fat pads | rel=r_associated | relid=0 | w=5
  1163. en:myopathia -- r_associated #0: 5 / 0.143 -> en:presynaptic defect at the neuromuscular junction
    n1=en:myopathia | n2=en:presynaptic defect at the neuromuscular junction | rel=r_associated | relid=0 | w=5
  1164. en:myopathia -- r_associated #0: 5 / 0.143 -> en:primarily affects lower limbs
    n1=en:myopathia | n2=en:primarily affects lower limbs | rel=r_associated | relid=0 | w=5
  1165. en:myopathia -- r_associated #0: 5 / 0.143 -> en:progessive external ophthalmoplegia
    n1=en:myopathia | n2=en:progessive external ophthalmoplegia | rel=r_associated | relid=0 | w=5
  1166. en:myopathia -- r_associated #0: 5 / 0.143 -> en:progression to proximal muscle weakness
    n1=en:myopathia | n2=en:progression to proximal muscle weakness | rel=r_associated | relid=0 | w=5
  1167. en:myopathia -- r_associated #0: 5 / 0.143 -> en:progression to wheelchair in fourth decade
    n1=en:myopathia | n2=en:progression to wheelchair in fourth decade | rel=r_associated | relid=0 | w=5
  1168. en:myopathia -- r_associated #0: 5 / 0.143 -> en:progressive distal and proximal symmetric limb weakness
    n1=en:myopathia | n2=en:progressive distal and proximal symmetric limb weakness | rel=r_associated | relid=0 | w=5
  1169. en:myopathia -- r_associated #0: 5 / 0.143 -> en:progressive distal muscle weakness
    n1=en:myopathia | n2=en:progressive distal muscle weakness | rel=r_associated | relid=0 | w=5
  1170. en:myopathia -- r_associated #0: 5 / 0.143 -> en:progressive ectopic ossification (neck, dorsal trunk, proximal limbs, sternocleidomastoid, masseters)
    n1=en:myopathia | n2=en:progressive ectopic ossification (neck, dorsal trunk, proximal limbs, sternocleidomastoid, masseters) | rel=r_associated | relid=0 | w=5
  1171. en:myopathia -- r_associated #0: 5 / 0.143 -> en:progressive interictal weakness is common
    n1=en:myopathia | n2=en:progressive interictal weakness is common | rel=r_associated | relid=0 | w=5
  1172. en:myopathia -- r_associated #0: 5 / 0.143 -> en:progressive loss of facial adipose tissue
    n1=en:myopathia | n2=en:progressive loss of facial adipose tissue | rel=r_associated | relid=0 | w=5
  1173. en:myopathia -- r_associated #0: 5 / 0.143 -> en:progressive muscle weakness
    n1=en:myopathia | n2=en:progressive muscle weakness | rel=r_associated | relid=0 | w=5
  1174. en:myopathia -- r_associated #0: 5 / 0.143 -> en:progressive proximal muscle involvement
    n1=en:myopathia | n2=en:progressive proximal muscle involvement | rel=r_associated | relid=0 | w=5
  1175. en:myopathia -- r_associated #0: 5 / 0.143 -> en:progressive proximal muscle weakness
    n1=en:myopathia | n2=en:progressive proximal muscle weakness | rel=r_associated | relid=0 | w=5
  1176. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proliferation of fatty tissue in muscle (in some patients)
    n1=en:myopathia | n2=en:proliferation of fatty tissue in muscle (in some patients) | rel=r_associated | relid=0 | w=5
  1177. en:myopathia -- r_associated #0: 5 / 0.143 -> en:prominent involvement of the biceps brachii muscles
    n1=en:myopathia | n2=en:prominent involvement of the biceps brachii muscles | rel=r_associated | relid=0 | w=5
  1178. en:myopathia -- r_associated #0: 5 / 0.143 -> en:prominent involvement of the quadriceps femoris muscles
    n1=en:myopathia | n2=en:prominent involvement of the quadriceps femoris muscles | rel=r_associated | relid=0 | w=5
  1179. en:myopathia -- r_associated #0: 5 / 0.143 -> en:prominent muscular appearance
    n1=en:myopathia | n2=en:prominent muscular appearance | rel=r_associated | relid=0 | w=5
  1180. en:myopathia -- r_associated #0: 5 / 0.143 -> en:prominent musculature
    n1=en:myopathia | n2=en:prominent musculature | rel=r_associated | relid=0 | w=5
  1181. en:myopathia -- r_associated #0: 5 / 0.143 -> en:prominent veins, lower limbs
    n1=en:myopathia | n2=en:prominent veins, lower limbs | rel=r_associated | relid=0 | w=5
  1182. en:myopathia -- r_associated #0: 5 / 0.143 -> en:protein aggregates immunopositive for actin and desmin
    n1=en:myopathia | n2=en:protein aggregates immunopositive for actin and desmin | rel=r_associated | relid=0 | w=5
  1183. en:myopathia -- r_associated #0: 5 / 0.143 -> en:protein aggregates resembling myofibrillar myopathy may be present
    n1=en:myopathia | n2=en:protein aggregates resembling myofibrillar myopathy may be present | rel=r_associated | relid=0 | w=5
  1184. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal and distal muscle atrophy
    n1=en:myopathia | n2=en:proximal and distal muscle atrophy | rel=r_associated | relid=0 | w=5
  1185. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal and distal muscle atrophy in lower limbs
    n1=en:myopathia | n2=en:proximal and distal muscle atrophy in lower limbs | rel=r_associated | relid=0 | w=5
  1186. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal limb muscle weakness (occurs later)
    n1=en:myopathia | n2=en:proximal limb muscle weakness (occurs later) | rel=r_associated | relid=0 | w=5
  1187. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal limb muscle weakness initially
    n1=en:myopathia | n2=en:proximal limb muscle weakness initially | rel=r_associated | relid=0 | w=5
  1188. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal lower limb amyotrophy
    n1=en:myopathia | n2=en:proximal lower limb amyotrophy | rel=r_associated | relid=0 | w=5
  1189. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal lower limb muscle weakness, later (in some patients)
    n1=en:myopathia | n2=en:proximal lower limb muscle weakness, later (in some patients) | rel=r_associated | relid=0 | w=5
  1190. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal lower limb muscle weakness, upper and lower (later onset)
    n1=en:myopathia | n2=en:proximal lower limb muscle weakness, upper and lower (later onset) | rel=r_associated | relid=0 | w=5
  1191. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle atrophy (in some patients)
    n1=en:myopathia | n2=en:proximal muscle atrophy (in some patients) | rel=r_associated | relid=0 | w=5
  1192. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness
    n1=en:myopathia | n2=en:proximal muscle weakness | rel=r_associated | relid=0 | w=5
  1193. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness (120270.0002)
    n1=en:myopathia | n2=en:proximal muscle weakness (120270.0002) | rel=r_associated | relid=0 | w=5
  1194. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness (85% of patients)
    n1=en:myopathia | n2=en:proximal muscle weakness (85% of patients) | rel=r_associated | relid=0 | w=5
  1195. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness (in some patients)
    n1=en:myopathia | n2=en:proximal muscle weakness (in some patients) | rel=r_associated | relid=0 | w=5
  1196. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness (occasional)
    n1=en:myopathia | n2=en:proximal muscle weakness (occasional) | rel=r_associated | relid=0 | w=5
  1197. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness and atrophy (may occur later)
    n1=en:myopathia | n2=en:proximal muscle weakness and atrophy (may occur later) | rel=r_associated | relid=0 | w=5
  1198. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness in upper limbs
    n1=en:myopathia | n2=en:proximal muscle weakness in upper limbs | rel=r_associated | relid=0 | w=5
  1199. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness more severe than distal muscle weakness
    n1=en:myopathia | n2=en:proximal muscle weakness more severe than distal muscle weakness | rel=r_associated | relid=0 | w=5
  1200. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness occurs later
    n1=en:myopathia | n2=en:proximal muscle weakness occurs later | rel=r_associated | relid=0 | w=5
  1201. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness, less severe
    n1=en:myopathia | n2=en:proximal muscle weakness, less severe | rel=r_associated | relid=0 | w=5
  1202. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness, limb-girdle distribution
    n1=en:myopathia | n2=en:proximal muscle weakness, limb-girdle distribution | rel=r_associated | relid=0 | w=5
  1203. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness, lower limbs, mild
    n1=en:myopathia | n2=en:proximal muscle weakness, lower limbs, mild | rel=r_associated | relid=0 | w=5
  1204. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness, mild
    n1=en:myopathia | n2=en:proximal muscle weakness, mild | rel=r_associated | relid=0 | w=5
  1205. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness, mild (in some patients)
    n1=en:myopathia | n2=en:proximal muscle weakness, mild (in some patients) | rel=r_associated | relid=0 | w=5
  1206. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscle weakness, mild, of shoulder and hip girdle muscles (in some patients)
    n1=en:myopathia | n2=en:proximal muscle weakness, mild, of shoulder and hip girdle muscles (in some patients) | rel=r_associated | relid=0 | w=5
  1207. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscles may be mildly affected
    n1=en:myopathia | n2=en:proximal muscles may be mildly affected | rel=r_associated | relid=0 | w=5
  1208. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal muscles more often affected
    n1=en:myopathia | n2=en:proximal muscles more often affected | rel=r_associated | relid=0 | w=5
  1209. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal myopathy
    n1=en:myopathia | n2=en:proximal myopathy | rel=r_associated | relid=0 | w=5
  1210. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal myopathy and sudden death
    n1=en:myopathia | n2=en:proximal myopathy and sudden death | rel=r_associated | relid=0 | w=5
  1211. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal upper limb amyotrophy
    n1=en:myopathia | n2=en:proximal upper limb amyotrophy | rel=r_associated | relid=0 | w=5
  1212. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal weakness
    n1=en:myopathia | n2=en:proximal weakness | rel=r_associated | relid=0 | w=5
  1213. en:myopathia -- r_associated #0: 5 / 0.143 -> en:proximal weakness of the lower limbs with longer disease duration
    n1=en:myopathia | n2=en:proximal weakness of the lower limbs with longer disease duration | rel=r_associated | relid=0 | w=5
  1214. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pseudoathletic appearance with prominent muscles before disease onset
    n1=en:myopathia | n2=en:pseudoathletic appearance with prominent muscles before disease onset | rel=r_associated | relid=0 | w=5
  1215. en:myopathia -- r_associated #0: 5 / 0.143 -> en:psychology qualifier
    n1=en:myopathia | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=5
  1216. en:myopathia -- r_associated #0: 5 / 0.143 -> en:pyruvate oxidation defect
    n1=en:myopathia | n2=en:pyruvate oxidation defect | rel=r_associated | relid=0 | w=5
  1217. en:myopathia -- r_associated #0: 5 / 0.143 -> en:quadriceps aplasia
    n1=en:myopathia | n2=en:quadriceps aplasia | rel=r_associated | relid=0 | w=5
  1218. en:myopathia -- r_associated #0: 5 / 0.143 -> en:quadriceps atrophy
    n1=en:myopathia | n2=en:quadriceps atrophy | rel=r_associated | relid=0 | w=5
  1219. en:myopathia -- r_associated #0: 5 / 0.143 -> en:quadriceps atrophy (later onset)
    n1=en:myopathia | n2=en:quadriceps atrophy (later onset) | rel=r_associated | relid=0 | w=5
  1220. en:myopathia -- r_associated #0: 5 / 0.143 -> en:quadriceps muscle spared
    n1=en:myopathia | n2=en:quadriceps muscle spared | rel=r_associated | relid=0 | w=5
  1221. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ragged red fibers (in some patients)
    n1=en:myopathia | n2=en:ragged red fibers (in some patients) | rel=r_associated | relid=0 | w=5
  1222. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ragged red fibers seen on biopsy
    n1=en:myopathia | n2=en:ragged red fibers seen on biopsy | rel=r_associated | relid=0 | w=5
  1223. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ragged-red fibers on muscle biopsy
    n1=en:myopathia | n2=en:ragged-red fibers on muscle biopsy | rel=r_associated | relid=0 | w=5
  1224. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ragged-red fibers seen on muscle biopsy
    n1=en:myopathia | n2=en:ragged-red fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1225. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ragged-red muscle fibers
    n1=en:myopathia | n2=en:ragged-red muscle fibers | rel=r_associated | relid=0 | w=5
  1226. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rare necrotic fibers
    n1=en:myopathia | n2=en:rare necrotic fibers | rel=r_associated | relid=0 | w=5
  1227. en:myopathia -- r_associated #0: 5 / 0.143 -> en:recovery between attacks
    n1=en:myopathia | n2=en:recovery between attacks | rel=r_associated | relid=0 | w=5
  1228. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rectus abdominis muscle separation
    n1=en:myopathia | n2=en:rectus abdominis muscle separation | rel=r_associated | relid=0 | w=5
  1229. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rectus fascia separation
    n1=en:myopathia | n2=en:rectus fascia separation | rel=r_associated | relid=0 | w=5
  1230. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rectus medial atrophy
    n1=en:myopathia | n2=en:rectus medial atrophy | rel=r_associated | relid=0 | w=5
  1231. en:myopathia -- r_associated #0: 5 / 0.143 -> en:red-ragged fibers (2p21del)
    n1=en:myopathia | n2=en:red-ragged fibers (2p21del) | rel=r_associated | relid=0 | w=5
  1232. en:myopathia -- r_associated #0: 5 / 0.143 -> en:reduced activity of mitochondrial respiratory chains (1 family)
    n1=en:myopathia | n2=en:reduced activity of mitochondrial respiratory chains (1 family) | rel=r_associated | relid=0 | w=5
  1233. en:myopathia -- r_associated #0: 5 / 0.143 -> en:reduced ankle dorsiflexion
    n1=en:myopathia | n2=en:reduced ankle dorsiflexion | rel=r_associated | relid=0 | w=5
  1234. en:myopathia -- r_associated #0: 5 / 0.143 -> en:reduced lower limb subcutaneous fat
    n1=en:myopathia | n2=en:reduced lower limb subcutaneous fat | rel=r_associated | relid=0 | w=5
  1235. en:myopathia -- r_associated #0: 5 / 0.143 -> en:reduced muscle bulk
    n1=en:myopathia | n2=en:reduced muscle bulk | rel=r_associated | relid=0 | w=5
  1236. en:myopathia -- r_associated #0: 5 / 0.143 -> en:reduced muscle mass
    n1=en:myopathia | n2=en:reduced muscle mass | rel=r_associated | relid=0 | w=5
  1237. en:myopathia -- r_associated #0: 5 / 0.143 -> en:reduced subcutaneous adipose tissue
    n1=en:myopathia | n2=en:reduced subcutaneous adipose tissue | rel=r_associated | relid=0 | w=5
  1238. en:myopathia -- r_associated #0: 5 / 0.143 -> en:redundancy of basal lamina with accumulated debris
    n1=en:myopathia | n2=en:redundancy of basal lamina with accumulated debris | rel=r_associated | relid=0 | w=5
  1239. en:myopathia -- r_associated #0: 5 / 0.143 -> en:relative muscle weakness, especially in pelvic girdle
    n1=en:myopathia | n2=en:relative muscle weakness, especially in pelvic girdle | rel=r_associated | relid=0 | w=5
  1240. en:myopathia -- r_associated #0: 5 / 0.143 -> en:relative sparing of the rectus femoris
    n1=en:myopathia | n2=en:relative sparing of the rectus femoris | rel=r_associated | relid=0 | w=5
  1241. en:myopathia -- r_associated #0: 5 / 0.143 -> en:relative sparing of the tibialis anterior
    n1=en:myopathia | n2=en:relative sparing of the tibialis anterior | rel=r_associated | relid=0 | w=5
  1242. en:myopathia -- r_associated #0: 5 / 0.143 -> en:replacement of affected muscle tissue with fatty tissue
    n1=en:myopathia | n2=en:replacement of affected muscle tissue with fatty tissue | rel=r_associated | relid=0 | w=5
  1243. en:myopathia -- r_associated #0: 5 / 0.143 -> en:replacement of myofibers with connective tissue
    n1=en:myopathia | n2=en:replacement of myofibers with connective tissue | rel=r_associated | relid=0 | w=5
  1244. en:myopathia -- r_associated #0: 5 / 0.143 -> en:respiratory distress (congenital form)
    n1=en:myopathia | n2=en:respiratory distress (congenital form) | rel=r_associated | relid=0 | w=5
  1245. en:myopathia -- r_associated #0: 5 / 0.143 -> en:respiratory muscles may be involved (more common in juvenile-onset)
    n1=en:myopathia | n2=en:respiratory muscles may be involved (more common in juvenile-onset) | rel=r_associated | relid=0 | w=5
  1246. en:myopathia -- r_associated #0: 5 / 0.143 -> en:retain some mechanical adipose tissue (joints, orbits, palms, soles)
    n1=en:myopathia | n2=en:retain some mechanical adipose tissue (joints, orbits, palms, soles) | rel=r_associated | relid=0 | w=5
  1247. en:myopathia -- r_associated #0: 5 / 0.143 -> en:retroperitoneal fibrosis (rare)
    n1=en:myopathia | n2=en:retroperitoneal fibrosis (rare) | rel=r_associated | relid=0 | w=5
  1248. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rhabdomyolysis
    n1=en:myopathia | n2=en:rhabdomyolysis | rel=r_associated | relid=0 | w=5
  1249. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rhabdomyolysis (in some patients)
    n1=en:myopathia | n2=en:rhabdomyolysis (in some patients) | rel=r_associated | relid=0 | w=5
  1250. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rhabdomyolysis may occur
    n1=en:myopathia | n2=en:rhabdomyolysis may occur | rel=r_associated | relid=0 | w=5
  1251. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rhabdomyolysis with exercise (in older patients)
    n1=en:myopathia | n2=en:rhabdomyolysis with exercise (in older patients) | rel=r_associated | relid=0 | w=5
  1252. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rhabdomyolysis, episodic
    n1=en:myopathia | n2=en:rhabdomyolysis, episodic | rel=r_associated | relid=0 | w=5
  1253. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rhabdomyolysis, episodic and recurrent
    n1=en:myopathia | n2=en:rhabdomyolysis, episodic and recurrent | rel=r_associated | relid=0 | w=5
  1254. en:myopathia -- r_associated #0: 5 / 0.143 -> en:right cataract
    n1=en:myopathia | n2=en:right cataract | rel=r_associated | relid=0 | w=5
  1255. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rigidity (uncommon)
    n1=en:myopathia | n2=en:rigidity (uncommon) | rel=r_associated | relid=0 | w=5
  1256. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rimmed vacuoles
    n1=en:myopathia | n2=en:rimmed vacuoles | rel=r_associated | relid=0 | w=5
  1257. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rimmed vacuoles on biopsy
    n1=en:myopathia | n2=en:rimmed vacuoles on biopsy | rel=r_associated | relid=0 | w=5
  1258. en:myopathia -- r_associated #0: 5 / 0.143 -> en:rimmed vacuoles with basophilic granular material
    n1=en:myopathia | n2=en:rimmed vacuoles with basophilic granular material | rel=r_associated | relid=0 | w=5
  1259. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ring fibers
    n1=en:myopathia | n2=en:ring fibers | rel=r_associated | relid=0 | w=5
  1260. en:myopathia -- r_associated #0: 5 / 0.143 -> en:roentgenographic
    n1=en:myopathia | n2=en:roentgenographic | rel=r_associated | relid=0 | w=5
  1261. en:myopathia -- r_associated #0: 5 / 0.143 -> en:sarcomere disappearance seen on muscle biopsy
    n1=en:myopathia | n2=en:sarcomere disappearance seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1262. en:myopathia -- r_associated #0: 5 / 0.143 -> en:sarcoplasmic accumulation of electron-dense granulofilamentous material
    n1=en:myopathia | n2=en:sarcoplasmic accumulation of electron-dense granulofilamentous material | rel=r_associated | relid=0 | w=5
  1263. en:myopathia -- r_associated #0: 5 / 0.143 -> en:sarcoplasmic inclusions
    n1=en:myopathia | n2=en:sarcoplasmic inclusions | rel=r_associated | relid=0 | w=5
  1264. en:myopathia -- r_associated #0: 5 / 0.143 -> en:sarcotubular myopathy
    n1=en:myopathia | n2=en:sarcotubular myopathy | rel=r_associated | relid=0 | w=5
  1265. en:myopathia -- r_associated #0: 5 / 0.143 -> en:scapular muscle atrophy
    n1=en:myopathia | n2=en:scapular muscle atrophy | rel=r_associated | relid=0 | w=5
  1266. en:myopathia -- r_associated #0: 5 / 0.143 -> en:scapuloperoneal amyotrophy
    n1=en:myopathia | n2=en:scapuloperoneal amyotrophy | rel=r_associated | relid=0 | w=5
  1267. en:myopathia -- r_associated #0: 5 / 0.143 -> en:scapuloperoneal muscular atrophy due to denervation
    n1=en:myopathia | n2=en:scapuloperoneal muscular atrophy due to denervation | rel=r_associated | relid=0 | w=5
  1268. en:myopathia -- r_associated #0: 5 / 0.143 -> en:scapuloperoneal myopathy
    n1=en:myopathia | n2=en:scapuloperoneal myopathy | rel=r_associated | relid=0 | w=5
  1269. en:myopathia -- r_associated #0: 5 / 0.143 -> en:scapuloperoneal weakness
    n1=en:myopathia | n2=en:scapuloperoneal weakness | rel=r_associated | relid=0 | w=5
  1270. en:myopathia -- r_associated #0: 5 / 0.143 -> en:secondary hypertrophy
    n1=en:myopathia | n2=en:secondary hypertrophy | rel=r_associated | relid=0 | w=5
  1271. en:myopathia -- r_associated #0: 5 / 0.143 -> en:secondary loss of merosin and desmin
    n1=en:myopathia | n2=en:secondary loss of merosin and desmin | rel=r_associated | relid=0 | w=5
  1272. en:myopathia -- r_associated #0: 5 / 0.143 -> en:secondary loss of sarcolemmal caveolin-3
    n1=en:myopathia | n2=en:secondary loss of sarcolemmal caveolin-3 | rel=r_associated | relid=0 | w=5
  1273. en:myopathia -- r_associated #0: 5 / 0.143 -> en:secondary myopathic changes
    n1=en:myopathia | n2=en:secondary myopathic changes | rel=r_associated | relid=0 | w=5
  1274. en:myopathia -- r_associated #0: 5 / 0.143 -> en:secondary myopathic features
    n1=en:myopathia | n2=en:secondary myopathic features | rel=r_associated | relid=0 | w=5
  1275. en:myopathia -- r_associated #0: 5 / 0.143 -> en:severe disability within 20 years of onset
    n1=en:myopathia | n2=en:severe disability within 20 years of onset | rel=r_associated | relid=0 | w=5
  1276. en:myopathia -- r_associated #0: 5 / 0.143 -> en:severe form shows absence of spontaneous activity at birth
    n1=en:myopathia | n2=en:severe form shows absence of spontaneous activity at birth | rel=r_associated | relid=0 | w=5
  1277. en:myopathia -- r_associated #0: 5 / 0.143 -> en:severe muscle hypotonia at birth
    n1=en:myopathia | n2=en:severe muscle hypotonia at birth | rel=r_associated | relid=0 | w=5
  1278. en:myopathia -- r_associated #0: 5 / 0.143 -> en:severe muscle wasting and atrophy, primarily in the legs
    n1=en:myopathia | n2=en:severe muscle wasting and atrophy, primarily in the legs | rel=r_associated | relid=0 | w=5
  1279. en:myopathia -- r_associated #0: 5 / 0.143 -> en:severe muscular hypotonia
    n1=en:myopathia | n2=en:severe muscular hypotonia | rel=r_associated | relid=0 | w=5
  1280. en:myopathia -- r_associated #0: 5 / 0.143 -> en:short stature
    n1=en:myopathia | n2=en:short stature | rel=r_associated | relid=0 | w=5
  1281. en:myopathia -- r_associated #0: 5 / 0.143 -> en:shortening of flexor profundus muscle-tendon unit
    n1=en:myopathia | n2=en:shortening of flexor profundus muscle-tendon unit | rel=r_associated | relid=0 | w=5
  1282. en:myopathia -- r_associated #0: 5 / 0.143 -> en:shortening of various muscle-tendon groups in feet
    n1=en:myopathia | n2=en:shortening of various muscle-tendon groups in feet | rel=r_associated | relid=0 | w=5
  1283. en:myopathia -- r_associated #0: 5 / 0.143 -> en:shoulder girdle muscle atrophy
    n1=en:myopathia | n2=en:shoulder girdle muscle atrophy | rel=r_associated | relid=0 | w=5
  1284. en:myopathia -- r_associated #0: 5 / 0.143 -> en:shoulder girdle muscle weakness and atrophy, progressive
    n1=en:myopathia | n2=en:shoulder girdle muscle weakness and atrophy, progressive | rel=r_associated | relid=0 | w=5
  1285. en:myopathia -- r_associated #0: 5 / 0.143 -> en:shoulder muscle hypoplasia
    n1=en:myopathia | n2=en:shoulder muscle hypoplasia | rel=r_associated | relid=0 | w=5
  1286. en:myopathia -- r_associated #0: 5 / 0.143 -> en:shoulder weakness
    n1=en:myopathia | n2=en:shoulder weakness | rel=r_associated | relid=0 | w=5
  1287. en:myopathia -- r_associated #0: 5 / 0.143 -> en:shoulder weakness and atrophy
    n1=en:myopathia | n2=en:shoulder weakness and atrophy | rel=r_associated | relid=0 | w=5
  1288. en:myopathia -- r_associated #0: 5 / 0.143 -> en:signs of denervation seen on biopsy
    n1=en:myopathia | n2=en:signs of denervation seen on biopsy | rel=r_associated | relid=0 | w=5
  1289. en:myopathia -- r_associated #0: 5 / 0.143 -> en:skeletal muscle biopsy shows dystrophic changes
    n1=en:myopathia | n2=en:skeletal muscle biopsy shows dystrophic changes | rel=r_associated | relid=0 | w=5
  1290. en:myopathia -- r_associated #0: 5 / 0.143 -> en:skeletal muscle biopsy shows hypertrophy of type 1 and 2 muscle fibers
    n1=en:myopathia | n2=en:skeletal muscle biopsy shows hypertrophy of type 1 and 2 muscle fibers | rel=r_associated | relid=0 | w=5
  1291. en:myopathia -- r_associated #0: 5 / 0.143 -> en:skeletal muscle biopsy shows impaired respiratory oxidation
    n1=en:myopathia | n2=en:skeletal muscle biopsy shows impaired respiratory oxidation | rel=r_associated | relid=0 | w=5
  1292. en:myopathia -- r_associated #0: 5 / 0.143 -> en:skeletal muscle biopsy shows minor variation in fiber size
    n1=en:myopathia | n2=en:skeletal muscle biopsy shows minor variation in fiber size | rel=r_associated | relid=0 | w=5
  1293. en:myopathia -- r_associated #0: 5 / 0.143 -> en:skeletal muscle damage
    n1=en:myopathia | n2=en:skeletal muscle damage | rel=r_associated | relid=0 | w=5
  1294. en:myopathia -- r_associated #0: 5 / 0.143 -> en:skeletal muscle shows decreased sarcoglycan proteins
    n1=en:myopathia | n2=en:skeletal muscle shows decreased sarcoglycan proteins | rel=r_associated | relid=0 | w=5
  1295. en:myopathia -- r_associated #0: 5 / 0.143 -> en:skeletal muscle shows dystrophic changes
    n1=en:myopathia | n2=en:skeletal muscle shows dystrophic changes | rel=r_associated | relid=0 | w=5
  1296. en:myopathia -- r_associated #0: 5 / 0.143 -> en:skeletal muscle weakness
    n1=en:myopathia | n2=en:skeletal muscle weakness | rel=r_associated | relid=0 | w=5
  1297. en:myopathia -- r_associated #0: 5 / 0.143 -> en:skin infection
    n1=en:myopathia | n2=en:skin infection | rel=r_associated | relid=0 | w=5
  1298. en:myopathia -- r_associated #0: 5 / 0.143 -> en:skin photosensitivity
    n1=en:myopathia | n2=en:skin photosensitivity | rel=r_associated | relid=0 | w=5
  1299. en:myopathia -- r_associated #0: 5 / 0.143 -> en:slim, muscular build (in some patients)
    n1=en:myopathia | n2=en:slim, muscular build (in some patients) | rel=r_associated | relid=0 | w=5
  1300. en:myopathia -- r_associated #0: 5 / 0.143 -> en:slow motor responses to sudden events (i.e., falling)
    n1=en:myopathia | n2=en:slow motor responses to sudden events (i.e., falling) | rel=r_associated | relid=0 | w=5
  1301. en:myopathia -- r_associated #0: 5 / 0.143 -> en:slowly progressive limb-girdle myopathy
    n1=en:myopathia | n2=en:slowly progressive limb-girdle myopathy | rel=r_associated | relid=0 | w=5
  1302. en:myopathia -- r_associated #0: 5 / 0.143 -> en:slowly-progressive muscle wasting and weakness with humeroperoneal and scapuloperoneal distribution
    n1=en:myopathia | n2=en:slowly-progressive muscle wasting and weakness with humeroperoneal and scapuloperoneal distribution | rel=r_associated | relid=0 | w=5
  1303. en:myopathia -- r_associated #0: 5 / 0.143 -> en:small and incompletely fused muscle fibers seen on biopsy
    n1=en:myopathia | n2=en:small and incompletely fused muscle fibers seen on biopsy | rel=r_associated | relid=0 | w=5
  1304. en:myopathia -- r_associated #0: 5 / 0.143 -> en:small endplate
    n1=en:myopathia | n2=en:small endplate | rel=r_associated | relid=0 | w=5
  1305. en:myopathia -- r_associated #0: 5 / 0.143 -> en:small or absent axon terminals
    n1=en:myopathia | n2=en:small or absent axon terminals | rel=r_associated | relid=0 | w=5
  1306. en:myopathia -- r_associated #0: 5 / 0.143 -> en:small rounded fibers
    n1=en:myopathia | n2=en:small rounded fibers | rel=r_associated | relid=0 | w=5
  1307. en:myopathia -- r_associated #0: 5 / 0.143 -> en:small, angulated muscle fibers seen on muscle biopsy
    n1=en:myopathia | n2=en:small, angulated muscle fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1308. en:myopathia -- r_associated #0: 5 / 0.143 -> en:small, firm, rubbery, flesh-colored nodules most commonly found on the head, neck, and trunk
    n1=en:myopathia | n2=en:small, firm, rubbery, flesh-colored nodules most commonly found on the head, neck, and trunk | rel=r_associated | relid=0 | w=5
  1309. en:myopathia -- r_associated #0: 5 / 0.143 -> en:smooth muscle may also become involved
    n1=en:myopathia | n2=en:smooth muscle may also become involved | rel=r_associated | relid=0 | w=5
  1310. en:myopathia -- r_associated #0: 5 / 0.143 -> en:soft fleshy palms (50%)
    n1=en:myopathia | n2=en:soft fleshy palms (50%) | rel=r_associated | relid=0 | w=5
  1311. en:myopathia -- r_associated #0: 5 / 0.143 -> en:soft tissue or tendinous calcinosis may occur
    n1=en:myopathia | n2=en:soft tissue or tendinous calcinosis may occur | rel=r_associated | relid=0 | w=5
  1312. en:myopathia -- r_associated #0: 5 / 0.143 -> en:soft tissue vascular malformations
    n1=en:myopathia | n2=en:soft tissue vascular malformations | rel=r_associated | relid=0 | w=5
  1313. en:myopathia -- r_associated #0: 5 / 0.143 -> en:some patients become wheelchair-dependent
    n1=en:myopathia | n2=en:some patients become wheelchair-dependent | rel=r_associated | relid=0 | w=5
  1314. en:myopathia -- r_associated #0: 5 / 0.143 -> en:some patients never achieve ambulation
    n1=en:myopathia | n2=en:some patients never achieve ambulation | rel=r_associated | relid=0 | w=5
  1315. en:myopathia -- r_associated #0: 5 / 0.143 -> en:some subcutaneous adipose tissue may remain on upper arms
    n1=en:myopathia | n2=en:some subcutaneous adipose tissue may remain on upper arms | rel=r_associated | relid=0 | w=5
  1316. en:myopathia -- r_associated #0: 5 / 0.143 -> en:sparing of anterior tibialis muscle
    n1=en:myopathia | n2=en:sparing of anterior tibialis muscle | rel=r_associated | relid=0 | w=5
  1317. en:myopathia -- r_associated #0: 5 / 0.143 -> en:sparing of small hand and finger muscles
    n1=en:myopathia | n2=en:sparing of small hand and finger muscles | rel=r_associated | relid=0 | w=5
  1318. en:myopathia -- r_associated #0: 5 / 0.143 -> en:sparing of the anterior tibial compartment
    n1=en:myopathia | n2=en:sparing of the anterior tibial compartment | rel=r_associated | relid=0 | w=5
  1319. en:myopathia -- r_associated #0: 5 / 0.143 -> en:sparing of the brachioradialis muscle (gives appearance of 'oblique amyotrophy')
    n1=en:myopathia | n2=en:sparing of the brachioradialis muscle (gives appearance of 'oblique amyotrophy') | rel=r_associated | relid=0 | w=5
  1320. en:myopathia -- r_associated #0: 5 / 0.143 -> en:spherocytosis
    n1=en:myopathia | n2=en:spherocytosis | rel=r_associated | relid=0 | w=5
  1321. en:myopathia -- r_associated #0: 5 / 0.143 -> en:spheroid bodies are composed of fine filamentous (myofibrillar) material
    n1=en:myopathia | n2=en:spheroid bodies are composed of fine filamentous (myofibrillar) material | rel=r_associated | relid=0 | w=5
  1322. en:myopathia -- r_associated #0: 5 / 0.143 -> en:spongy degeneration
    n1=en:myopathia | n2=en:spongy degeneration | rel=r_associated | relid=0 | w=5
  1323. en:myopathia -- r_associated #0: 5 / 0.143 -> en:Steinert's disease
    n1=en:myopathia | n2=en:Steinert's disease | rel=r_associated | relid=0 | w=5
  1324. en:myopathia -- r_associated #0: 5 / 0.143 -> en:steinert's disease
    n1=en:myopathia | n2=en:steinert's disease | rel=r_associated | relid=0 | w=5
  1325. en:myopathia -- r_associated #0: 5 / 0.143 -> en:Steinert's myotonic dystrophy
    n1=en:myopathia | n2=en:Steinert's myotonic dystrophy | rel=r_associated | relid=0 | w=5
  1326. en:myopathia -- r_associated #0: 5 / 0.143 -> en:stiffness (uncommon)
    n1=en:myopathia | n2=en:stiffness (uncommon) | rel=r_associated | relid=0 | w=5
  1327. en:myopathia -- r_associated #0: 5 / 0.143 -> en:Stormoken syndrome
    n1=en:myopathia | n2=en:Stormoken syndrome | rel=r_associated | relid=0 | w=5
  1328. en:myopathia -- r_associated #0: 5 / 0.143 -> en:structurally abnormal mitochondria
    n1=en:myopathia | n2=en:structurally abnormal mitochondria | rel=r_associated | relid=0 | w=5
  1329. en:myopathia -- r_associated #0: 5 / 0.143 -> en:subcutaneous edema
    n1=en:myopathia | n2=en:subcutaneous edema | rel=r_associated | relid=0 | w=5
  1330. en:myopathia -- r_associated #0: 5 / 0.143 -> en:subcutaneous fat markedly reduced
    n1=en:myopathia | n2=en:subcutaneous fat markedly reduced | rel=r_associated | relid=0 | w=5
  1331. en:myopathia -- r_associated #0: 5 / 0.143 -> en:subsarcolemmal accumulation of enlarged mitochondria with variably sized rectangular or elongated rhomboidal paracrystalline inclusions
    n1=en:myopathia | n2=en:subsarcolemmal accumulation of enlarged mitochondria with variably sized rectangular or elongated rhomboidal paracrystalline inclusions | rel=r_associated | relid=0 | w=5
  1332. en:myopathia -- r_associated #0: 5 / 0.143 -> en:subsarcolemmal accumulation of normal mitochondria (in some patients)
    n1=en:myopathia | n2=en:subsarcolemmal accumulation of normal mitochondria (in some patients) | rel=r_associated | relid=0 | w=5
  1333. en:myopathia -- r_associated #0: 5 / 0.143 -> en:subsarcolemmal accumulations of abnormally shaped mitochondria (on electron microscopy)
    n1=en:myopathia | n2=en:subsarcolemmal accumulations of abnormally shaped mitochondria (on electron microscopy) | rel=r_associated | relid=0 | w=5
  1334. en:myopathia -- r_associated #0: 5 / 0.143 -> en:subsarcolemmal accumulations of abnormally shaped mitochondria seen on electron microscopy
    n1=en:myopathia | n2=en:subsarcolemmal accumulations of abnormally shaped mitochondria seen on electron microscopy | rel=r_associated | relid=0 | w=5
  1335. en:myopathia -- r_associated #0: 5 / 0.143 -> en:subsarcolemmal accumulations of abnormally shaped mitochondria seen with electronmicroscopy
    n1=en:myopathia | n2=en:subsarcolemmal accumulations of abnormally shaped mitochondria seen with electronmicroscopy | rel=r_associated | relid=0 | w=5
  1336. en:myopathia -- r_associated #0: 5 / 0.143 -> en:subsarcolemmal hyaline bodies in type 1 fibers only
    n1=en:myopathia | n2=en:subsarcolemmal hyaline bodies in type 1 fibers only | rel=r_associated | relid=0 | w=5
  1337. en:myopathia -- r_associated #0: 5 / 0.143 -> en:subsarcolemmal lipofuscin-positive deposits
    n1=en:myopathia | n2=en:subsarcolemmal lipofuscin-positive deposits | rel=r_associated | relid=0 | w=5
  1338. en:myopathia -- r_associated #0: 5 / 0.143 -> en:subsarcolemmal mitochondrial accumulation
    n1=en:myopathia | n2=en:subsarcolemmal mitochondrial accumulation | rel=r_associated | relid=0 | w=5
  1339. en:myopathia -- r_associated #0: 5 / 0.143 -> en:subsarcolemmal mitochondrial aggregates
    n1=en:myopathia | n2=en:subsarcolemmal mitochondrial aggregates | rel=r_associated | relid=0 | w=5
  1340. en:myopathia -- r_associated #0: 5 / 0.143 -> en:superior rectus atrophy
    n1=en:myopathia | n2=en:superior rectus atrophy | rel=r_associated | relid=0 | w=5
  1341. en:myopathia -- r_associated #0: 5 / 0.143 -> en:swelling of the affected areas
    n1=en:myopathia | n2=en:swelling of the affected areas | rel=r_associated | relid=0 | w=5
  1342. en:myopathia -- r_associated #0: 5 / 0.143 -> en:swelling of the extremities, episodic
    n1=en:myopathia | n2=en:swelling of the extremities, episodic | rel=r_associated | relid=0 | w=5
  1343. en:myopathia -- r_associated #0: 5 / 0.143 -> en:swelling of the hands and feet (in 1 patient)
    n1=en:myopathia | n2=en:swelling of the hands and feet (in 1 patient) | rel=r_associated | relid=0 | w=5
  1344. en:myopathia -- r_associated #0: 5 / 0.143 -> en:swelling of the hands and feet, episodic
    n1=en:myopathia | n2=en:swelling of the hands and feet, episodic | rel=r_associated | relid=0 | w=5
  1345. en:myopathia -- r_associated #0: 5 / 0.143 -> en:symmetrical muscle wasting
    n1=en:myopathia | n2=en:symmetrical muscle wasting | rel=r_associated | relid=0 | w=5
  1346. en:myopathia -- r_associated #0: 5 / 0.143 -> en:symmetrical, proximal limb muscle atrophy (pelvic, scapular, trunk muscles)
    n1=en:myopathia | n2=en:symmetrical, proximal limb muscle atrophy (pelvic, scapular, trunk muscles) | rel=r_associated | relid=0 | w=5
  1347. en:myopathia -- r_associated #0: 5 / 0.143 -> en:symptoms are progressive for a few years, and then become stationary
    n1=en:myopathia | n2=en:symptoms are progressive for a few years, and then become stationary | rel=r_associated | relid=0 | w=5
  1348. en:myopathia -- r_associated #0: 5 / 0.143 -> en:symptoms may be induced by heat
    n1=en:myopathia | n2=en:symptoms may be induced by heat | rel=r_associated | relid=0 | w=5
  1349. en:myopathia -- r_associated #0: 5 / 0.143 -> en:syncope
    n1=en:myopathia | n2=en:syncope | rel=r_associated | relid=0 | w=5
  1350. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tenderness of lower extremities
    n1=en:myopathia | n2=en:tenderness of lower extremities | rel=r_associated | relid=0 | w=5
  1351. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tendinous and tuberous xanthoma
    n1=en:myopathia | n2=en:tendinous and tuberous xanthoma | rel=r_associated | relid=0 | w=5
  1352. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tendon tears
    n1=en:myopathia | n2=en:tendon tears | rel=r_associated | relid=0 | w=5
  1353. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tetanus-like muscle contractions
    n1=en:myopathia | n2=en:tetanus-like muscle contractions | rel=r_associated | relid=0 | w=5
  1354. en:myopathia -- r_associated #0: 5 / 0.143 -> en:thenar amyotrophy (rare)
    n1=en:myopathia | n2=en:thenar amyotrophy (rare) | rel=r_associated | relid=0 | w=5
  1355. en:myopathia -- r_associated #0: 5 / 0.143 -> en:thenar eminence hypoplasia
    n1=en:myopathia | n2=en:thenar eminence hypoplasia | rel=r_associated | relid=0 | w=5
  1356. en:myopathia -- r_associated #0: 5 / 0.143 -> en:therapeutic aspects
    n1=en:myopathia | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=5
  1357. en:myopathia -- r_associated #0: 5 / 0.143 -> en:thick palmar fascia
    n1=en:myopathia | n2=en:thick palmar fascia | rel=r_associated | relid=0 | w=5
  1358. en:myopathia -- r_associated #0: 5 / 0.143 -> en:thickened subcutaneous tissue
    n1=en:myopathia | n2=en:thickened subcutaneous tissue | rel=r_associated | relid=0 | w=5
  1359. en:myopathia -- r_associated #0: 5 / 0.143 -> en:thickening of fascia of forearm
    n1=en:myopathia | n2=en:thickening of fascia of forearm | rel=r_associated | relid=0 | w=5
  1360. en:myopathia -- r_associated #0: 5 / 0.143 -> en:thickening of the fascial structures of the palm and fingers
    n1=en:myopathia | n2=en:thickening of the fascial structures of the palm and fingers | rel=r_associated | relid=0 | w=5
  1361. en:myopathia -- r_associated #0: 5 / 0.143 -> en:thin filament shortening and disorganization (in some patients)
    n1=en:myopathia | n2=en:thin filament shortening and disorganization (in some patients) | rel=r_associated | relid=0 | w=5
  1362. en:myopathia -- r_associated #0: 5 / 0.143 -> en:toe and foot dorsiflexor weakness
    n1=en:myopathia | n2=en:toe and foot dorsiflexor weakness | rel=r_associated | relid=0 | w=5
  1363. en:myopathia -- r_associated #0: 5 / 0.143 -> en:toe-walking gait
    n1=en:myopathia | n2=en:toe-walking gait | rel=r_associated | relid=0 | w=5
  1364. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tortuous lymphatic tracts
    n1=en:myopathia | n2=en:tortuous lymphatic tracts | rel=r_associated | relid=0 | w=5
  1365. en:myopathia -- r_associated #0: 5 / 0.143 -> en:transient eosinophilic myositis (seen on muscle biopsy) in the first decade
    n1=en:myopathia | n2=en:transient eosinophilic myositis (seen on muscle biopsy) in the first decade | rel=r_associated | relid=0 | w=5
  1366. en:myopathia -- r_associated #0: 5 / 0.143 -> en:transient muscle weakness occur in 75% of patients, particularly in the arms and hands
    n1=en:myopathia | n2=en:transient muscle weakness occur in 75% of patients, particularly in the arms and hands | rel=r_associated | relid=0 | w=5
  1367. en:myopathia -- r_associated #0: 5 / 0.143 -> en:transient neonatal hypotonia (less common)
    n1=en:myopathia | n2=en:transient neonatal hypotonia (less common) | rel=r_associated | relid=0 | w=5
  1368. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tremor at birth, involving most skeletal muscle groups, especially jaw muscles and lower limb muscles
    n1=en:myopathia | n2=en:tremor at birth, involving most skeletal muscle groups, especially jaw muscles and lower limb muscles | rel=r_associated | relid=0 | w=5
  1369. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tremor of the upper limb
    n1=en:myopathia | n2=en:tremor of the upper limb | rel=r_associated | relid=0 | w=5
  1370. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tremors subside over the first 2 to 3 months of life
    n1=en:myopathia | n2=en:tremors subside over the first 2 to 3 months of life | rel=r_associated | relid=0 | w=5
  1371. en:myopathia -- r_associated #0: 5 / 0.143 -> en:triceps aplasia
    n1=en:myopathia | n2=en:triceps aplasia | rel=r_associated | relid=0 | w=5
  1372. en:myopathia -- r_associated #0: 5 / 0.143 -> en:triceps weakness
    n1=en:myopathia | n2=en:triceps weakness | rel=r_associated | relid=0 | w=5
  1373. en:myopathia -- r_associated #0: 5 / 0.143 -> en:trichomegaly
    n1=en:myopathia | n2=en:trichomegaly | rel=r_associated | relid=0 | w=5
  1374. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tubular aggregates (in some patients)
    n1=en:myopathia | n2=en:tubular aggregates (in some patients) | rel=r_associated | relid=0 | w=5
  1375. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tubular aggregates in muscle fibers may occur
    n1=en:myopathia | n2=en:tubular aggregates in muscle fibers may occur | rel=r_associated | relid=0 | w=5
  1376. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tubular aggregates in type 2 skeletal muscle fibers
    n1=en:myopathia | n2=en:tubular aggregates in type 2 skeletal muscle fibers | rel=r_associated | relid=0 | w=5
  1377. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tubular aggregates mainly in type 1 fibers
    n1=en:myopathia | n2=en:tubular aggregates mainly in type 1 fibers | rel=r_associated | relid=0 | w=5
  1378. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tubular aggregates seen on biopsy
    n1=en:myopathia | n2=en:tubular aggregates seen on biopsy | rel=r_associated | relid=0 | w=5
  1379. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tubular aggregates seen on muscle biopsy
    n1=en:myopathia | n2=en:tubular aggregates seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1380. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tubulofilamentous inclusions
    n1=en:myopathia | n2=en:tubulofilamentous inclusions | rel=r_associated | relid=0 | w=5
  1381. en:myopathia -- r_associated #0: 5 / 0.143 -> en:tubulofilamentous nuclear or cytoplasmic inclusions on biopsy
    n1=en:myopathia | n2=en:tubulofilamentous nuclear or cytoplasmic inclusions on biopsy | rel=r_associated | relid=0 | w=5
  1382. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 1 and type 2 muscle fibers with 'minicore' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria
    n1=en:myopathia | n2=en:type 1 and type 2 muscle fibers with 'minicore' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria | rel=r_associated | relid=0 | w=5
  1383. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 1 fiber atrophy
    n1=en:myopathia | n2=en:type 1 fiber atrophy | rel=r_associated | relid=0 | w=5
  1384. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 1 fiber atrophy seen on muscle biopsy
    n1=en:myopathia | n2=en:type 1 fiber atrophy seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1385. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 1 fiber predominance
    n1=en:myopathia | n2=en:type 1 fiber predominance | rel=r_associated | relid=0 | w=5
  1386. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 1 fiber predominance seen on muscle biopsy
    n1=en:myopathia | n2=en:type 1 fiber predominance seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1387. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 1 fibers are at least 12% smaller than type 2 fibers
    n1=en:myopathia | n2=en:type 1 fibers are at least 12% smaller than type 2 fibers | rel=r_associated | relid=0 | w=5
  1388. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 1 muscle fiber predominance
    n1=en:myopathia | n2=en:type 1 muscle fiber predominance | rel=r_associated | relid=0 | w=5
  1389. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 1 muscle fibers with clearly demarcated central 'core' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria
    n1=en:myopathia | n2=en:type 1 muscle fibers with clearly demarcated central 'core' regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria | rel=r_associated | relid=0 | w=5
  1390. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 2 fiber atrophy see on biopsy
    n1=en:myopathia | n2=en:type 2 fiber atrophy see on biopsy | rel=r_associated | relid=0 | w=5
  1391. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 2 fiber hypertrophy
    n1=en:myopathia | n2=en:type 2 fiber hypertrophy | rel=r_associated | relid=0 | w=5
  1392. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 2 fiber predominance
    n1=en:myopathia | n2=en:type 2 fiber predominance | rel=r_associated | relid=0 | w=5
  1393. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 2 muscle fiber atrophy
    n1=en:myopathia | n2=en:type 2 muscle fiber atrophy | rel=r_associated | relid=0 | w=5
  1394. en:myopathia -- r_associated #0: 5 / 0.143 -> en:type 2 muscle fiber predominance
    n1=en:myopathia | n2=en:type 2 muscle fiber predominance | rel=r_associated | relid=0 | w=5
  1395. en:myopathia -- r_associated #0: 5 / 0.143 -> en:ubiquinone decreased
    n1=en:myopathia | n2=en:ubiquinone decreased | rel=r_associated | relid=0 | w=5
  1396. en:myopathia -- r_associated #0: 5 / 0.143 -> en:unable to walk
    n1=en:myopathia | n2=en:unable to walk | rel=r_associated | relid=0 | w=5
  1397. en:myopathia -- r_associated #0: 5 / 0.143 -> en:upper and/or lower limbs may be affected
    n1=en:myopathia | n2=en:upper and/or lower limbs may be affected | rel=r_associated | relid=0 | w=5
  1398. en:myopathia -- r_associated #0: 5 / 0.143 -> en:upper arm and pelvic muscle weakness and atrophy (later onset)
    n1=en:myopathia | n2=en:upper arm and pelvic muscle weakness and atrophy (later onset) | rel=r_associated | relid=0 | w=5
  1399. en:myopathia -- r_associated #0: 5 / 0.143 -> en:upper limb involvement and distal muscle involvement may occur later in disease course (often by second decade)
    n1=en:myopathia | n2=en:upper limb involvement and distal muscle involvement may occur later in disease course (often by second decade) | rel=r_associated | relid=0 | w=5
  1400. en:myopathia -- r_associated #0: 5 / 0.143 -> en:upper limb involvement occurs later or not at all
    n1=en:myopathia | n2=en:upper limb involvement occurs later or not at all | rel=r_associated | relid=0 | w=5
  1401. en:myopathia -- r_associated #0: 5 / 0.143 -> en:upper limb muscle hypoplasia
    n1=en:myopathia | n2=en:upper limb muscle hypoplasia | rel=r_associated | relid=0 | w=5
  1402. en:myopathia -- r_associated #0: 5 / 0.143 -> en:upper limb muscle weakness may be more severe than lower limb weakness
    n1=en:myopathia | n2=en:upper limb muscle weakness may be more severe than lower limb weakness | rel=r_associated | relid=0 | w=5
  1403. en:myopathia -- r_associated #0: 5 / 0.143 -> en:upper limb weakness
    n1=en:myopathia | n2=en:upper limb weakness | rel=r_associated | relid=0 | w=5
  1404. en:myopathia -- r_associated #0: 5 / 0.143 -> en:usually a unilateral disorder
    n1=en:myopathia | n2=en:usually a unilateral disorder | rel=r_associated | relid=0 | w=5
  1405. en:myopathia -- r_associated #0: 5 / 0.143 -> en:usually no myopathic changes on biopsy
    n1=en:myopathia | n2=en:usually no myopathic changes on biopsy | rel=r_associated | relid=0 | w=5
  1406. en:myopathia -- r_associated #0: 5 / 0.143 -> en:uterine muscle may be stiff during pregnancy
    n1=en:myopathia | n2=en:uterine muscle may be stiff during pregnancy | rel=r_associated | relid=0 | w=5
  1407. en:myopathia -- r_associated #0: 5 / 0.143 -> en:vacuolar degeneration
    n1=en:myopathia | n2=en:vacuolar degeneration | rel=r_associated | relid=0 | w=5
  1408. en:myopathia -- r_associated #0: 5 / 0.143 -> en:vacuolar membranes immunostain with sarcolemmal proteins
    n1=en:myopathia | n2=en:vacuolar membranes immunostain with sarcolemmal proteins | rel=r_associated | relid=0 | w=5
  1409. en:myopathia -- r_associated #0: 5 / 0.143 -> en:vacuolar myopathy
    n1=en:myopathia | n2=en:vacuolar myopathy | rel=r_associated | relid=0 | w=5
  1410. en:myopathia -- r_associated #0: 5 / 0.143 -> en:vacuolar myopathy may occur
    n1=en:myopathia | n2=en:vacuolar myopathy may occur | rel=r_associated | relid=0 | w=5
  1411. en:myopathia -- r_associated #0: 5 / 0.143 -> en:vacuolated muscle fibers show reduplication of the basement membrane
    n1=en:myopathia | n2=en:vacuolated muscle fibers show reduplication of the basement membrane | rel=r_associated | relid=0 | w=5
  1412. en:myopathia -- r_associated #0: 5 / 0.143 -> en:vacuoles appear to be exocytosing material at the cell surface
    n1=en:myopathia | n2=en:vacuoles appear to be exocytosing material at the cell surface | rel=r_associated | relid=0 | w=5
  1413. en:myopathia -- r_associated #0: 5 / 0.143 -> en:vacuoles are autophagocytic
    n1=en:myopathia | n2=en:vacuoles are autophagocytic | rel=r_associated | relid=0 | w=5
  1414. en:myopathia -- r_associated #0: 5 / 0.143 -> en:vacuoles are autophagocytic and contain granular and membranous cellular debris
    n1=en:myopathia | n2=en:vacuoles are autophagocytic and contain granular and membranous cellular debris | rel=r_associated | relid=0 | w=5
  1415. en:myopathia -- r_associated #0: 5 / 0.143 -> en:vacuoles containing neutral lipids seen on muscle biopsy
    n1=en:myopathia | n2=en:vacuoles containing neutral lipids seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1416. en:myopathia -- r_associated #0: 5 / 0.143 -> en:vacuoles predominantly in type 2 fibers seen on muscle biopsy
    n1=en:myopathia | n2=en:vacuoles predominantly in type 2 fibers seen on muscle biopsy | rel=r_associated | relid=0 | w=5
  1417. en:myopathia -- r_associated #0: 5 / 0.143 -> en:variability in fiber size
    n1=en:myopathia | n2=en:variability in fiber size | rel=r_associated | relid=0 | w=5
  1418. en:myopathia -- r_associated #0: 5 / 0.143 -> en:variable deficiencies of mitochondrial respiratory chain enzymes
    n1=en:myopathia | n2=en:variable deficiencies of mitochondrial respiratory chain enzymes | rel=r_associated | relid=0 | w=5
  1419. en:myopathia -- r_associated #0: 5 / 0.143 -> en:variable fiber size
    n1=en:myopathia | n2=en:variable fiber size | rel=r_associated | relid=0 | w=5
  1420. en:myopathia -- r_associated #0: 5 / 0.143 -> en:variation of fiber size and shape
    n1=en:myopathia | n2=en:variation of fiber size and shape | rel=r_associated | relid=0 | w=5
  1421. en:myopathia -- r_associated #0: 5 / 0.143 -> en:variation of myofiber diameter
    n1=en:myopathia | n2=en:variation of myofiber diameter | rel=r_associated | relid=0 | w=5
  1422. en:myopathia -- r_associated #0: 5 / 0.143 -> en:velopharyngeal muscle weakness
    n1=en:myopathia | n2=en:velopharyngeal muscle weakness | rel=r_associated | relid=0 | w=5
  1423. en:myopathia -- r_associated #0: 5 / 0.143 -> en:vertigo
    n1=en:myopathia | n2=en:vertigo | rel=r_associated | relid=0 | w=5
  1424. en:myopathia -- r_associated #0: 5 / 0.143 -> en:walking may be limited
    n1=en:myopathia | n2=en:walking may be limited | rel=r_associated | relid=0 | w=5
  1425. en:myopathia -- r_associated #0: 5 / 0.143 -> en:wasted lower leg muscles
    n1=en:myopathia | n2=en:wasted lower leg muscles | rel=r_associated | relid=0 | w=5
  1426. en:myopathia -- r_associated #0: 5 / 0.143 -> en:wasting, especially temporal, neck, and facial muscles
    n1=en:myopathia | n2=en:wasting, especially temporal, neck, and facial muscles | rel=r_associated | relid=0 | w=5
  1427. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weak extraocular muscles
    n1=en:myopathia | n2=en:weak extraocular muscles | rel=r_associated | relid=0 | w=5
  1428. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness and wasting of the lower limbs
    n1=en:myopathia | n2=en:weakness and wasting of the lower limbs | rel=r_associated | relid=0 | w=5
  1429. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness of all intrinsic hand muscles (later)
    n1=en:myopathia | n2=en:weakness of all intrinsic hand muscles (later) | rel=r_associated | relid=0 | w=5
  1430. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness of ankle and toe extensor (dorsiflexor) muscles
    n1=en:myopathia | n2=en:weakness of ankle and toe extensor (dorsiflexor) muscles | rel=r_associated | relid=0 | w=5
  1431. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness of ankle plantar flexion
    n1=en:myopathia | n2=en:weakness of ankle plantar flexion | rel=r_associated | relid=0 | w=5
  1432. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness of anterior compartment tibial muscles
    n1=en:myopathia | n2=en:weakness of anterior compartment tibial muscles | rel=r_associated | relid=0 | w=5
  1433. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness of long finger extensor muscles (occurs later)
    n1=en:myopathia | n2=en:weakness of long finger extensor muscles (occurs later) | rel=r_associated | relid=0 | w=5
  1434. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness of neck extensors (rare)
    n1=en:myopathia | n2=en:weakness of neck extensors (rare) | rel=r_associated | relid=0 | w=5
  1435. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness of neck muscles may occur later
    n1=en:myopathia | n2=en:weakness of neck muscles may occur later | rel=r_associated | relid=0 | w=5
  1436. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness of the anterior tibial muscle and toe extensors
    n1=en:myopathia | n2=en:weakness of the anterior tibial muscle and toe extensors | rel=r_associated | relid=0 | w=5
  1437. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness of the extensor muscles of the hands (initially)
    n1=en:myopathia | n2=en:weakness of the extensor muscles of the hands (initially) | rel=r_associated | relid=0 | w=5
  1438. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness of the intrinsic hand muscles (in some patients)
    n1=en:myopathia | n2=en:weakness of the intrinsic hand muscles (in some patients) | rel=r_associated | relid=0 | w=5
  1439. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle)
    n1=en:myopathia | n2=en:weakness of the muscles in the anterior compartment of the lower leg (particularly the tibialis anterior muscle) | rel=r_associated | relid=0 | w=5
  1440. en:myopathia -- r_associated #0: 5 / 0.143 -> en:weakness, axial and limb muscles, upper limb muscles more affected than lower limbs
    n1=en:myopathia | n2=en:weakness, axial and limb muscles, upper limb muscles more affected than lower limbs | rel=r_associated | relid=0 | w=5
  1441. en:myopathia -- r_associated #0: 5 / 0.143 -> en:wheelchair dependency in 20% of patients by age 40
    n1=en:myopathia | n2=en:wheelchair dependency in 20% of patients by age 40 | rel=r_associated | relid=0 | w=5
  1442. en:myopathia -- r_associated #0: 5 / 0.143 -> en:wide variation in fiber size
    n1=en:myopathia | n2=en:wide variation in fiber size | rel=r_associated | relid=0 | w=5
  1443. en:myopathia -- r_associated #0: 5 / 0.143 -> en:with external ophthalmoplegia
    n1=en:myopathia | n2=en:with external ophthalmoplegia | rel=r_associated | relid=0 | w=5
  1444. en:myopathia -- r_associated #0: 5 / 0.143 -> en:wrist swelling
    n1=en:myopathia | n2=en:wrist swelling | rel=r_associated | relid=0 | w=5
  1445. en:myopathia -- r_associated #0: 5 / 0.143 -> en:z-band streaming
    n1=en:myopathia | n2=en:z-band streaming | rel=r_associated | relid=0 | w=5
  1446. en:myopathia -- r_associated #0: 5 / 0.143 -> en:z-disk degeneration
    n1=en:myopathia | n2=en:z-disk degeneration | rel=r_associated | relid=0 | w=5
  1447. en:myopathia -- r_associated #0: 5 / 0.143 -> en:z-disk streaming
    n1=en:myopathia | n2=en:z-disk streaming | rel=r_associated | relid=0 | w=5
  1448. en:myopathia -- r_associated #0: 5 / 0.143 -> en:z-disks with abnormal homogeneous material
    n1=en:myopathia | n2=en:z-disks with abnormal homogeneous material | rel=r_associated | relid=0 | w=5
  1449. en:myopathia -- r_associated #0: 5 / 0.143 -> en:z-line streaming see on electron microscopy
    n1=en:myopathia | n2=en:z-line streaming see on electron microscopy | rel=r_associated | relid=0 | w=5
  1450. en:myopathia -- r_associated #0: 5 / 0.143 -> Erb (myopathie d')
    n1=en:myopathia | n2=Erb (myopathie d') | rel=r_associated | relid=0 | w=5
  1451. en:myopathia -- r_associated #0: 5 / 0.143 -> externe
    n1=en:myopathia | n2=externe | rel=r_associated | relid=0 | w=5
  1452. en:myopathia -- r_associated #0: 5 / 0.143 -> faiblesse musculaire
    n1=en:myopathia | n2=faiblesse musculaire | rel=r_associated | relid=0 | w=5
  1453. en:myopathia -- r_associated #0: 5 / 0.143 -> fatigue musculaire
    n1=en:myopathia | n2=fatigue musculaire | rel=r_associated | relid=0 | w=5
  1454. en:myopathia -- r_associated #0: 5 / 0.143 -> glycogénose de type iii
    n1=en:myopathia | n2=glycogénose de type iii | rel=r_associated | relid=0 | w=5
  1455. en:myopathia -- r_associated #0: 5 / 0.143 -> hypoglycémie
    n1=en:myopathia | n2=hypoglycémie | rel=r_associated | relid=0 | w=5
  1456. en:myopathia -- r_associated #0: 5 / 0.143 -> hypogonadisme
    n1=en:myopathia | n2=hypogonadisme | rel=r_associated | relid=0 | w=5
  1457. en:myopathia -- r_associated #0: 5 / 0.143 -> Landouzy-Dejerine (myopathie de)
    n1=en:myopathia | n2=Landouzy-Dejerine (myopathie de) | rel=r_associated | relid=0 | w=5
  1458. en:myopathia -- r_associated #0: 5 / 0.143 -> Landouzy-Dejerine (myopathie facioscapulohumérale de)
    n1=en:myopathia | n2=Landouzy-Dejerine (myopathie facioscapulohumérale de) | rel=r_associated | relid=0 | w=5
  1459. en:myopathia -- r_associated #0: 5 / 0.143 -> Landouzy-Déjerine (myopathie facioscapulohumérale de)
    n1=en:myopathia | n2=Landouzy-Déjerine (myopathie facioscapulohumérale de) | rel=r_associated | relid=0 | w=5
  1460. en:myopathia -- r_associated #0: 5 / 0.143 -> Leyden-Moebius (myopathie de)
    n1=en:myopathia | n2=Leyden-Moebius (myopathie de) | rel=r_associated | relid=0 | w=5
  1461. en:myopathia -- r_associated #0: 5 / 0.143 -> lombo-pelvifémorale (myopathie)
    n1=en:myopathia | n2=lombo-pelvifémorale (myopathie) | rel=r_associated | relid=0 | w=5
  1462. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie d'Illingworth-Cori-Forbes
    n1=en:myopathia | n2=maladie d'Illingworth-Cori-Forbes | rel=r_associated | relid=0 | w=5
  1463. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie de Cori
    n1=en:myopathia | n2=maladie de Cori | rel=r_associated | relid=0 | w=5
  1464. en:myopathia -- r_associated #0: 5 / 0.143 -> Maladie de Cori
    n1=en:myopathia | n2=Maladie de Cori | rel=r_associated | relid=0 | w=5
  1465. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie de Forbes
    n1=en:myopathia | n2=maladie de Forbes | rel=r_associated | relid=0 | w=5
  1466. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie de la peau
    n1=en:myopathia | n2=maladie de la peau | rel=r_associated | relid=0 | w=5
  1467. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie de Landouzy-Déjerine
    n1=en:myopathia | n2=maladie de Landouzy-Déjerine | rel=r_associated | relid=0 | w=5
  1468. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie de landouzy-déjerine
    n1=en:myopathia | n2=maladie de landouzy-déjerine | rel=r_associated | relid=0 | w=5
  1469. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie de langueur
    n1=en:myopathia | n2=maladie de langueur | rel=r_associated | relid=0 | w=5
  1470. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie de peau
    n1=en:myopathia | n2=maladie de peau | rel=r_associated | relid=0 | w=5
  1471. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie de steinert
    n1=en:myopathia | n2=maladie de steinert | rel=r_associated | relid=0 | w=5
  1472. en:myopathia -- r_associated #0: 5 / 0.143 -> Maladie dégénérative
    n1=en:myopathia | n2=Maladie dégénérative | rel=r_associated | relid=0 | w=5
  1473. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie dermatologique
    n1=en:myopathia | n2=maladie dermatologique | rel=r_associated | relid=0 | w=5
  1474. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie du myocarde
    n1=en:myopathia | n2=maladie du myocarde | rel=r_associated | relid=0 | w=5
  1475. en:myopathia -- r_associated #0: 5 / 0.143 -> maladie du noyau central
    n1=en:myopathia | n2=maladie du noyau central | rel=r_associated | relid=0 | w=5
  1476. en:myopathia -- r_associated #0: 5 / 0.143 -> Maladies
    n1=en:myopathia | n2=Maladies | rel=r_associated | relid=0 | w=5
  1477. en:myopathia -- r_associated #0: 5 / 0.143 -> mental
    n1=en:myopathia | n2=mental | rel=r_associated | relid=0 | w=5
  1478. en:myopathia -- r_associated #0: 5 / 0.143 -> multicore
    n1=en:myopathia | n2=multicore | rel=r_associated | relid=0 | w=5
  1479. en:myopathia -- r_associated #0: 5 / 0.143 -> multicore (myopathie à )
    n1=en:myopathia | n2=multicore (myopathie à ) | rel=r_associated | relid=0 | w=5
  1480. en:myopathia -- r_associated #0: 5 / 0.143 -> multiples
    n1=en:myopathia | n2=multiples | rel=r_associated | relid=0 | w=5
  1481. en:myopathia -- r_associated #0: 5 / 0.143 -> myocardiopathie
    n1=en:myopathia | n2=myocardiopathie | rel=r_associated | relid=0 | w=5
  1482. en:myopathia -- r_associated #0: 5 / 0.143 -> Myofasciite à macrophages
    n1=en:myopathia | n2=Myofasciite à macrophages | rel=r_associated | relid=0 | w=5
  1483. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie à central core
    n1=en:myopathia | n2=myopathie à central core | rel=r_associated | relid=0 | w=5
  1484. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie à cores centraux
    n1=en:myopathia | n2=myopathie à cores centraux | rel=r_associated | relid=0 | w=5
  1485. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie à corps d'inclusion
    n1=en:myopathia | n2=myopathie à corps d'inclusion | rel=r_associated | relid=0 | w=5
  1486. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie à corps granuleux
    n1=en:myopathia | n2=myopathie à corps granuleux | rel=r_associated | relid=0 | w=5
  1487. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie à foyers multiples
    n1=en:myopathia | n2=myopathie à foyers multiples | rel=r_associated | relid=0 | w=5
  1488. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie à inclusion
    n1=en:myopathia | n2=myopathie à inclusion | rel=r_associated | relid=0 | w=5
  1489. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie à némaline
    n1=en:myopathia | n2=myopathie à némaline | rel=r_associated | relid=0 | w=5
  1490. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie à stockage de polysaccharides
    n1=en:myopathia | n2=myopathie à stockage de polysaccharides | rel=r_associated | relid=0 | w=5
  1491. en:myopathia -- r_associated #0: 5 / 0.143 -> Myopathie à stockage de polysaccharides
    n1=en:myopathia | n2=Myopathie à stockage de polysaccharides | rel=r_associated | relid=0 | w=5
  1492. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie atrophique
    n1=en:myopathia | n2=myopathie atrophique | rel=r_associated | relid=0 | w=5
  1493. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie avec acidose lactique et anémie sidéroblastique
    n1=en:myopathia | n2=myopathie avec acidose lactique et anémie sidéroblastique | rel=r_associated | relid=0 | w=5
  1494. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie avec surcharge en desmine
    n1=en:myopathia | n2=myopathie avec surcharge en desmine | rel=r_associated | relid=0 | w=5
  1495. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie centro-lobulaire
    n1=en:myopathia | n2=myopathie centro-lobulaire | rel=r_associated | relid=0 | w=5
  1496. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie centro-nucléaire
    n1=en:myopathia | n2=myopathie centro-nucléaire | rel=r_associated | relid=0 | w=5
  1497. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie centrolobulaire
    n1=en:myopathia | n2=myopathie centrolobulaire | rel=r_associated | relid=0 | w=5
  1498. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie centronucléaire
    n1=en:myopathia | n2=myopathie centronucléaire | rel=r_associated | relid=0 | w=5
  1499. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie congénitale à central core
    n1=en:myopathia | n2=myopathie congénitale à central core | rel=r_associated | relid=0 | w=5
  1500. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie congénitale à cores centraux
    n1=en:myopathia | n2=myopathie congénitale à cores centraux | rel=r_associated | relid=0 | w=5
  1501. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie congénitale à déficit en collagène VI
    n1=en:myopathia | n2=myopathie congénitale à déficit en collagène VI | rel=r_associated | relid=0 | w=5
  1502. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie congénitale à déficit en mérosine
    n1=en:myopathia | n2=myopathie congénitale à déficit en mérosine | rel=r_associated | relid=0 | w=5
  1503. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie congénitale à foyers multiples
    n1=en:myopathia | n2=myopathie congénitale à foyers multiples | rel=r_associated | relid=0 | w=5
  1504. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie congénitale à noyaux centraux
    n1=en:myopathia | n2=myopathie congénitale à noyaux centraux | rel=r_associated | relid=0 | w=5
  1505. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie congénitale des fibres lentes
    n1=en:myopathia | n2=myopathie congénitale des fibres lentes | rel=r_associated | relid=0 | w=5
  1506. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie congénitale des fibres rapides
    n1=en:myopathia | n2=myopathie congénitale des fibres rapides | rel=r_associated | relid=0 | w=5
  1507. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie d'erb
    n1=en:myopathia | n2=myopathie d'erb | rel=r_associated | relid=0 | w=5
  1508. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie d'Erb
    n1=en:myopathia | n2=myopathie d'Erb | rel=r_associated | relid=0 | w=5
  1509. en:myopathia -- r_associated #0: 5 / 0.143 -> Myopathie de Bethlem
    n1=en:myopathia | n2=Myopathie de Bethlem | rel=r_associated | relid=0 | w=5
  1510. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de Bethlem
    n1=en:myopathia | n2=myopathie de Bethlem | rel=r_associated | relid=0 | w=5
  1511. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de Centronucléaire
    n1=en:myopathia | n2=myopathie de Centronucléaire | rel=r_associated | relid=0 | w=5
  1512. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de Congenital Fiber-Type Disproportion
    n1=en:myopathia | n2=myopathie de Congenital Fiber-Type Disproportion | rel=r_associated | relid=0 | w=5
  1513. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de desminopathie
    n1=en:myopathia | n2=myopathie de desminopathie | rel=r_associated | relid=0 | w=5
  1514. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de distale
    n1=en:myopathia | n2=myopathie de distale | rel=r_associated | relid=0 | w=5
  1515. en:myopathia -- r_associated #0: 5 / 0.143 -> Myopathie de Duchenne
    n1=en:myopathia | n2=Myopathie de Duchenne | rel=r_associated | relid=0 | w=5
  1516. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de Facioscapulohumérale
    n1=en:myopathia | n2=myopathie de Facioscapulohumérale | rel=r_associated | relid=0 | w=5
  1517. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de Limb-girdle
    n1=en:myopathia | n2=myopathie de Limb-girdle | rel=r_associated | relid=0 | w=5
  1518. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de Minicore
    n1=en:myopathia | n2=myopathie de Minicore | rel=r_associated | relid=0 | w=5
  1519. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de Miotubulaire
    n1=en:myopathia | n2=myopathie de Miotubulaire | rel=r_associated | relid=0 | w=5
  1520. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de Miyoshi
    n1=en:myopathia | n2=myopathie de Miyoshi | rel=r_associated | relid=0 | w=5
  1521. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de Myofibrillaire
    n1=en:myopathia | n2=myopathie de Myofibrillaire | rel=r_associated | relid=0 | w=5
  1522. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de Rigid Spine Syndrome
    n1=en:myopathia | n2=myopathie de Rigid Spine Syndrome | rel=r_associated | relid=0 | w=5
  1523. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de Scapulopéricardique
    n1=en:myopathia | n2=myopathie de Scapulopéricardique | rel=r_associated | relid=0 | w=5
  1524. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de type becker
    n1=en:myopathia | n2=myopathie de type becker | rel=r_associated | relid=0 | w=5
  1525. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie de type leyden-mobius
    n1=en:myopathia | n2=myopathie de type leyden-mobius | rel=r_associated | relid=0 | w=5
  1526. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures
    n1=en:myopathia | n2=myopathie des ceintures | rel=r_associated | relid=0 | w=5
  1527. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 1B
    n1=en:myopathia | n2=myopathie des ceintures de type 1B | rel=r_associated | relid=0 | w=5
  1528. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2A
    n1=en:myopathia | n2=myopathie des ceintures de type 2A | rel=r_associated | relid=0 | w=5
  1529. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2B
    n1=en:myopathia | n2=myopathie des ceintures de type 2B | rel=r_associated | relid=0 | w=5
  1530. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2C
    n1=en:myopathia | n2=myopathie des ceintures de type 2C | rel=r_associated | relid=0 | w=5
  1531. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2D
    n1=en:myopathia | n2=myopathie des ceintures de type 2D | rel=r_associated | relid=0 | w=5
  1532. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2E
    n1=en:myopathia | n2=myopathie des ceintures de type 2E | rel=r_associated | relid=0 | w=5
  1533. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2I
    n1=en:myopathia | n2=myopathie des ceintures de type 2I | rel=r_associated | relid=0 | w=5
  1534. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2L
    n1=en:myopathia | n2=myopathie des ceintures de type 2L | rel=r_associated | relid=0 | w=5
  1535. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2N
    n1=en:myopathia | n2=myopathie des ceintures de type 2N | rel=r_associated | relid=0 | w=5
  1536. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2O
    n1=en:myopathia | n2=myopathie des ceintures de type 2O | rel=r_associated | relid=0 | w=5
  1537. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2P
    n1=en:myopathia | n2=myopathie des ceintures de type 2P | rel=r_associated | relid=0 | w=5
  1538. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2Q
    n1=en:myopathia | n2=myopathie des ceintures de type 2Q | rel=r_associated | relid=0 | w=5
  1539. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2R
    n1=en:myopathia | n2=myopathie des ceintures de type 2R | rel=r_associated | relid=0 | w=5
  1540. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2S
    n1=en:myopathia | n2=myopathie des ceintures de type 2S | rel=r_associated | relid=0 | w=5
  1541. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2T
    n1=en:myopathia | n2=myopathie des ceintures de type 2T | rel=r_associated | relid=0 | w=5
  1542. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2U
    n1=en:myopathia | n2=myopathie des ceintures de type 2U | rel=r_associated | relid=0 | w=5
  1543. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2V
    n1=en:myopathia | n2=myopathie des ceintures de type 2V | rel=r_associated | relid=0 | w=5
  1544. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2W
    n1=en:myopathia | n2=myopathie des ceintures de type 2W | rel=r_associated | relid=0 | w=5
  1545. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2X
    n1=en:myopathia | n2=myopathie des ceintures de type 2X | rel=r_associated | relid=0 | w=5
  1546. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2Y
    n1=en:myopathia | n2=myopathie des ceintures de type 2Y | rel=r_associated | relid=0 | w=5
  1547. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie des ceintures de type 2Z
    n1=en:myopathia | n2=myopathie des ceintures de type 2Z | rel=r_associated | relid=0 | w=5
  1548. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie distale de gowers
    n1=en:myopathia | n2=myopathie distale de gowers | rel=r_associated | relid=0 | w=5
  1549. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie distale de Udd
    n1=en:myopathia | n2=myopathie distale de Udd | rel=r_associated | relid=0 | w=5
  1550. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie distale tardive de Gowers
    n1=en:myopathia | n2=myopathie distale tardive de Gowers | rel=r_associated | relid=0 | w=5
  1551. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie distale type Nonaka
    n1=en:myopathia | n2=myopathie distale type Nonaka | rel=r_associated | relid=0 | w=5
  1552. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie du VIH
    n1=en:myopathia | n2=myopathie du VIH | rel=r_associated | relid=0 | w=5
  1553. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie en ceinture
    n1=en:myopathia | n2=myopathie en ceinture | rel=r_associated | relid=0 | w=5
  1554. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie et néphropathie
    n1=en:myopathia | n2=myopathie et néphropathie | rel=r_associated | relid=0 | w=5
  1555. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie facio-scapulo-humérale
    n1=en:myopathia | n2=myopathie facio-scapulo-humérale | rel=r_associated | relid=0 | w=5
  1556. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie infectieuse
    n1=en:myopathia | n2=myopathie infectieuse | rel=r_associated | relid=0 | w=5
  1557. en:myopathia -- r_associated #0: 5 / 0.143 -> Myopathie métabolique
    n1=en:myopathia | n2=Myopathie métabolique | rel=r_associated | relid=0 | w=5
  1558. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie métabolique d'origine génétique
    n1=en:myopathia | n2=myopathie métabolique d'origine génétique | rel=r_associated | relid=0 | w=5
  1559. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie minicore récessive
    n1=en:myopathia | n2=myopathie minicore récessive | rel=r_associated | relid=0 | w=5
  1560. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie mitochondriale
    n1=en:myopathia | n2=myopathie mitochondriale | rel=r_associated | relid=0 | w=5
  1561. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie mitochondriale avec délétion de l'ADN mitochondrial
    n1=en:myopathia | n2=myopathie mitochondriale avec délétion de l'ADN mitochondrial | rel=r_associated | relid=0 | w=5
  1562. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie multi-core
    n1=en:myopathia | n2=myopathie multi-core | rel=r_associated | relid=0 | w=5
  1563. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie multicore avec retard mental
    n1=en:myopathia | n2=myopathie multicore avec retard mental | rel=r_associated | relid=0 | w=5
  1564. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie multicore avec retard mental, petite taille et hypogonadisme hypogonadotrophique
    n1=en:myopathia | n2=myopathie multicore avec retard mental, petite taille et hypogonadisme hypogonadotrophique | rel=r_associated | relid=0 | w=5
  1565. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie myotonique
    n1=en:myopathia | n2=myopathie myotonique | rel=r_associated | relid=0 | w=5
  1566. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie myotonique, nanisme, chondrodystrophie, et anomalies oculaires et faciales
    n1=en:myopathia | n2=myopathie myotonique, nanisme, chondrodystrophie, et anomalies oculaires et faciales | rel=r_associated | relid=0 | w=5
  1567. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie myotubulaire
    n1=en:myopathia | n2=myopathie myotubulaire | rel=r_associated | relid=0 | w=5
  1568. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie némaline
    n1=en:myopathia | n2=myopathie némaline | rel=r_associated | relid=0 | w=5
  1569. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie non précisée
    n1=en:myopathia | n2=myopathie non précisée | rel=r_associated | relid=0 | w=5
  1570. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie oculaire avec sensibilité au curare
    n1=en:myopathia | n2=myopathie oculaire avec sensibilité au curare | rel=r_associated | relid=0 | w=5
  1571. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie primitive progressive
    n1=en:myopathia | n2=myopathie primitive progressive | rel=r_associated | relid=0 | w=5
  1572. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie primitive progressive de leyden-moebius
    n1=en:myopathia | n2=myopathie primitive progressive de leyden-moebius | rel=r_associated | relid=0 | w=5
  1573. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie pseudo-hypertrophique de becker
    n1=en:myopathia | n2=myopathie pseudo-hypertrophique de becker | rel=r_associated | relid=0 | w=5
  1574. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie pseudo-hypertrophique de duchenne, variété bénigne
    n1=en:myopathia | n2=myopathie pseudo-hypertrophique de duchenne, variété bénigne | rel=r_associated | relid=0 | w=5
  1575. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie pseudo-hypertrophique type Duchenne
    n1=en:myopathia | n2=myopathie pseudo-hypertrophique type Duchenne | rel=r_associated | relid=0 | w=5
  1576. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie pseudo-hypertrophique type duchenne
    n1=en:myopathia | n2=myopathie pseudo-hypertrophique type duchenne | rel=r_associated | relid=0 | w=5
  1577. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie pseudohypertrophique de Becker
    n1=en:myopathia | n2=myopathie pseudohypertrophique de Becker | rel=r_associated | relid=0 | w=5
  1578. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie samaritaine
    n1=en:myopathia | n2=myopathie samaritaine | rel=r_associated | relid=0 | w=5
  1579. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie scapulo-humérale d'erb
    n1=en:myopathia | n2=myopathie scapulo-humérale d'erb | rel=r_associated | relid=0 | w=5
  1580. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie toxique
    n1=en:myopathia | n2=myopathie toxique | rel=r_associated | relid=0 | w=5
  1581. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie tunisienne
    n1=en:myopathia | n2=myopathie tunisienne | rel=r_associated | relid=0 | w=5
  1582. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie type Bramwell
    n1=en:myopathia | n2=myopathie type Bramwell | rel=r_associated | relid=0 | w=5
  1583. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie type leyden-möbius
    n1=en:myopathia | n2=myopathie type leyden-möbius | rel=r_associated | relid=0 | w=5
  1584. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie viscérale familiale avec ophtalmoplégie externe
    n1=en:myopathia | n2=myopathie viscérale familiale avec ophtalmoplégie externe | rel=r_associated | relid=0 | w=5
  1585. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathie, cataracte, hypogonadisme (syndrome de)
    n1=en:myopathia | n2=myopathie, cataracte, hypogonadisme (syndrome de) | rel=r_associated | relid=0 | w=5
  1586. en:myopathia -- r_associated #0: 5 / 0.143 -> Myopathies
    n1=en:myopathia | n2=Myopathies | rel=r_associated | relid=0 | w=5
  1587. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathies (troubles digestifs des)
    n1=en:myopathia | n2=myopathies (troubles digestifs des) | rel=r_associated | relid=0 | w=5
  1588. en:myopathia -- r_associated #0: 5 / 0.143 -> myopathies métaboliques
    n1=en:myopathia | n2=myopathies métaboliques | rel=r_associated | relid=0 | w=5
  1589. en:myopathia -- r_associated #0: 5 / 0.143 -> myotonie atrophique
    n1=en:myopathia | n2=myotonie atrophique | rel=r_associated | relid=0 | w=5
  1590. en:myopathia -- r_associated #0: 5 / 0.143 -> myotonie dystrophique
    n1=en:myopathia | n2=myotonie dystrophique | rel=r_associated | relid=0 | w=5
  1591. en:myopathia -- r_associated #0: 5 / 0.143 -> myotubulaire (myopathie)
    n1=en:myopathia | n2=myotubulaire (myopathie) | rel=r_associated | relid=0 | w=5
  1592. en:myopathia -- r_associated #0: 5 / 0.143 -> nanisme, retard mental, anomalies oculaires
    n1=en:myopathia | n2=nanisme, retard mental, anomalies oculaires | rel=r_associated | relid=0 | w=5
  1593. en:myopathia -- r_associated #0: 5 / 0.143 -> némaline (myopathie à)
    n1=en:myopathia | n2=némaline (myopathie à) | rel=r_associated | relid=0 | w=5
  1594. en:myopathia -- r_associated #0: 5 / 0.143 -> Nevin (myopathie de type)
    n1=en:myopathia | n2=Nevin (myopathie de type) | rel=r_associated | relid=0 | w=5
  1595. en:myopathia -- r_associated #0: 5 / 0.143 -> opacité du cristallin
    n1=en:myopathia | n2=opacité du cristallin | rel=r_associated | relid=0 | w=5
  1596. en:myopathia -- r_associated #0: 5 / 0.143 -> opacités cornéennes cristallines, myopathie et néphropathie
    n1=en:myopathia | n2=opacités cornéennes cristallines, myopathie et néphropathie | rel=r_associated | relid=0 | w=5
  1597. en:myopathia -- r_associated #0: 5 / 0.143 -> ophtalmoplégie
    n1=en:myopathia | n2=ophtalmoplégie | rel=r_associated | relid=0 | w=5
  1598. en:myopathia -- r_associated #0: 5 / 0.143 -> ophtalmoplégie et myopathie
    n1=en:myopathia | n2=ophtalmoplégie et myopathie | rel=r_associated | relid=0 | w=5
  1599. en:myopathia -- r_associated #0: 5 / 0.143 -> ophtalmoplégie externe progressive, myopathie proximale et mort subite
    n1=en:myopathia | n2=ophtalmoplégie externe progressive, myopathie proximale et mort subite | rel=r_associated | relid=0 | w=5
  1600. en:myopathia -- r_associated #0: 5 / 0.143 -> polykystique
    n1=en:myopathia | n2=polykystique | rel=r_associated | relid=0 | w=5
  1601. en:myopathia -- r_associated #0: 5 / 0.143 -> rein
    n1=en:myopathia | n2=rein | rel=r_associated | relid=0 | w=5
  1602. en:myopathia -- r_associated #0: 5 / 0.143 -> rein polykystique, cataracte et cécité congénitale
    n1=en:myopathia | n2=rein polykystique, cataracte et cécité congénitale | rel=r_associated | relid=0 | w=5
  1603. en:myopathia -- r_associated #0: 5 / 0.143 -> retard
    n1=en:myopathia | n2=retard | rel=r_associated | relid=0 | w=5
  1604. en:myopathia -- r_associated #0: 5 / 0.143 -> rhabdomyolyse
    n1=en:myopathia | n2=rhabdomyolyse | rel=r_associated | relid=0 | w=5
  1605. en:myopathia -- r_associated #0: 5 / 0.143 -> signes biologiques de la mort
    n1=en:myopathia | n2=signes biologiques de la mort | rel=r_associated | relid=0 | w=5
  1606. en:myopathia -- r_associated #0: 5 / 0.143 -> sphérocytose
    n1=en:myopathia | n2=sphérocytose | rel=r_associated | relid=0 | w=5
  1607. en:myopathia -- r_associated #0: 5 / 0.143 -> statines
    n1=en:myopathia | n2=statines | rel=r_associated | relid=0 | w=5
  1608. en:myopathia -- r_associated #0: 5 / 0.143 -> Steinert (dystonie myotonique de)
    n1=en:myopathia | n2=Steinert (dystonie myotonique de) | rel=r_associated | relid=0 | w=5
  1609. en:myopathia -- r_associated #0: 5 / 0.143 -> Steinert (maladie de)
    n1=en:myopathia | n2=Steinert (maladie de) | rel=r_associated | relid=0 | w=5
  1610. en:myopathia -- r_associated #0: 5 / 0.143 -> Stormoken (syndrome de)
    n1=en:myopathia | n2=Stormoken (syndrome de) | rel=r_associated | relid=0 | w=5
  1611. en:myopathia -- r_associated #0: 5 / 0.143 -> surdité
    n1=en:myopathia | n2=surdité | rel=r_associated | relid=0 | w=5
  1612. en:myopathia -- r_associated #0: 5 / 0.143 -> surdité et démence ou psychose
    n1=en:myopathia | n2=surdité et démence ou psychose | rel=r_associated | relid=0 | w=5
  1613. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome
    n1=en:myopathia | n2=syndrome | rel=r_associated | relid=0 | w=5
  1614. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome cataracte-ataxie-surdité et retard mental
    n1=en:myopathia | n2=syndrome cataracte-ataxie-surdité et retard mental | rel=r_associated | relid=0 | w=5
  1615. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome cataracte, microcéphalie, arrêt de croissance et cyphoscoliose
    n1=en:myopathia | n2=syndrome cataracte, microcéphalie, arrêt de croissance et cyphoscoliose | rel=r_associated | relid=0 | w=5
  1616. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome d'Ehlers Danlos avec cyphoscoliose, myopathie et surdité
    n1=en:myopathia | n2=syndrome d'Ehlers Danlos avec cyphoscoliose, myopathie et surdité | rel=r_associated | relid=0 | w=5
  1617. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome de
    n1=en:myopathia | n2=syndrome de | rel=r_associated | relid=0 | w=5
  1618. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome de kearns et sayre
    n1=en:myopathia | n2=syndrome de kearns et sayre | rel=r_associated | relid=0 | w=5
  1619. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome de Kearns et Sayre
    n1=en:myopathia | n2=syndrome de Kearns et Sayre | rel=r_associated | relid=0 | w=5
  1620. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome de Kearns-Sayre
    n1=en:myopathia | n2=syndrome de Kearns-Sayre | rel=r_associated | relid=0 | w=5
  1621. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome des cils longs
    n1=en:myopathia | n2=syndrome des cils longs | rel=r_associated | relid=0 | w=5
  1622. en:myopathia -- r_associated #0: 5 / 0.143 -> Syndrome MELAS
    n1=en:myopathia | n2=Syndrome MELAS | rel=r_associated | relid=0 | w=5
  1623. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome melas
    n1=en:myopathia | n2=syndrome melas | rel=r_associated | relid=0 | w=5
  1624. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome muscle-eye-brain
    n1=en:myopathia | n2=syndrome muscle-eye-brain | rel=r_associated | relid=0 | w=5
  1625. en:myopathia -- r_associated #0: 5 / 0.143 -> syndrome myopathie à inclusions - maladie de Paget - démence fronto-temporale
    n1=en:myopathia | n2=syndrome myopathie à inclusions - maladie de Paget - démence fronto-temporale | rel=r_associated | relid=0 | w=5
  1626. en:myopathia -- r_associated #0: 5 / 0.143 -> tibiale (myopathie)
    n1=en:myopathia | n2=tibiale (myopathie) | rel=r_associated | relid=0 | w=5
  1627. en:myopathia -- r_associated #0: 5 / 0.143 -> trichomégalie
    n1=en:myopathia | n2=trichomégalie | rel=r_associated | relid=0 | w=5
  1628. en:myopathia -- r_associated #0: 5 / 0.143 -> trichomégalie avec retard mental, nanisme, et dégénérescence pigmentée de la rétine
    n1=en:myopathia | n2=trichomégalie avec retard mental, nanisme, et dégénérescence pigmentée de la rétine | rel=r_associated | relid=0 | w=5
  1629. en:myopathia -- r_associated #0: 5 / 0.143 -> trichomégalie-cataracte-sphérocytose
    n1=en:myopathia | n2=trichomégalie-cataracte-sphérocytose | rel=r_associated | relid=0 | w=5
  1630. en:myopathia -- r_associated #0: 5 / 0.143 -> trouble myocardique
    n1=en:myopathia | n2=trouble myocardique | rel=r_associated | relid=0 | w=5
  1631. en:myopathia -- r_associated #0: 5 / 0.143 -> Ullrich (myopathie d')
    n1=en:myopathia | n2=Ullrich (myopathie d') | rel=r_associated | relid=0 | w=5
  1632. en:myopathia -- r_associated #0: 5 / 0.143 -> VIH (myopathie du)
    n1=en:myopathia | n2=VIH (myopathie du) | rel=r_associated | relid=0 | w=5
  1633. en:myopathia -- r_associated #0: 5 / 0.143 -> Walker-Warburg (syndrome de)
    n1=en:myopathia | n2=Walker-Warburg (syndrome de) | rel=r_associated | relid=0 | w=5
  1634. en:myopathia -- r_associated #0: 5 / 0.143 -> Walton et Nattrass (myopathie de)
    n1=en:myopathia | n2=Walton et Nattrass (myopathie de) | rel=r_associated | relid=0 | w=5
≈ 60 relations entrantes

  1. en:myopathy --- r_associated #0: 80 --> en:myopathia
    n1=en:myopathy | n2=en:myopathia | rel=r_associated | relid=0 | w=80
  2. maladie du muscle --- r_associated #0: 79 --> en:myopathia
    n1=maladie du muscle | n2=en:myopathia | rel=r_associated | relid=0 | w=79
  3. myopathie --- r_associated #0: 76 --> en:myopathia
    n1=myopathie | n2=en:myopathia | rel=r_associated | relid=0 | w=76
  4. maladie musculaire --- r_associated #0: 66 --> en:myopathia
    n1=maladie musculaire | n2=en:myopathia | rel=r_associated | relid=0 | w=66
  5. myopathy --- r_associated #0: 63 --> en:myopathia
    n1=myopathy | n2=en:myopathia | rel=r_associated | relid=0 | w=63
  6. myopathie atypique --- r_associated #0: 50 --> en:myopathia
    n1=myopathie atypique | n2=en:myopathia | rel=r_associated | relid=0 | w=50
  7. en:myonosus --- r_associated #0: 30 --> en:myopathia
    n1=en:myonosus | n2=en:myopathia | rel=r_associated | relid=0 | w=30
  8. myopathie multicore congénitale avec ophtalmoplégie externe --- r_associated #0: 28 --> en:myopathia
    n1=myopathie multicore congénitale avec ophtalmoplégie externe | n2=en:myopathia | rel=r_associated | relid=0 | w=28
  9. syndrome de myopathie, cataracte, hypogonadisme --- r_associated #0: 28 --> en:myopathia
    n1=syndrome de myopathie, cataracte, hypogonadisme | n2=en:myopathia | rel=r_associated | relid=0 | w=28
  10. myopathie à axes multiples --- r_associated #0: 21 --> en:myopathia
    n1=myopathie à axes multiples | n2=en:myopathia | rel=r_associated | relid=0 | w=21
  11. myopathies --- r_associated #0: 21 --> en:myopathia
    n1=myopathies | n2=en:myopathia | rel=r_associated | relid=0 | w=21
  12. PTPN22 gene --- r_associated #0: 20 --> en:myopathia
    n1=PTPN22 gene | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  13. affection musculaire --- r_associated #0: 20 --> en:myopathia
    n1=affection musculaire | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  14. arthrogrypose --- r_associated #0: 20 --> en:myopathia
    n1=arthrogrypose | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  15. atrophie --- r_associated #0: 20 --> en:myopathia
    n1=atrophie | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  16. desmoïde --- r_associated #0: 20 --> en:myopathia
    n1=desmoïde | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  17. dystrophie musculaire --- r_associated #0: 20 --> en:myopathia
    n1=dystrophie musculaire | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  18. en:central nervous system --- r_associated #0: 20 --> en:myopathia
    n1=en:central nervous system | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  19. en:other and unspecified myopathies --- r_associated #0: 20 --> en:myopathia
    n1=en:other and unspecified myopathies | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  20. en:soft tissue disorder --- r_associated #0: 20 --> en:myopathia
    n1=en:soft tissue disorder | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  21. encéphalomyopathie, acidose lactique et accidents vasculaires cérébraux --- r_associated #0: 20 --> en:myopathia
    n1=encéphalomyopathie, acidose lactique et accidents vasculaires cérébraux | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  22. glycogénose de type III --- r_associated #0: 20 --> en:myopathia
    n1=glycogénose de type III | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  23. maladie --- r_associated #0: 20 --> en:myopathia
    n1=maladie | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  24. maladie dégénérative --- r_associated #0: 20 --> en:myopathia
    n1=maladie dégénérative | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  25. maladie génétique --- r_associated #0: 20 --> en:myopathia
    n1=maladie génétique | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  26. maladie héréditaire --- r_associated #0: 20 --> en:myopathia
    n1=maladie héréditaire | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  27. musculaire --- r_associated #0: 20 --> en:myopathia
    n1=musculaire | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  28. myoadénylate désaminase --- r_associated #0: 20 --> en:myopathia
    n1=myoadénylate désaminase | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  29. myofasciite à macrophages --- r_associated #0: 20 --> en:myopathia
    n1=myofasciite à macrophages | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  30. myopathie de Duchenne --- r_associated #0: 20 --> en:myopathia
    n1=myopathie de Duchenne | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  31. myopathie métabolique --- r_associated #0: 20 --> en:myopathia
    n1=myopathie métabolique | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  32. myopathie à bâtonnets --- r_associated #0: 20 --> en:myopathia
    n1=myopathie à bâtonnets | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  33. myopathique --- r_associated #0: 20 --> en:myopathia
    n1=myopathique | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  34. médecine --- r_associated #0: 20 --> en:myopathia
    n1=médecine | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  35. pathologie
    (maladie)
     --- r_associated #0: 20 --> en:myopathia
    n1=pathologie
    (maladie)
    | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  36. syndrome MEB --- r_associated #0: 20 --> en:myopathia
    n1=syndrome MEB | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  37. syndrome MELAS --- r_associated #0: 20 --> en:myopathia
    n1=syndrome MELAS | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  38. syndrome Muscle-Eye-Brain --- r_associated #0: 20 --> en:myopathia
    n1=syndrome Muscle-Eye-Brain | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  39. syndrome de Walker-Warburg --- r_associated #0: 20 --> en:myopathia
    n1=syndrome de Walker-Warburg | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  40. syndrome myopathique --- r_associated #0: 20 --> en:myopathia
    n1=syndrome myopathique | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  41. troubles musculaires --- r_associated #0: 20 --> en:myopathia
    n1=troubles musculaires | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  42. xyphoïdalgie --- r_associated #0: 20 --> en:myopathia
    n1=xyphoïdalgie | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  43. épilepsie myoclonique à fibres rouges en lambeau --- r_associated #0: 20 --> en:myopathia
    n1=épilepsie myoclonique à fibres rouges en lambeau | n2=en:myopathia | rel=r_associated | relid=0 | w=20
  44. dextrinose limite --- r_associated #0: 15 --> en:myopathia
    n1=dextrinose limite | n2=en:myopathia | rel=r_associated | relid=0 | w=15
  45. maladie d'Illingworth-Cori-Forbes --- r_associated #0: 15 --> en:myopathia
    n1=maladie d'Illingworth-Cori-Forbes | n2=en:myopathia | rel=r_associated | relid=0 | w=15
  46. maladie de Cori --- r_associated #0: 15 --> en:myopathia
    n1=maladie de Cori | n2=en:myopathia | rel=r_associated | relid=0 | w=15
  47. maladie de Forbes --- r_associated #0: 15 --> en:myopathia
    n1=maladie de Forbes | n2=en:myopathia | rel=r_associated | relid=0 | w=15
  48. Myopathie --- r_associated #0: 10 --> en:myopathia
    n1=Myopathie | n2=en:myopathia | rel=r_associated | relid=0 | w=10
  49. en:arthrogryposis --- r_associated #0: 10 --> en:myopathia
    n1=en:arthrogryposis | n2=en:myopathia | rel=r_associated | relid=0 | w=10
  50. en:multiple core myopathy --- r_associated #0: 10 --> en:myopathia
    n1=en:multiple core myopathy | n2=en:myopathia | rel=r_associated | relid=0 | w=10
  51. en:muscular dystrophy --- r_associated #0: 10 --> en:myopathia
    n1=en:muscular dystrophy | n2=en:myopathia | rel=r_associated | relid=0 | w=10
  52. en:myodystrophia --- r_associated #0: 10 --> en:myopathia
    n1=en:myodystrophia | n2=en:myopathia | rel=r_associated | relid=0 | w=10
  53. myopathe (anesthésie d'un) --- r_associated #0: 10 --> en:myopathia
    n1=myopathe (anesthésie d'un) | n2=en:myopathia | rel=r_associated | relid=0 | w=10
  54. ARTHROGRYPOSE --- r_associated #0: 5 --> en:myopathia
    n1=ARTHROGRYPOSE | n2=en:myopathia | rel=r_associated | relid=0 | w=5
  55. Maladie dégénérative --- r_associated #0: 5 --> en:myopathia
    n1=Maladie dégénérative | n2=en:myopathia | rel=r_associated | relid=0 | w=5
  56. Maladie génétique --- r_associated #0: 5 --> en:myopathia
    n1=Maladie génétique | n2=en:myopathia | rel=r_associated | relid=0 | w=5
  57. Maladie héréditaire --- r_associated #0: 5 --> en:myopathia
    n1=Maladie héréditaire | n2=en:myopathia | rel=r_associated | relid=0 | w=5
  58. Syndrome MELAS --- r_associated #0: 5 --> en:myopathia
    n1=Syndrome MELAS | n2=en:myopathia | rel=r_associated | relid=0 | w=5
  59. Syndrome de Walker-Warburg --- r_associated #0: 5 --> en:myopathia
    n1=Syndrome de Walker-Warburg | n2=en:myopathia | rel=r_associated | relid=0 | w=5
  60. en:rod disease --- r_associated #0: 5 --> en:myopathia
    n1=en:rod disease | n2=en:myopathia | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr